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Zusammenfassung 
 
Die Stabilität unseres Genoms wird kontinuierlich durch endogene und exogene 
Faktoren gefährdet. Es entstehen Fehler in der DNA Sequenz, die durch DNA 
Reparaturmechanismen ausgebessert werden. Kommt es nicht dazu kann dies 
dauerhafte Mutationen zur Folge haben. Diese können zur Entstehung von Krankheiten 
und zur Entwicklung von Tumoren führen. Für die Reparatur der verschiedenen DNA 
Schäden gibt es entsprechend unterschiedliche Mechanismen. Eines der Hauptproteine 
in der Erkennung und Reparatur von DNA Doppelstrangbrüchen ist Nibrin (NBN). 
Mutationen von NBN führen im Menschen zur erblichen Krankheit Nijmegen-
Breakage-Syndrom (NBS) (Varon et al.,1998). Zu dem typischen Erscheinungsbild von 
NBS Patienten gehört das Auftreten von Mikrozephalie, Immunschwäche, erhöhte 
Empfindlichkeit gegenüber Strahlungen und eine Veranlagung zur Entwicklung von 
Tumoren (Varon et al.,1998; Cybulski et al.,2004; Assaf et al.,2008; Bogdanova et 
al.,2008; Huang et al.,2008; Watanabe et al.,2009). Des Weiteren zeigen diese Patienten 
unterschiedliche Veränderungen der Haut und deren Bestandteile. So kommt es zu einer 
Veränderung der Pigmentierung und Porokeratose sowie vereinzelten und dünnen 
Haaren (van der Burgt et al.,1996; Group,2000; Wolf and Shwayder,2009; 
Chrzanowska et al.,2012). Auch wurden Mutationen von NBN in malignen Melanomen 
festgestellt (Debniak et al.,2003; Thirumaran et al.,2006; Meyer et al.,2007). Da unsere 
Haut die Barriere unseres Köpers ist und ihn vor äußeren Einflüssen schützt, ist eine 
funktionierende Reparatur von Schäden im Erbgut besonders wichtig, besonders 
angesichts der hohen Rate von Zellteilungen und Erneuerungen in der Haut. Durch die 
in NBS Patienten auftretenden Hautveränderungen scheint eine Involvierung von NBN 
in den Reparaturmechanismen der Haut denkbar zu sein. Um dies zu untersuchen, 
wurde ein Mausmodell erstellt, in dem Nbn nach der Geburt in der Haut ausgeschaltet 
wird.  
Die Nbn
Krox20-Cre
 Mäuse zeigten einen Verlust des Fellkleides zu einem Zeitpunkt, 
der mit der ersten Anagenphase nach der Embryonalentwicklung einhergeht. Zu diesem 
Zeitpunkt kommt es eigentlich zu der Entstehung neuer Haare. Durch den Verlust von 
Nbn in den Mäusen kam es zu einer Anhäufung von DNA Schäden. Diese konnten nicht 
repariert werden. Des Weiteren kam es zum Verlust der Stammzelleigenschaften der 
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Zellen des Haarfollikels. Beides zusammen führte zu Haarverlust  und verhinderte die 
Entstehung neuer Haare. Ältere Mäuse (3 Monate) ohne Nbn zeigten außerdem eine 
Verdickung der Epidermis. Versuche zeigten, dass es sich dabei um ein der 
menschlichen Schuppenflechte (Psoriasis) ähnliches Erscheinungsbild handelte. So 
zeigten die Mäuse eine Vergrößerung der Epidermis, Einwanderung von Immunzellen, 
Aktivierungen und Veränderungen in der Expression von psoriasis-typischen Markern. 
Das zusätzliche Ausschalten von p53 in der Haut der Mäuse führte zu einer 
Verschlechterung des Erscheinungsbildes. Die Mäuse entwickelten neben der 
Schuppenflechte Vorstufen von Tumoren in der Haut. Diese Beobachtungen belegen 
eine wichtige Rolle von Nbn in der Aufrechterhaltung der Homöostase der Haut und des 
Haarzyklus. Auch wird dadurch ein Mitwirken von Nbn in der Verhinderung von 
Hautkrebsentstehung und Schuppenflechte deutlich.    
Die Rolle von Atm (Ataxia telangiectasia mutated) im Zusammenhang mit Nbn in 
der Haut wurde ebenfalls anhand eines Mausmodells untersucht. Dabei stellte sich 
heraus, dass die Rolle von Atm vom Zelltyp abhängt. Atm Ausschaltung in den 
Keratinozyten der Epidermis hatte keinen Einfluss auf das Erscheinungsbild der Nbn 
deletierten Mäuse. Es scheint daher keine essentielle Funktion von Atm im Verbindung 
mit Nbn in diesen Zellen zu existieren. In den Stammzellen des Haarfollikels hingegen 
war Atm für die Phosphorylierung von Histon H2A.X nötig. Die vorliegenden 
Untersuchungen konnten die Funktion von Atm in Verbindung mit Nbn in 
proliferierenden Zellen zeigen. 
Der Verlust von Nbn Aktivität in der Maus führt über einen Verlust der 
Haarfollikelstammzellen zu einem Haarverlust und über eine gesteigerte Proliferation 
der basalen Keratinozyten zu einem der menschlichen Schuppenflechte sehr ähnlichem 
Krankheitsbild.   
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Abstract 
 
The stability of our genome is constantly threatened by endogenous and exogenous 
processes causing errors in the DNA. Those have to be repaired as otherwise mutations 
can give rise to disease or tumor development. This is accomplished by various ways of 
DNA damage signaling and repair. One of the main proteins involved in the signaling 
and repair of DNA double strand breaks is Nbrin (NBN). A mutation of this protein is 
known to cause Nijmegen breakage syndrome (NBS) (Varon et al.,1998). Patients with 
NBS present with various clinical conditions e.g. microcephaly, immunodeficiency, 
radio sensitivity and a predisposition for tumor development (Varon et al.,1998; 
Cybulski et al.,2004; Assaf et al.,2008; Bogdanova et al.,2008; Huang et al.,2008; 
Watanabe et al.,2009). NBS patients show different skin malignancies as abnormal 
pigmentation, Porokeratosis and thin and sparse hair (van der Burgt et al.,1996; 
Group,2000; Wolf and Shwayder,2009; Chrzanowska et al.,2012). Mutations of NBN 
were discovered in malignant melanoma (Debniak et al.,2003; Thirumaran et al.,2006; 
Meyer et al.,2007). As the skin is our protection against environmental threats and 
undergoes a continuous self-renewal, the repair of DNA damages is crucial. The skin 
malignancies of NBS patients point toward an involvement of NBN in the DNA damage 
signaling and repair in the skin. A mouse model of Nbn deletion after birth in the 
epidermis and hair follicles was created to investigate Nbn function in the skin.  
The Nbn
Krox20-Cre
 mice exhibited a hair loss starting with the first wave of hair 
follicle growth (anagen phase) after birth. The hair loss was due to an increase of DNA 
damages and a failure in repair of those. Apoptosis rate was elevated and epidermal 
stem cell properties were disrupted. The hair follicles were not able to regenerate. 
Additionally, a thickening of the epidermis was detected in Nbn deleted mice with 3 
months of age. Analyses revealed that the mice exhibited a psoriasis-like phenotype. An 
enlargement of the epidermis, invasion of immune cells, activation and expression 
changes of psoriasis typical markers were observed. Combined inactivation with p53 
led to a worsening of the phenotype of the mice. Precancerous lesions were present. 
These findings show the importance of Nbn in skin and hair follicle homeostasis and in 
the prevention of skin cancer and psoriasis.  
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The role of Atm (Ataxia telangiectasia mutated) in combination with Nbn in the skin 
was also investigated using a deletion mouse model. The influence of Atm on Nbn was 
found to depend on the cell type. In keratinocytes only a minor role of Atm was 
detected. However, Atm played an important role in hair follicle cells, where it was 
needed for the phosphorylation of Histone H2A.X. The role of Atm in combination with 
Nbn in proliferating tissue was shown by this.  
 
Loss of Nbn activity in mice leads to the loss of hair follicle stem cells which causes 
hair loss and an increased proliferation of the basal keratinocytes gives rise to a 
psoriasis-like phenotype.   
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1. Introduction 
1.1 DNA damage and repair  
Throughout a whole lifespan the stability of the genome is constantly threatened by 
endogenous and exogenous processes which interfere with the DNA (Deoxyribonucleic 
acid) and induce lesions (Friedberg et al.,2004). This might have serious consequences 
because the DNA is not renewed during cell cycle but replicated, meaning that every 
change within the DNA that was not repaired on time, is going to be stabilized as a 
mutation and passed on to the daughter cells. This may lead to genomic instability. An 
accumulation of mutations can induce serious defects in the cells, which can cause 
death, early aging of the effected cells and cancer can also be a consequence. DNA 
damages within the germline can lead to infertility or cause genetic disorders and 
illnesses in the offspring. Taken together this demonstrates the importance of proper 
DNA repair machinery in prevention of genomic instabilities, diseases and cancer.  
The exogenous factors most known to induce DNA damage are ultraviolet (UV)-
light, radiation and chemicals but food and drugs have to be considered too (Hollaender 
and Duggar,1938; Friedberg,2003; Friedberg,2008). These last two can influence the 
endogenous level of damage inducing reactions by increasing the number of metabolism 
products able to cause DNA lesions. Reactive oxygen, carbonyl species, lipid 
peroxidation products, nitrogen species and endogenous alkylating agents as well as 
metabolites of estrogen and cholesterol are known to be endogenous DNA damaging 
agents (De Bont and van Larebeke,2004). While endogenous damage occurs on its own 
most exogenous factors can be avoided (Hoeijmakers,2009). For example damages due 
to UV light can be kept at a minimum by avoiding unprotected exposure of the skin to 
sun light. 
The amount and character of the damage can vary depending on the factor and the 
affected areas. DNA lesions might consist of changes or deletion of bases and 
nucleotides leading to a disturbed conformation within the DNA and the inability to 
perform proper replication. Also breaks of a single or both DNA strands can occur 
making replication impossible or worse leading to abnormal separation of the 
chromosomes during cell division (Warmerdam and Kanaar,2010). For all these 
different types of lesions specialized DNA damage repair mechanisms exist. The DNA 
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damage response (DDR) can be divided into responses to lesions and breaks on DNA 
single strands (ssDNA) and to DNA double strand breaks (DSBs) (Figure 1). DDR is 
initiated by sensor proteins leading to fast and reversible changes in cell-behavior, e.g. 
cell cycle arrest, senescence or apoptosis of affected cells to reduce spreading of 
mutations (Stracker and Petrini,2011). The activation of DDR can be observed in 
preneoplastic lesions representing an inducible obstacle for tumorigenesis (Bartkova et 
al.,2005; Gorgoulis et al.,2005).  
In the following the focus is on DSBs, their repair and signaling while the other 
DNA damage responses are explained briefly. 
 
 
Figure 1: DNA damage repair pathways 
In Figure 1 a schema of DNA damage repair pathways is shown. In yellow the different types of 
DNA damages are indicated. Green symbols show the possible repair pathways belonging to the different 
damages. The most prominent proteins involved in those repair mechanism are visualized in blue. BER: 
Base excision repair; NER: Nucleotide excision repair; TC-NER: transcription-coupled NER; GG-NER: 
global genome NER; MMR: Mismatch repair; NHEJ: Non-homologous end joining; HRR: Homologous 
recombination repair    
 
1.1.1 Single strand damage repair 
Damage of DNA single strands mostly consists of defects on a small number of 
bases or nucleotides. In some cases a break of a single DNA strand can occur. For each 
type of ssDNA damage there are specialized repair mechanisms e.g. base or nucleotide 
excision repair. 
  Introduction 
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1.1.1.1 Base excision repair  
The base excision repair (BER) removes small DNA lesions concerning one base. 
Damages BER repairs are oxidation and alkylation on bases and accidently added 
Uracil. BER is initiated by DNA glycosylases. Which one is active depends on the 
existing damage as DNA glycosylases are damage specific. The appropriate glycosylase 
removes damaged bases through hydrolytation leaving an abasic apurine site. Apurine 
endonuclease cuts the DNA backbone leaving a 5’desoxyribosephosphate. This is 
removed by the DNA polymerase Polβ leaving a gap of one nucleotide. Polβ fills this 
gap by its polymerase activity and the DNA strand is ligated by DNA ligase III. 
Through the long-patch BER 2-10 bases can be removed and repaired. For this long-
patch BER other factors are needed in addition to Polβ, glycosylase, endonuclases (in 
long-patch BER: flap structure-specific endonuclease 1 (FEN1)) and Poly(ADP-Ribose) 
polymerase (PARP). Those are Polynucleotidkinase (PNK), proliferating cell nuclear 
antigen (PCNA) and the polymerase Polδ which act together to cleave the damaged 
bases, modify the DNA ends and fill the gap. Ligation occurs through DNA ligase I. 
Long-patch BER can also repair single strand DNA breaks (Hoeijmakers,2001; 
Bohr,2002; Hoeijmakers,2009). 
 
1.1.1.2 Nucleotide excision repair 
Nucleotide excision repair (NER) removes helix distorting DNA lesions concerning 
one DNA strand. These lesions are often caused by UV light damaging the DNA. 
During replication those lesions hinder the DNA polymerase to process the DNA strand. 
The characterization of NER was mostly possible due to a genetic skin disease called 
Xeroderma pigmentosum (XP). The patients show a hypersensibility to UV exposure 
leading to hyper- or depigmentation of the exposed skin area. The risk for skin 
carcinoma development in these patients is increased over a thousand fold compared to 
non-patient population.  
NER involves the nucleotide excision repairosom, a complex of over 25 proteins. 
This complex can separate and replace a fragment of up to 30 nucleotides. Depending 
on the cell being actively proliferating or non-dividing different types of NER take 
place. In non-dividing cells global genome NER (GG-NER) is conducted while in 
dividing cells transcription-coupled NER (TC-NER) repairs the damage. From these 
subspecies of NER TC-NER is faster which is needed due to a limited time span for 
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repair during replication. During both GG-NER and TC-NER the complimentary DNA 
strand can be used as synthesis foundation which abolishes the risk of wrong repair 
(Hoeijmakers,2001; Friedberg,2003; Hoeijmakers,2009).  
 
1.1.1.3 Mismatch repair 
The most common way within the cell to induce DNA damage is through mistakes 
during replication. As a consequence one base is inserted at a wrong position and the 
two DNA strands are not able to pair properly at this position, a mismatch of bases 
appears. Another reason for this can also be the desamiation of a base or another change 
on a single base caused by chemicals or other reactive species. Those single base 
damages can be easily established as mutations if not recognized by damage response 
machinery. Mismatch repair (MMR) is the pathway reacting to those single base lesions 
and to insertion and deletion mismatches with a small number of nucleotides involved. 
First the mismatch is recognized and bound. Then an excision of the wrong base or 
fragment occurs. The first step is accomplished by various complexes of the Mut 
protein family which are also involved in the second step. In addition proteins that are 
part of the BER damage response are engaged and the new synthesis of the DNA 
fragment and the ligation appear to be mastered mainly by those proteins 
(Hoeijmakers,2001; Friedberg,2003).  
 
1.1.1.4 Single strand break repair 
Breaks of ssDNA are not so common. They are caused by free radicals from cell 
metabolism attacking desoxyribose or by exogenous substances and processes. ssDNA 
breaks (SSBs) can arise during BER and be a consequence of Topoisomerase I 
inhibition. DNA replication and transcription are hindered by SSBs. SSBs are 
associated with inheritable neurodegenerative diseases.  
DNA single strand breaks are detected and bound by Parp1. Parp1 and other 
proteins are poly(ADP-ribosyl)ated initiating the binding of XRCC1 (X-ray cross-
complementing Protein 1). This activates APE1 (Apurinic/apyrimidinic endonuclease 
1), PNK and APTX (Aparataxin) to start the end processing. DNA polymerase β fills 
the gap using the other DNA strand as a template and the DNA pieces are connected via 
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Ligase III to form a repaired, intact and complementary DNA strand (Polo and 
Jackson,2011). 
 
1.1.2 Double strand break repair 
Breaks in DNA double strands can be caused by ionizing radiation (IR), x rays, UV 
light, chemicals, reactive oxygen species (ROS) and other free radicals from cell 
metabolism. Retroviral integration, treatment with Topoisomerase II inhibitors, like 
etoposide and camptothecin used in cancer treatment, and shortened telomeres due to 
aging can initiate DSBs. During replication an existing SSB or other lesions on one 
DNA strand are often transformed into a DSB. DSBs can even be wanted in cells e.g. 
during development and adaptations in the immune system and enable genetic diversity 
during meiosis. In mitotic cells DSBs lead to non-intact chromosomes making proper 
chromosome segregation unlikely. Consequences might be loss of heterozygosity, 
aneuploidy and chromosomal translocation leading to abnormal cells with a higher risk 
for cancer. Therefore functional DSB signaling and repair is essential for cancer 
treatment to limit cell proliferation of abnormal cells and thereby reduce additional 
accumulation of further mutations. DNA repair for DSBs can be divided into two 
processes: non-homologous end joining (NHEJ) and homologous recombination repair 
(HRR). The step deciding what process is chosen is DSB resection which is needed for 
HRR but not for NHEJ (Hoeijmakers,2001; Friedberg,2003; Wyman and Kanaar,2006; 
Stracker and Petrini,2011). 
 
1.1.2.1 Non-homologous end joining  
Non-homologous end joining is the most common way for DSB repair in cells as it 
can take place at every point in time during cell cycle. NHEJ is fast and therefore can 
reduce potential oncogenic translocations (Warmerdam and Kanaar,2010). DSB repair 
through NHEJ often leads to deletion or insertion on the repair side because NHEJ does 
not use a template like the homologous chromatin to synthesize over the DSB (Takata et 
al.,1998). NHEJ therefore is considered to be error prone. 
Non-homologous end joining starts with binding of Ku70/Ku80 heterodimer to the 
broken DNA ends (Figure 2). The Ku heterodimer recruits and activates DNA-PKcs 
(DNA-dependent protein kinase catalytic subunit) to form a holoenzyme (Gottlieb and 
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Jackson,1993). DNA-PK (DNA-dependent protein kinase) holoenzyme brings the DNA 
ends into close proximity to each other making it possible for the nuclease Artemis, 
PNK, Aprataxin and PNK like factor to process the DNA. DNA polymerase TdT 
(terminal deoxynucleotidyl transferase) or translesion DNA polymerase polµ or polλ are 
involved depending on damage characteristics. While TdT is able to add untemplated 
nucleotides to DNA ends, polµ and polλ are able to incorporate nucleotides from the 
other DNA end before filling the gap between both ends (Wyman and Kanaar,2006). 
XLF (XRCC4 like factor) - XRCC4 - Ligase IV complex aggregates the processed 
DNA to make a complete DNA double strand (Figure 2) (Lieber and Wilson,2010).  
For NHEJ alternative pathways exist in case one of its components is mutated or 
completely absent. Those pathways need small homologies on the DSB ends to 
function. Components are mostly proteins from HRR like MRN (Mre11 (Meiotic 
recombination 11)-Rad50-Nbn (Nibrin)) complex, Parp1, XRCC1 and DNA Ligases I 
and III (McVey and Lee,2008; Lieber and Wilson,2010).  
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Figure 2: Non homologous end joining 
Figure 2 shows a schematic outline of NHEJ. A DSB is induced and the breakage site is recognized 
and bound. The gap in the DNA strands is bridged and filled. Afterwards the DNA ends are ligated. This 
pathway is considered error prone because wrong bases might be added as no template is available to 
synthesis the DNA strand accordingly. Adapted from Lieber and Wilson 2010 (Lieber and Wilson,2010)  
 
1.1.2.2 Homologous recombination repair 
During S and G2 phase of the cell cycle DSB repair is accomplished by homologous 
recombination repair. HRR needs the homologous chromatin to rejoin the broken DNA 
ends (Takata et al.,1998) and therefore is error free. Insertion of lost bases is possible 
while homologous recombination takes place. 
HRR is initiated by DSB resection starting with binding of Mre11-Rad50-Nbn 
complex to the ends of broken DNA (Figure 3). Together with auxiliary factors like 
CtIP (C-terminal binding protein interacting protein), Exo1 (Exonuclease 1), DNA 
replication ATP-dependent (Adenosine triphosphate) helicase/nuclease DNA2 and 
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ATP-dependent helicases from RECQ family, the DNA ends are kept in close proximity 
and 5’- to 3’ nucleolytic processing can be accomplished (Longhese et al.,2010). 
Together with CtIP MRN resects DNA ends producing 3’- single strand (ss) overhangs 
(Paull and Gellert,1998; Sartori et al.,2007) which ssDNA-binding complex RPA 
(replication protein A) envelops (Figure 3). RPA is replaced by Rad51, with Rad52 and 
proteins of the Fanconi anemia (FA) pathway assisting. Proteins of FA pathway e.g. 
BRCA2 (breast cancer 2) and PALB2 (partner and localizer of BRCA2) are usually 
acting in detection and repair of interstrand cross-links (Moldovan and D'Andrea,2009). 
Rad51 and other associated proteins initiate a search for homologous regions on the 
sister chromatid and strand invasion in the homologous template (Figure 3). After DNA 
synthesis through PCNA and DNA polymerase β DNA Ligase I is activated. 
Intermediates of homologous recombination are cleaved and resolved by Resolvase and 
DNA helicases leaving repaired and intact DNA double strands (Figure 3) (Mazon et 
al.,2010). 
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Figure 3: Homologous recombination repair 
HRR is visualized in an abbreviated version in Figure 3. The DSB occurs on one of the chromatins. 
MRN recognizes the free DNA, binds and produces single strand overhangs. Those are necessary to 
accomplish strand invasion into the sister chromatin. DNA is synthesized according to the matching DNA 
strand of the sister chromatin. Afterwards the junction is resolved and DNA strands are ligated. HRR is 
error free due to the homologous chromatin that is used for DNA synthesis. Adapted from Wyman and 
Kanaar, 2006 and Mazon et al., 2010 (Wyman and Kanaar,2006; Mazon et al.,2010)  
 
1.1.3 Signaling pathways for DNA damages 
DNA breaks play a role during cell cycle progression. An unrepaired break can 
cause abnormal cells, cancer and cell death. Therefore at important steps during the cell 
cycle DNA integrity is checked and damages lead to an arrest or stop of cell cycle 
progression. DNA damage checkpoints are before (G1/S) and during replication (intra 
S) and before cell division (G2/M) (Figure 4). Those checkpoints inhibit segregation 
and duplication of aggrieved DNA. They do not recognize DNA damages directly but 
react to complexes formed and accumulated at damage sides. Accumulation of DDR 
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proteins guarantees a higher interaction rate between proteins and damaged DNA 
making a fast reaction to DSB possible and reducing the risk for improper activation of 
DDR. The proteins involved in DNA damage checkpoints can be divided into 
subgroups by their responsibilities: damage sensors, transducers, mediators and 
effectors (Warmerdam and Kanaar,2010; Polo and Jackson,2011).  
 
 
Figure 4: Cell cycle 
The cell cycle (Figure 4) is divided into Interphase and Mitosis. Interphase is composed of G1 
(growth 1), S and G2 phases. During G1 phase the cell is preparing for DNA synthesis (S). In S phase the 
DNA is replicated and in G2 phase the cell prepares for Mitosis. During Mitosis the cell divides into two 
identical cells. Mitosis is subdivided in Pro-, Meta-, Ana- and Telophase. Each phase represents different 
steps in the process of the separation into two cells. Afterwards the cells can continue cycling or go into 
resting in G0 phase. During the cell cycle the DNA is checked for damages at G1/S, IntraS and G2/M 
checkpoints.  
 
The DNA damage checkpoints are controlled by ATM (ataxia telangiectasia 
mutated) and ATR (Ataxia telangiectasia and Rad3-related) signaling. Both proteins are, 
like DNA-PKcs, members of the PIKK (phosphoinositide three-kinase-related kinase) 
family. Proteins targeted by these two pathways are transcription factors, cell cycle 
regulators, apoptotic machinery and DNA repair factors. Through ATM, ATR and other 
members of the PIKK family they are phosphorylated on serine and threonine, 
activating the damage checkpoints and thereby ensuring DNA integrity. Members of the 
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PIKK family are able to phosphorylate Histone H2A.X on Serine 139 making it 
γH2A.X (Burma et al.,2001; Stiff et al.,2004; Friesner et al.,2005). This causes a change 
in chromatin structure making DNA more accessible for e.g. damage repair proteins 
(Kinner et al.,2008; Lovejoy and Cortez,2009; Warmerdam and Kanaar,2010).  
 
1.1.3.1 ATM signaling 
Breaks in double strand DNA induce the ATM pathway leading to cell cycle 
checkpoint activation. The sensor for DSB is MRN complex (Lavin and Kozlov,2007). 
DNA ends are bound by the DNA binding domain at the globular head region of Mre11 
(Meiotic recombination 11) and the ATPase domain of Rad50 (de Jager et al.,2001). 
Stability of DNA binding increases with Mre11 heterodimerisation while Rad50 links 
the DNA ends (de Jager et al.,2001; Williams et al.,2008). Endonuclease activity of 
Mre11 is also involved in further progressing of the broken DNA (Williams et al.,2008). 
Lack of Mre11 inhibits binding of DNA breaks and therefore the ATM pathway 
(Kitagawa et al.,2004). MRN recruits and activates the serine-threonine protein kinase 
(Savitsky et al.,1995; Kastan and Lim,2000) ATM which itself is a transducer. It has to 
be noted that MRN is involved in HRR independently of its interaction with ATM. 
However without ATM involvement activation of cell cycle checkpoint after DSB 
would not be possible (Shiloh,2003; Lee and Paull,2005; Shiloh,2006). In addition 
ATM has been shown to be involved in stopping and removing of RNA (Ribonucleic 
acid) polymerase I and II at DNA breaks (Kruhlak et al.,2007; Shanbhag et al.,2010). 
Activation of ATM is dependent on its autophosphorylation at Serine 1981 (Bakkenist 
and Kastan,2003) and binding to MRN complex via NBN’s C-terminal binding domain 
for ATM. Even in absence of NBN ATM is able to phosphorylate p53 on Serine 15 
increasing stability of p53 and inducing p53 dependent apoptosis. After 
autophosphorylation on Serine 1981 the inactive oligomer of ATM is disassociated into 
active monomers (Bakkenist and Kastan,2003). For complete activation additional 
autophosphorylation occurs on Serine 367 and 1893 (Kozlov et al.,2006). ATM 
autophosphorylation is dependent on its previous acetylation which itself is not 
sufficient to establish DNA binding. Besides acetylation a change in chromatin structure 
e.g. through DSBs or chemical reagents induces autophosphorylation of ATM 
(Bakkenist and Kastan,2003). For autophosphorylated and MRN-bound ATM kinase 
activity is enabled. MRN complex links to both DNA ends and ATM bringing them into 
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close proximity. The mediator proteins MDC1 (mediator of DNA damage checkpoint 1) 
interacts with NBN and 53BP1 (p53 binding protein 1) and binds to Rad50. This 
increases the accumulation of MRN complex at DSB sides. In addition BRCA1, ATM, 
the effector kinases Chk1 (Checkpoint kinase 1) and Chk2 are activated which spreads 
the checkpoint signal throughout the nucleus. Phosphorylation of Chk1 by ATM 
induces disassociation of Chk1 from chromatin. Activation of Chk2 by ATM-dependent 
phosphorylation enables the protein to phosphorylate Cdc25A (Cell division cycle 25 
homolog A). Cdc25A normally dephosphorylates Cdk2 (Cyclin-dependent kinase 2) but 
its phosphorylation leads to proteasomal degradation. As a consequence Cdk2 is not 
dephosphorylated detaining DNA synthesis. This reduces the risk of damaged DNA 
being spread. To ensure the proper activation of the ATM dependent checkpoint 
proteins like Nbn, Artemis and Histone H2A.X have to be phosphorylated during the 
pathway. For each checkpoint different proteins are involved in the ATM cascade. All 
those proteins are phosphorylated and therefore activated through ATM arresting cell 
cycle at the respective checkpoint. Activation of G1 checkpoint is induced with p53, 
Mdm2 (mouse double minute 2) and Chk2. S phase checkpoint is activated through 
Brca1, FANCD2 (FA complementation group D2) and SMC1 (structural maintenance 
of chromosomes protein 1) while a combination of Brca1 and Rad17 is responsible for 
cell cycle checkpoint activation at G2/M (Bakkenist and Kastan,2003). 
 
1.1.3.2 ATR signaling 
For activation of DNA damage checkpoints via ATR pathway ssDNA is essential. 
Those can be due to cross-links, DSB with single strand overhangs, base adducts and 
replicational stress. Heterotrimeric RPA binds directly to ssDNA and signals the 
accumulation of ssDNA during the damage processing. Increased activation of ATR 
signaling is due to long ssDNA at DNA break sides. ATR is recruited to the DNA ends 
by RPA with ATRIP (ATR interacting partner) as bridge protein. Binding of ATR to 
DNA can also be accomplished through MRN complex. Mre11 can bind to ssDNA 
producing a conformation of the complex in which Nbn can bind ATR instead of ATM 
(Williams et al.,2010). Activation of ATR involves ATRIP and 9-1-1 (Rad9-Rad1-
Hus1) complex. 9-1-1 is bound from RPA to the DNA on 5’primer ends putting all 
factors into close proximity. With the help of TopBP1 (topoisomerase-binding protein1) 
and Calspin Chk1, which is phosphorylated and disassociates from chromatin, and Chk2 
  Introduction 
13 
 
are activated. This spreads the signal throughout the nucleus and activates the ATR 
dependent cell cycle checkpoint. Besides this signaling pathway ATR is active in every 
cell cycle, controlling replication and repairing damaged replication forks.  
 
1.1.4 The MRN complex 
MRN can be considered the sensor for DSB (Lavin and Kozlov,2007) as it directly 
binds free DNA ends and besides being active in HRR, acts in ATM and ATR cell cycle 
checkpoint signaling and in an alternative pathways for NHEJ (Lavin and Kozlov,2007; 
McVey and Lee,2008; Lieber and Wilson,2010; Williams et al.,2010). Its importance is 
underlined by high genomic conservation of Mre11 and Rad50 through all three life 
domains: bacteria, archaea and eucaryota (Hopfner et al.,2000; de Jager et al.,2004; 
Stracker and Petrini,2011). Orthologies of Nbn appear only in eukaryotes and here with 
a smaller homology than Mre11 and Rad50 but functional conservation is seen in all 
domains (Dolganov et al.,1996; Carney et al.,1998). The main function of MRN 
complex in mitotic cells is to promote HRR between sister chromatids after damages 
during DNA replication (Bressan et al.,1999). In response to DSBs the MRN complex 
binds to the free DNA ends. It is also able to bind to chromosome ends with extremely 
short or no telomeres left (Sabourin and Zakian,2008). MRN function at longer 
telomeres and at replications forks is to avoid DSBs even in the absence of shelterin or 
ATM (Zhu et al.,2000; Verdun and Karlseder,2007). Main functions of MRN complex 
are binding and processing of DNA, establishing connections of broken DNA over short 
and long distances and initiation of DSB repair and checkpoint signaling. Due to all 
these functions MRN can be assumed to be a sensor, signaling and effector complex. 
Whenever DSBs arise and are repaired MRN is involved meaning MRN focis are 
formed in NHEJ, HRR, adaption mechanisms in the immune system (V(D)J 
rearrangement during B- and T-cell development), at telomeres and replication forks. 
For example the endonuclease activity of it is involved in HRR induction (Buis et 
al.,2008; Williams et al.,2008) while false nuclease activity at telomeres can cause 
fusion of chromosomes (Deng et al.,2009). Which repair or signaling pathway is 
activated by the MRN complex is dependent on its macromolecular shape and 
conformation. Availability of interaction sides, post-translational modifications and 
allosteric regulations due to existing interactions influence the outcome of MRN 
activity. For example when Mre11 dimer binds two DNA ends it is symmetric, making 
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it possible for ATM to bind inducing the ATM signaling or to start DSB repair. If 
Mre11 dimer binds to one DNA end its structure is asymmetric blocking ATM but 
binding ATR. As a consequence replication forks can be rescued or the ATR pathway 
starts.  
Mre11 and Rad50 form the head region of the MRN complex. This is the main area 
for binding and processing within the MRN (Stewart et al.,1999). It is composed of two 
Mre11 nucleases and two Rad50 ABC-ATPase domains with Mre11 bound to Rad50 
via its coiled-coil structures (Stewart et al.,1999). Rad50 has ATPase and adenylate 
kinase activity and is able to bind DNA (Paull and Gellert,1999; Bhaskara et al.,2007). 
The ATPase domain is spread on two places at the opposite ends of the primary 
sequence. Those two parts are arranged next to each other when the middle sequence 
folds and forms a coiled-coil zinc finger domain (Hopfner et al.,2000; Hopfner et 
al.,2002). This coiled-coil domain allows two MRN complexes to link together enabling 
larger distances for DNA bridging (Moreno-Herrero et al.,2005). MRE11 comprises a 
C-terminal DNA binding domain and an N-terminal phosphoesterase. Both 3’-5’ 
dsDNA (double strand DNA) exonuclease and ssDNA endonuclease activities of the 
MRN complex are due to Mre11 (Hopfner et al.,2001). The ssDNA endonuclase and 3’-
5’ exonuclease activity of Mre11 are independent of Rad50 and Nbn but an activity 
increase can be seen when MRN complex is formed (Paull and Gellert,1998; Williams 
et al.,2007). In addition Nbn binds to Mre11-Rad50. Nbn acts as a regulator and an 
anchor for other proteins. It is linked to Mre11 via an N-terminal phosphoprotein 
binding side. Combined with Rad50 it controls nuclease activity from Mre11. Nbn 
interacts with and activates ATM or ATR. Sterical hindering created through Mre11 
binding to one DNA end prevents linking of ATM to Nbn but leaves enough space for 
ATR to bind. Association of Nbn with ATM is dynamic and DSB dependent while 
binding to Mre11-Rad50 is constant. Due to two dual phosphopeptide binding domains 
opposite one another Nbn is a mulitmodular adaptor for phosphorylated proteins during 
DDR. Some of the known interacting proteins are CtIP, ATR, ATM and MDC1.  
 
1.1.5 Diseases involving DNA signaling and repair proteins 
The functional link between genomic deficiencies due to insufficient DDR and 
cancer is strengthened by several genomic instability disorders showing a moderate to 
serve increase in cancer formation. These disorders include Bloom’s syndrome, 
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Werner’s syndrome, Fanconi anemia (FA), Ataxia telangiectasia (AT), AT like disorder 
and Nijmegen breakage syndrome (NBS) (Digweed,1993; Hoeijmakers,2001; 
Bohr,2002; McKinnon,2004).  
The listed diseases are rare and inherited in recessive manner. Mutated human genes 
involved in these genomic instability disorders have been described to be essential for 
several biological functions such as DNA replication, DNA damage response, DNA 
repair, cell cycle checkpoint control and apoptosis (Kang et al.,2002; Friedberg et 
al.,2004; McKinnon,2004; Warmerdam and Kanaar,2010). Mutations among the 
proteins of the DNA damage response and the signaling of DNA damages or lack of 
proteins cause serious defects including neurodegenerative diseases, hypersensitivity to 
sunlight, cancer, early aging and developmental disorders. In mouse model knockout of 
involved proteins can lead to embryonic lethality (Zhu et al.,2001; Frappart et al.,2005).  
Xeroderma pigmentosum, Cockayne syndrome and Trichothiodystrophy are 
illnesses aroused by defects in NER causing point mutations among the genome. Those 
diseases are characterized with hypersensitivity against sunlight most obvious in XP 
patients having an over 1000 fold increased risk for skin cancer induced by UV light. 
They also show a higher risk for inner tumor formation and neurodegeneration. 
Cockayne syndrome and Trichothiodystrophy patients on the other hand do not show an 
increased risk for cancer development. This is due to defects in TC-NER where cells are 
more sensitive for lesions causing apoptosis induction thereby providing a protection 
against tumor formation. Increased levels of apoptosis might be responsible for 
premature aging observed in those patients. In Cockayne syndrome patients reduced 
growth and neurological defects like mental retardation and dysmyelation are found. For 
Trichothiodystrophy patients the most obvious appearances are brittle hair and nails and 
scaly skin. Other symptoms are similar to those observed in Cockayne syndrome 
(Hoeijmakers,2001; Bohr,2002).  
Werner’s syndrome and Bloom’s syndrome are both associated with defects in HRR 
in particular defects involving the RECQ helicase. Patients of both illnesses have 
elevated risk for developing cancer (Hoeijmakers,2001; Bohr,2002). Hereditary non-
polyposis colorectal cancer is caused by defects in MMR inducing genome and 
chromosome instability with an increased mutation rate (Hoeijmakers,2001; 
Bohr,2002). Genome instability is also involved in Fanconi anemia. FA is a 
heterogeneous disease with cells highly sensible against DNA damaging agents and 
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with an elevated cancer risk. Patients with mutations in BRCA1 or BRCA2 show a 
higher risk for developing breast or ovarian cancer.  
Ataxia telangiectasia, AT-like disorder and Nijmegen breakage syndrome are 
diseases caused by defects within ATM signaling and therefore a non-functional 
response and repair after DSBs. Etiological for AT is a mutation of ATM. This results 
in a neurodegenerative disease that has its onset in early childhood. Cerebellar 
degradation in these patients leads to ataxic movements, progressive dysarthria and 
ocular telangiectasia and therefore often leads to a life in a wheelchair 
(McKinnon,2004). Additional symptoms of AT are hypersensitivity to x-rays, 
chromosome instability, sterility, defects in immune system development and a high 
risk for lymphomas (Hoeijmakers,2001; McKinnon,2004). AT like disorder is 
characterized by similar effects as AT but caused by a mutation of Mre11 
(Hoeijmakers,2001).  
 
1.1.5.1 Nijmegen breakage syndrome (NBS) [OMIM 251260] 
NBS is a hereditary autosomal recessive chromosome instability disorder (Varon et 
al.,1998). It is caused by a genomic defect of NBN (Nibrin, previously known as NBS1= 
Nijmegen breakage syndrome 1) (Varon et al.,1998). The NBN protein is involved in 
the MRN complex for signaling and initiation of DSB repair. NBS manly occurs in 
central and eastern European countries with 90 % of patients having the so called 
“Slavic” 657del5 (c.657-661delACAAA) mutation (Varon et al.,1998). The most 
frequently observed cytogenetic anomalies are rearrangements on chromosomes 7 and 
14. Those chromosomes contain immunoglobulin and T cell receptor genes which 
undergo recombination involving DSBs during lymphoid development (Varon et 
al.,1998). Clinical symptoms for NBS are microcephaly, bird shaped face, 
immunodeficiency, growth and mental retardation, predisposition for lymphoreticular 
malignancies and in women primary ovarian failure (Varon et al.,1998; Assaf et 
al.,2008). In addition NBS patients are highly sensitive to radiation and therefore should 
not be treated with x-rays or CT (x-ray computed tomography) (Varon et al.,1998; 
Assaf et al.,2008). Those treatments with IR raise the risk to develop cancer in the 
patients (Varon et al.,1998; Assaf et al.,2008). In female patients heterozygote for NBN 
mutation a 3-fold increase in breast cancer risk was detected (Bogdanova et al.,2008) 
and the tumor latency und metastasis rate of mammary tumors is increased (Wan and 
  Introduction 
17 
 
Crowe,2012). Male patients with haploinsufficiency of NBN have a predisposition for 
prostate cancer (Cybulski et al.,2004). Mutations of NBN are additionally found in 
malignant melanoma (Debniak et al.,2003; Meyer et al.,2007), basal cell carcinoma 
(Thirumaran et al.,2006), meduloblastoma (Huang et al.,2008) and glioblastoma 
(Watanabe et al.,2009). Heterozygote mutations of NBN are associated with 
nasopharyngeal carcinoma (Zheng et al.,2011), lung cancer (Yang et al.,2012), 
colorectal carcinoma and non-Hodgkin lymphoma (Steffen et al.,2004). In skin besides 
melanoma development, other malignancies can be observed. An abnormal 
pigmentation of the skin can be seen in the majority of the patients (van der Burgt et 
al.,1996; Group,2000; Chrzanowska et al.,2012) and cutaneous noncaseating 
granulomas were described (Yoo et al.,2008; Vogel et al.,2010). Porokeratosis, a 
malfunction in epidermis development, was also observed (Wolf and Shwayder,2009). 
Hair of NBS patients are sparse and thin (Chrzanowska et al.,2012). 
 
1.1.6 Nibrin  
Nibrin (NBN) has been identified to be the protein causing Nijmegen breakage 
syndrome if genetically mutated (Varon et al.,1998). Therefore it was formerly known 
as NBS1 (Nijmegen breakage syndrome 1). NBN is located on human chromosome 
segment 8q21.3 (Saar et al.,1997). Nbn is the mammalian equivalent to Xrs2 in 
Saccharomyces cerevisiae although only 28 % genetically homologous (Dolganov et 
al.,1996; Carney et al.,1998). Homologies to human NBN have been found in rat, 
mouse, dog, cow and monkey but not in chicken (Carney et al.,1998). NBN consists of 
16 exons interspersed with introns to a complete cDNA (complementary DNA) size of 
over 50kb. Due to two polyadenylation signals in the 3’ untranslated region of the 
cDNA (positions c.2440G and c.4386T) a 2.4 kb and 4.4 kb transcript exist (Carney et 
al.,1998; Varon et al.,1998). After splicing an mRNA (messenger RNA) of 754 aa 
(amino acids) remains and forms the protein with a size of 95 kDa. This protein is 
absent in NBS patients (Carney et al.,1998). No global similarities to other proteins 
have been found but two functional domains were identified. These domains are a fork-
head-associated domain (FHA) (Hofmann and Bucher,1995) and a breast cancer 
carboxy-terminal domain (BRCT) (Bork et al.,1997), both located within the amino-
terminal region of NBN (Figure 6) (Varon et al.,1998). FHA and BRCT together seem 
to be important for the formation of nuclear foci involving NBN at DNA damage sides 
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(Tauchi et al.,2002; Cerosaletti and Concannon,2003). A second BRCT domain was 
identified in Xenopus laevis that seems to be partially conserved in humans (Xu et 
al.,2008). Mutation screening of NBS patients revealed six different mutations within 
the NBN gene between nucleotides 657 and 1142 (Varon et al.,1998). The most 
common mutation of the gene 657del5 (c.657-661delACAAA), is placed within Exon 6. 
This mutation leads to a frame shift creating an alternative start codon and a 70 kDa 
protein of 555 aa (Figure 5), truncated on its N-terminal part, is expressed (Maser et 
al.,2001). In addition a small 26 kDa protein can be found containing the N-terminal 
FHA and BRCT domains of NBN (Figure 5). In the rare mutation 835del4 (c.835-
838delCAGA) a similar mechanism can be observed (Tupler et al.,1997; Varon et 
al.,1998) (Figure 5). All mutations described so far result in a frame shift and an N-
terminal truncation removing the FHA and BRCT domains of Nibrin (Varon et 
al.,1998). In tissue of patients this leads to an expression of a small protein containing 
FHA and BRCT domains and a bigger protein presenting the C-terminal rest of NBN 
(Figure 5). These hypomorphic mutations thereby create protein-pieces that are able to 
partially rescue NBN activity. This is indicated by the reduced lymphoma risk in 
patients with a high expression of N-terminally truncated 70 kDa NBN protein (Kruger 
et al.,2007).    
 
Figure 5: NBN mutations 
The full length protein of NBN is shown here. In addition the proteins resulting from the two most 
common mutations are depicted. Those mutations are 657del5 and 835del4.   
 
NBN is the p95 component of the MRE11-RAD50 complex (Carney et al.,1998) 
leading to the name of MRE11-RAD50-NBN complex. Both MRE11 and RAD50 are 
cytoplasmic proteins and in absence of NBN cannot locate in the nucleus (Carney et 
al.,1998). If NBN is N-terminal truncated NBN, MRE11 and RAD50 can be detected in 
the nucleus but the characteristic foci formation is inhibited (Desai-Mehta et al.,2001). 
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Deletion of the last C-terminal 101 aa of NBN leaves a protein not able to interact with 
MRE11 but able to localize in the nucleus and induce foci formation (Desai-Mehta et 
al.,2001). These findings indicate the essential role of NBN in foci formation after 
DSBs (Desai-Mehta et al.,2001). The nuclear localization domains (NLS) of Nbn are at 
amino acids 468-472, 550-554 and 592-596 (Vissinga et al.,2009) (Figure 6). Moreover 
a nuclear export signal (NES) is part of Nbn (from aa 653 to 662) (Vissinga et al.,2009) 
(Figure 6). Both NLS and NES are important for the distribution of Nbn in cytoplasm or 
nucleus. Localization of Mre11 together with Nbn is dependent on both types of signals 
(Vissinga et al.,2009). Lack of one NLS does not inhibit the nuclear import of NBN but 
leads to a lower protein level in the nucleus (Desai-Mehta et al.,2001; Vissinga et 
al.,2009). Additionally DNA binding ability of the MRN complex and MRE11 nuclease 
activity are regulated by NBN (Paull and Gellert,1999; Lee et al.,2003). This interaction 
with MRE11 is accomplished at amino acids 653-754 (Figure 6) (Desai-Mehta et 
al.,2001). At the amino-terminal end NBN has an additional motif of 20 aa (aa 734 to 
754) (Figure 6) that interacts with ATM (Falck et al.,2005; You et al.,2005). ATM 
phosphorylates NBN at serine 278, 343, 397 and 615 (Figure 6) (Gatei et al.,2000; Lim 
et al.,2000; Wu et al.,2000; Zhao et al.,2000). Additional phosphorylation sites of NBN 
were found via mass spectrometry on serines and threonins at 337, 341, 432 and 602 
(Figure 6) (Dephoure et al.,2008; Gauci et al.,2009). The ATM dependent 
phosphorylation occurs after DNA damage by γ-radiation and UV-light (Gatei et 
al.,2000; Wu et al.,2000). The timing and accumulation of ATM and NBN and therefore 
the MRN complex at the damage sites are dependent on these phosphorylations (Wen et 
al.,2012). The phosphorylation of NBN through ATM also is essential for functional S 
phase checkpoint pathway (Lim et al.,2000). CHK1, CHK2 and G2/M checkpoint 
activation require both NBN and ATM activation (Dasika et al.,1999; Gatei et al.,2000; 
Buscemi et al.,2001). Additional activation of NBN is seen in unwinding of DNA 
complexes and cleavage of paired hairpin structures (Paull and Gellert,1999). Recently 
an involvement of NBN in the phosphorylation and thereby activation of Akt (protein 
kinase-B) kinase was discovered (Wang et al.,2013). Nbn interacts with the mTOR 
(mechanistic target of rapamycin)/Rictor (rapamycin-insensitive companion of 
mTOR)/SIN1 (stress-activated protein kinase interacting protein 1) complex (mTORC2) 
leading to Akt activation (Wang et al.,2013). 
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Figure 6: Protein structure of NBN 
Figure 6 displays the protein structure of NBN. The phosphorylation sites and types are indicated. 
The different domains that have been found are visualized in different colors and their location is labeled.  
 
Several mouse models of NBS have been created. Studies on these models were able 
to point out the essential role of Nbn in the development of the central nervous system 
(CNS) (Frappart et al.,2005; Assaf et al.,2008; Dar et al.,2011; Rodrigues et al.,2013; 
Liu et al.,2014) and the eye (Yang et al.,2006; Rodrigues et al.,2013). Additionally Nbn 
was found to be involved in the class switch recombination (Kracker et al.,2005) and 
V(D)J recombination (Saidi et al.,2010) within the immune systems development, 
maturation and adjustment. At chromosome ends Nbn is important to maintain 
telomeres (Ranganathan et al.,2001). The function of Nbn in mice so far has been 
intensively investigated in the CNS, B- and T-cell development. 
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1.2 Skin and hair 
The skin is the organ of the body forming the protective barrier against 
environmental threats. Together with its appendixes it protects the organism against 
infections, damaging agents, liquid loss and extreme temperatures. Due to its protective 
function skin itself is continuously injured on various levels and to various extends. 
Therefore skin needs a high ability for self-renewal which is accomplished by stem cells 
within. Proliferation defects can lead to diseases concerning reduced protectoral 
function of the skin, non-effective wound healing or cancer, depending on hypo- or 
hyper-proliferation.  
 
1.2.1 Structure of the skin 
The skin of mammals is composed of three layers: epidermis, dermis and subcutis. 
The inner layer is the subcutis. Blood vessels and nerve fibers connecting the skin with 
underlying tissues are located in the subcutis along with fat cells. The subcutis borders 
against the collagen rich dermis, while the keratinized epidermis forms the outer layer. 
The mesenchymally derived dermis provides support and nourishment for the epidermis 
(Wang et al.,2012). Epidermis and dermis are being separated by a basement membrane 
formed of extracellular matrix proteins. Ectoderm derived epidermis consists of 
keratinocytes in different stages of maturation which are arranged in distinguishable 
layers. Looking from the skin surface these are the Stratum corneum, Stratum lucidum, 
Stratum granulosum, Stratum spinosum and the Stratum basale, which borders against 
the basement membrane (BM) (Figure 7). Stratum corneum, Stratum granulosum and 
Stratum spinosum are also referred to as suprabasal layers while Stratum basale is also 
named basal layer. High numbers of intermediate filaments assembled of keratin 
proteins ensure a tight connection between epidermal cells. Within the basal layer cells 
are highly proliferating. They divide a limited number of cell cycles, differentiate and 
then detach from the BM to turn into cells of the suprabasal layers thereby traveling 
towards the skin surface (Barrandon and Green,1987). This process is called 
cornification and comprises many changes in gene expression. One example is the 
change in Keratin expression between the layers. Keratin 15 is expressed in stem cells 
of the hair follicle and the basal keratinocytes (Liu et al.,2003; Morris et al.,2004). Basal 
keratinocytes, the cells of the Stratum basale, express Keratin 14 while cells of all layers 
more differentiated (suprabasal layers) express Keratin 10 (Fuchs and Green,1980). The 
  Introduction 
22 
 
cornification is not a normal cell death as cells have to be kept in their positions 
(Eckhart et al.,2013). Cells that finally reach the outmost layer are anucleated, elongated 
and dead. These cells are being shed and replaced by outward moving cells 
approximately every two weeks in human. Cells of the basal layer, considered progeny 
stem cells, on their part can arise from epithelial stem cells that reside in the hair follicle 
bulge area (Cotsarelis et al.,1990; Jones and Watt,1993; Jones et al.,1995; Taylor et 
al.,2000; Oshima et al.,2001; Ito et al.,2005; Levy et al.,2007). 
 
Figure 7: Layers of the epidermis 
The different layers of the epidermis are displayed in Figure 7. The basal membrane forms the border 
towards the dermis. On it the cells of the Stratum basale are localized. Those proliferating cells 
differentiate, moving towards the skin surface. During this movement they turn into cells of the Stratum 
spinosum, Stratum granulosum, Stratum lucidum, Stratum conjunctum and Stratum disjunctum. Those 
last two layers together form the Stratum corneum.  
 
Epidermis consists mainly of keratinocytes and hair follicles but also contains 
melanocytes for pigmentation, sensory Merkel cells for pressure detection, dentritic 
Langerhans cells for the immune defense system of the skin and a small amount of 
extracellular matrix proteins. Dermis on the other hand consists mostly of extracellular 
matrix proteins. Cells localized in the dermis are fibroblasts, smooth muscle cells, 
neurons for pain and temperature determination, Mast cells for the immune response 
and arrector pili muscles that are able to raise the hair. The blood vessels of the skin lie 
within the dermis. Hair follicles, sebaceous glands and perspiratory glands reach into 
the dermis but are parts of the epidermis. The opening of the hair channel in the surface 
of the skin is named Infundibulum. Its lower end is aligned with the sebaceous gland 
duct insertion into the hair channel (Schneider et al.,2009).  
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1.2.2 The hair follicle 
The first signs of a developing hair follicle can be found around mouse embryonic 
day 14.5. At this time point a thickening of the epidermis at the side of a later hair 
follicle can be observed. The placode protrudes slightly into the dermis which gives the 
induction signal (first dermal signal) and starts the down growth of the placode into the 
dermis. Thereby a cluster of dermal mesenchymal cells is enveloped by the matrix cells 
of the down growing developing hair follicle, forming the dermal papilla (DP) (Figure 
8) (Hardy,1992; Kishimoto et al.,2000; Wang et al.,2012). The specialized fibroblasts of 
the DP are thought to control the number of matrix cells and through this influencing 
the hair size (Paus and Cotsarelis,1999). The cells of the DP release the second dermal 
signal causing the placode derived cells (matrix cells) to proliferate rapidly thereby 
producing the hair shaft and inducing maturing of the hair follicles (Hardy,1992; Paus 
and Cotsarelis,1999; Kishimoto et al.,2000; Wang et al.,2012). The lower part of the 
hair follicle, where this takes place, is the hair bulb. Reaching the downward boarder of 
the dermis the hair follicle is mature (Alonso and Fuchs,2006). The bulb contains, 
besides the dermal papilla and transient amplifying matrix cells, the hair follicle 
pigmentary unit (Schneider et al.,2009). The pigmentary unit is formed by melanocytes 
distributed in the hair matrix (Paus and Cotsarelis,1999). Melanocytes of pigmentary 
unit of the hair produce the hair pigment and thereby color. They originate in the neural 
crest (Sieber-Blum and Grim,2004; Sieber-Blum et al.,2004). The pattern of hair 
follicles is controlled by activators and inhibitors like proteins of the Wnt (wingless-
type MMTV integration site family) pathway, Dkk-1 (Dickkopf-1), ectodysplasin A 
receptor (Edar) and BMPs (bone morphogenetic proteins) (Fuchs,2007; Wang et 
al.,2012).  
The hair follicle is constantly separated from the dermis by the basement membrane 
and therefore is a structure of the epidermis (Alonso and Fuchs,2006). During down 
growth and rod formation the matrix cells undergo a limited number of cell divisions 
before differentiation. Those transient amplifying cells cause the hair follicles 
enlargement to a diameter of several cells. The inner matrix daughter cells travel 
upward and differentiate into concentric cylinders, building the central hair shaft and 
engulfing the hair channel. This structure is named inner root sheath (IRS) (Figure 8) 
(Alonso and Fuchs,2006). Both the IRS and the hair shaft differentiate into three 
distinguished cell layers (Fuchs,2007). The IRS cells are dead keratinized cells that 
support the hair shaft. The hair shaft is a fibrous structure that consists of compacted 
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terminally differentiated dead keratinocytes (Trichocytes) (Schneider et al.,2009). IRS 
cells accompany the hair shaft during outgrowth and degenerate till they reach the upper 
part of the hair follicle and apoptosis is induced (Lindner et al.,1997). The hair shaft 
growing out of the skin surface is not surrounded by IRS cells anymore (Alonso and 
Fuchs,2006). Besides IRS the hair follicle contains an outer root sheath (ORS). IRS and 
ORS are separated by the companion layer (Fuchs,2007). The ORS also contains 
melanocytes (Staricco,1963), Langerhans’cells (Gilliam et al.,1998) and Merkel cells 
(Kim and Holbrook,1995). It remains in contact to the basement membrane while the 
inner layer that differentiates to form the IRS has no connection to the basement 
membrane (Fuchs,2007). 
 
Figure 8: Skin and hair follicle structure 
Figure 8 shows the layout of the epidermis. The hair follicle and the sebaceous gland are a part of the 
epidermis and are surrounded by the basal membrane. This separates all epidermal structures from the 
dermis. The structural design of the hair follicle with its different compartments is illustrated. 
 
A part of the ORS is the hair bulge. It is located at the insertion of the arrector pili 
muscle below the opening of the sebaceous gland and marks the end of the permanent 
portion of the hair follicle (Figure 8) (Cotsarelis et al.,1990). It contains hair follicle 
stem cells taking part in regeneration of hair during anagen phase (Paus and 
Cotsarelis,1999). During every down growth of the hair follicle a cell layer is added 
giving the typical bulge structure. The bulge stem cells are able to form every cell line 
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of a mature hair follicle (Taylor et al.,2000; Oshima et al.,2001). The bulge remains 
within the skin even if the rest of the hair is ripped out (Cotsarelis et al.,1990).  
 
1.2.3 Hair cycling 
The hair in mammals undergoes a continuous cycle of growth (anagen), regression 
(catagen) and resting (telogen) (Figure 9) (Alonso and Fuchs,2006). In mice the first 
mature hair follicles can be found six days after birth (P6) on their backs (Alonso and 
Fuchs,2006). The hair growth directly after birth still belongs to the hair follicle 
morphogenesis and does not represent the first anagen phase. Only after first catagen 
and telogen phases took place the first real anagen phase follows (Muller-Rover et 
al.,2001). The hair cycle progresses in a wave like form, e.g. first catagen starts at P14 
at the head and reaches the tail around P18 (Alonso and Fuchs,2006). First telogen 
follows at P19 and lasts around two days while later telogen phases can last over two 
weeks (Alonso and Fuchs,2006). The first anagen phase follows around four weeks 
after birth (Muller-Rover et al.,2001). While the mouse ages synchronization between 
hair cycles all over the body decreases (Plikus and Chuong,2008). The correct and 
continuing cycling of the hair needs many different factors and their interactions. For 
example anagen phases are terminated with, among other factors, fibroblast growth 
factor 5 (FGF5) (Hebert et al.,1994; Rosenquist and Martin,1996). Hair follicles during 
this cycle stages are characterized as long and straight, but they are bend to a degree that 
the hair lies flat on the body surface (Alonso and Fuchs,2006). After differentiation of 
all available matrix cells in the hair follicle during anagen phase catagen onset starts 
(Alonso and Fuchs,2006).  
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Figure 9: The hair cycle 
During embryo development the hair follicle morphogenesis starts and continues after birth. The 
follicle elongates, the hair is produced and the hair cycle starts. It is divided into anagen, catagen and 
telogen phase. During catagen phase the hair stops growing and retreats to the skin surface. Through the 
epithelial strand the dermal papilla stays connected and follows towards the surface. Once the regression 
continued till the bulge and arrector pili muscle are reached it stops and the club hair is formed. The 
follicle can rest in telogen phase. Due to a new signal down growth of the follicle is initiated and a new 
hair germ is formed. This and the growth of the hair are included in anagen phase. The new hair produdes 
through the same opening in the skin and continues to grow till the next catagen phase follows. Adapted 
from Fuchs, 2007 (Fuchs,2007)  
 
The catagen phase during hair growth is the phase in which regression takes place. 
This is established through apoptosis of most follicular keratinocytes and additional 
melanocytes (Slominski et al.,1994; Lindner et al.,1997). The end of catagen is 
characterized with condensing of the dermal papilla and its upward movement till it is 
below the hair follicle bulge (Figure 9) (Paus and Cotsarelis,1999). If the DP is not able 
to reach the bulge, the hair is not processed any further and quits the cycling, meaning 
this hair is not regenerated but lost. This process can be induced by hairless protein 
(Ahmad et al.,1998; Panteleyev et al.,1998; Potter et al.,2001). The only known hair 
type where this doesn’t apply are the whiskers of rodents. For those the dermal papilla 
never reaches the bulge during cycling (Fuchs,2007). During catagen apoptosis of 
epithelial cells is observed in ORS and bulge cells but not within cells of the IRS 
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(Lindner et al.,1997). The hair shaft ceases growth, closes and rounds its end thereby 
forming the club hair. It rises up to the non-cycling upper follicle and stays anchored 
there during telogen (Figure 9). An epithelial strand connects the DP with the upper 
follicle and retracts as the DP nears the upper part (Alonso and Fuchs,2006). This strand 
is completely disintegrated when the dermal papilla resides directly underneath the 
permanent and non-cycling upper follicle (Fuchs,2007). 
Resting or quiescence phase of hair follicle cycling is the telogen phase. While 
telogen is named resting phase it does still involve a high number of changes in gen 
activities (Lin et al.,2004). During this phase the hair shaft turns into a dead club hair 
that can be shed later e.g. during washing (Paus and Cotsarelis,1999). During telogen 
the hair follicle stem cells reside on the base of the follicle close to the dermal papilla. A 
new induction signal can stimulate the stem cells causing them to proliferate and form a 
new hair (Alonso and Fuchs,2006). The stem cells that are able to form a new hair 
originate within the bulge (Cotsarelis et al.,1990).  
During anagen phase the new hair is synthesized (Figure 9). The synthesis is similar 
to the morphogenesis of hair during embryonic development (Hardy,1992; Alonso and 
Fuchs,2006). The new hair protrudes through the skin surface using the same opening 
the former hair occupied (Alonso and Fuchs,2006). With aging of the individual the 
telogen phase elongates leading to a decelerated hair growth (Schneider et al.,2009). 
 
1.2.4 Differences in epidermal structures between human and mice 
Although the general layout of the epidermal structures and the hair cycling in 
human and mouse is congruently there are differences in the details.  
For mice the maintenance of the fur is more crucial compared to humans 
(Fuchs,2007). In mice 8 types of hair are discriminated. Those are pelage (coat hair), 
vibrissae (Whiskers), cilia (eyelashes), tail hair, ear hair, hair around feet, nipples, 
genital and perianal area (Nakamura et al.,2001; Schmidt-Ullrich and Paus,2005; 
Schneider et al.,2009). While in humans two major types of hair are discriminated: 
heavily pigmented terminal hair (e.g. on the head) and vellus hair (e.g. on the face) 
(Schneider et al.,2009). In both species the number of hair follicles per cm
2
 is strongly 
dependent on the body region. In mice club hair stay within the hair channel even when 
a new hair starts to grow out the same skin opening. This can happen for more than one 
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cycle, accumulating club hair which contributes to the tightness of the animals fur 
(Schneider et al.,2009). Human club hair are pushed out during the outgrowth of a new 
hair and are lost. At birth humans have around 5 million of hair follicles. While the 
body growth no new hair follicles are added, only existing follicle change their 
appearance and size and thereby the growing hair (Paus and Cotsarelis,1999). While 
human fetal hair follicle cycling is synchronized it starts getting non-synchronized after 
birth. In adult humans every hair has its own cycle rhythm (Paus and Foitzik,2004; 
Schneider et al.,2009). The hair cycle in mice starts in a wavelike form from back to tail 
with a very high synchronization. While aging the synchronicity decreases but is not 
completely lost. The length of the hair cycle phases increases with age in both human 
and mice. In mice this gain is the same for all over the body, while in human the cycling 
of hair varies extremely depending on the body region. The anagen phase of hair 
follicles on the human scalp can last two to 8 years. Within the area of the eyebrow on 
the other hand it only lasts two to three months. Duration of the anagen phase in this 
way also determines the maximal hair length for every tissue area (Paus and 
Cotsarelis,1999). The human scalp hair can rest in telogen phase up to two or three 
months. Each day a number of 50 to 150 scalp hair are shed due to telogen (Paus and 
Cotsarelis,1999). In human testosterone has a strong effect on hair growth. It influences 
the hair via the androgen receptor of the DP (Sawaya,1994; Kaufman,1996). It can 
cause increases in hair follicle sizes as in growth of a beard during male adolescences or 
cause miniaturization of hair follicles on the scalp leading to a bald head. The 
consequence of testosterone depends on the number of androgen receptors, androgen 
metabolism and the secretory response of the dermal papilla cells (Hembree et al.,1996; 
Hibberts et al.,1998)    
For humans the maintenance of a dense layer of epidermis is an important way for 
self-protection of the human body (Fuchs,2007). The epidermis of mice is thick at first 
but thins out two weeks after birth during the first telogen phase and remains thin. It has 
a size of 10-15 µm on the body and in areas with thick epidermis e.g. footpad 
150-400 µm. In both human and mice the epidermis is thicker in areas lacking hair 
follicles.  Human thick epidermis reaches up to 300-400 µm but thin epidermis still has 
a size of 50-100 µm. These differences depend on the number of cell layers within the 
epidermal layers. For example the spinous layer is built by multiple keratinocyte layers 
in humans while in mice it is always one keratinocyte layer. Stratum lucidum does not 
exist in mice and in human it can be found only in hair free areas like the palm. There 
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are different types of glands in human and mice. Mice have vibrissae. Those are not the 
same as whiskers in human males. Human whiskers are terminal hair without further 
use while vibrissae are important e.g. for the orientation in dark. The vibrissae hair bulb 
is surrounded by a blood sinus and free ending nerve fibers. Together those structures 
form a sensory organ.  
Another major difference is the pigmentation of the epidermis. The cells responsible 
for this are melanocytes. In humans they are distributed throughout the epidermis while 
in mice they are only found in the pigmentary unit of the hair and in the hair itself. In 
human melanocyte contribute in a high level to the protection against UV light. The 
number of melanocytes remains the same even if the skin is pigmented stronger. This 
pigmentation only depends on the activation level of the melanocytes. In mice the skin 
color can also change. This is dependent in the hair cycle phase. During anagen phase 
skin is grey to black and converts to a pale pink in telogen phase.  
 
1.2.5 Psoriasis 
In humans various skin diseases are known. Those range from infections, reactions 
to substances, chronic conditions up to cancer. One of the most wildly spread diseases 
with a high impact on the patient’s life quality is psoriasis.  
Psoriasis was described for the first time as a distinguished disease by Robert Willan 
in 1808 (Willan,1808). Psoriasis is a chronic skin disease, with a high variation in 
distribution from 0 % up to 8,5 % in the population dependent on age, race and 
geography (Christophers,2001; Parisi et al.,2013). There are different clinical 
manifestations of psoriasis. Those forms are guttate psoriasis, pustular psoriasis, 
erythrodermic psoriasis and plaque psoriasis (Griffiths and Barker,2007). Plaque 
psoriasis is also known as psoriasis vulgaris and is the most common type of the disease 
(Griffiths and Barker,2007). As most studies were performed on psoriasis vulgaris I will 
furthermore refer to it as psoriasis.  
Except very limited exceptions humans are the only species in which psoriasis 
occurs in nature. Only two cases in monkeys are known so fare. One case describes it in 
a rhesus monkey (Lowe et al.,1981) and another one in a cynomolgus monkey (Zanolli 
et al.,1989). 
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Compared to the rest of the population patients with psoriasis exhibit a decreased 
risk to develop other skin diseases like allergic contact dermatitis (Henseler and 
Christophers,1995). On the other hand the rate of obesity, heart diseases and diabetes 
seems to be elevated but it is not known if those are negatively influenced by psoriasis 
or provide a background for psoriasis outbreak (Henseler and Christophers,1995; 
Basko-Plluska and Petronic-Rosic,2012). The risk for non-melanoma skin cancer, such 
as squamous cell carcinoma and basal cell carcinoma, is raised while melanoma 
development is comparable to non-patient population (Pouplard et al.,2013). The 
increase in non-melanoma skin cancer is dependent on the prior treatment of psoriasis 
with immunosuppressors and PUVA (8-methoxypsoralen-ultraviolet-A) (Pouplard et 
al.,2013). Development of solid tumors that are commonly linked to smoking and 
alcohol consumption are seen more often in psoriasis patients but like diabetes this 
might not be a consequence but a cause of psoriasis (Pouplard et al.,2013).  
The psoriatic areas in patients are sharply distinguishable from non-affected areas. 
Psoriasis plaques are reddish, itchy, scaly and dander are silvery. The disease mostly 
appears on body parts were skin is stretched repeatedly like joints. Additionally nails 
are often affected and an inflammatory arthritis associated with psoriasis (psoriatic 
arthritis) can appear (Moll and Wright,1973; Hertl,2011). In psoriasis uniform 
elongation of rete ridges and acanthosis (thickening of the epidermis) can be seen. 
Simultaneously thinning of suprapapillary epidermis, parakeratosis (nucleus is not 
degraded), increase in amount of capillarys, a thinning or absence of the granula layer 
takes place and leucocytes (e.g. Neutrophils and Mast cells) infiltrate the dermis 
(Griffiths and Barker,2007; Gudjonsson et al.,2007; Hertl,2011). 
According to the point of outbreak of disease psoriasis is subdivided in two types 
(Henseler and Christophers,1985; Stuart et al.,2002). For type 1 psoriasis the first 
outbreak of the disease occurs under the age of 40  (Henseler and Christophers,1985).) 
Type 1 is associated with human lymphocyte antigen (HLA) Cw6 and heredity 
transmission while type 2 is not inherited. Type 2 psoriasis has its onset at an age 
around 60 years (Henseler and Christophers,1985). The gender of the parent 
transmitting psoriasis seems to be of relevance. Children from fathers with psoriasis 
develop the disease more often than those of a mother with psoriasis (Burden et 
al.,1998; Rahman et al.,1999). The same applies for psoriatic arthritis (Rahman et 
al.,1999). The role of a genetic component, which is indicated by psoriasis occurring 
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more often within families, is strengthened by bone marrow transplantations. Patients 
with psoriasis receiving a bone marrow transplant were free of psoriasis afterwards 
(Eedy et al.,1990; Jowitt and Yin,1990; Mori et al.,2012). Another patients receiving 
transplant from a donor with psoriasis was reported to develop psoriasis even while he 
was psoriasis free before (Snowden and Heaton,1997). In addition several possible gene 
loci for psoriasis were found (reviewed in (Basko-Plluska and Petronic-Rosic,2012)). 
As in bone marrow transplant patients the immune cells from the patient are destroyed 
and replaced with immune cells arising from the transplant, those observations 
implicate an involvement of the immune system in psoriasis development (Snowden 
and Heaton,1997).  
Psoriasis is considered an autoimmune disease caused by B- and/or T-cell activation 
without a detectable inflammation or other source (Davidson and Diamond,2001). The 
T-cell population accumulating in psoriasis produces type 1 cytokines and expresses 
Interleukin-17 (Uyemura et al.,1993; Teunissen et al.,1998). In non-affected skin areas 
of psoriasis patients levels of some cytokines, e.g. TNF-α, IL-1α and IL-1β, are raised 
compared to non-patient population (Uyemura et al.,1993). Additionally T helper cells 
type 1 and type 17 were identified in psoriasis lesions (Lowes et al.,2008). Both 
Interleukine-17 level and Interleukine-22 expression is elevated in psoriasis (Wolk et 
al.,2006; Lowes et al.,2008). The expression patterns of many proliferation modulating 
factors were researched in the skin of psoriasis patients. For example Signal transducers 
and activators of transcription 3 (Stat3) is activated in psoriasis (Sano et al.,2005) and 
blockage of Stat3 activation with STA-21 (deoxytetrangomycin, antibiotic) leads to a 
recovery of psoriasis (Song et al.,2005; Miyoshi et al.,2011). In cell culture STA-21 
reduces the expression of the Stat3 transcriptional target and cell cycle progression 
promoter c-Myc (myelocytomatosis oncogene) (Miyoshi et al.,2011). An up regulation 
of c-Myc can be seen in culture of cells from psoriasis lesions but the level of c-Myc 
and p53 expression was found to be unchanged in psoriasis patients (Elder et al.,1990; 
Schmid et al.,1993). This indicates differences between cells within the actual lesion 
and cells of psoriasis patients in culture. Therefore the underlying processes of psoriasis 
cannot be mimicked in cell culture. For research on psoriasis various mouse models 
were created. They include spontaneous, transgene, reconstituted and xenograft models 
but none were able to mimic human psoriasis in all known factors (Gudjonsson et 
al.,2007; Wagner et al.,2010; Johnson-Huang et al.,2012; Augustin et al.,2013; Perera et 
al.,2014). This is due to differences in the skin of human and mice described before.  
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1.2.6 DNA damage in the skin  
The skin forms the outer barrier of the body against the environment. Due to this 
barrier function and the exposure to UV from sunlight, the skin cells have a high risk to 
DNA damages caused by exogenous factors. Epidermal cells also have an elevated risk 
to obtain DNA damages due to mistakes during replication because skin cells undergo a 
constant proliferation and division to replace the shed cells. In addition the IR from 
radiotherapeutic treatment has a high effect on skin. This is indicated by occurrence of 
acute and chronic dermatitis and a higher rate of skin cancers in patients with IR 
treatment (Goldschmidt and Sherwin,1980). In all cases proper DNA damage signaling 
and repair is essential to maintain a functional and healthy skin. As the example of NBN 
deficient patients shows, a defective DNA damage signaling and repair causes a vast 
number of different defects in the skin up to development of skin cancer.  
About the concrete functions and pathways of DNA damage signaling and repair in 
skin little is known. So fare it was shown that continuous application of UV radiation 
results in a reduced speed in degradation of the UV products in epidermal stem cells and 
progenitor cells compared to more differentiated skin cells (Nijhof et al.,2007). This can 
raise the amount of DNA damages after a certain dose of UV. It was observed that the 
apoptosis rate after UV B depends strongly on the epidermal layer. It decreases from the 
inner layer to the outer layer (Schafer et al.,2010). Basal cells show a high rate of 
apoptosis while suprabasal cells show much lower apoptosis levels (Schafer et 
al.,2010). After UV B irradiation NFE2L2 (Nuclear factor (Erythroid-derived 2)-like 2) 
expression selectively protects suprabasal keratinocytes against apoptosis by activation 
of cytoprotective genes and resulting amplified ROS detoxification (Schafer et 
al.,2010). This finding explains the apoptosis gradient after UV B application and the 
mechanism might contribute to skin cancer prevention by eliminating damaged stem 
cells that are located in the basal epidermal layer (Schafer et al.,2010). On the other 
hand it was also demonstrated the epidermal stem cells are resistant to radiation while 
progenitors are irradiation sensitive (Rachidi et al.,2007). The irradiated epidermal stem 
cells show a down regulation in genes involved in apoptosis while genes enhancing the 
proliferation are up regulated compared to progenitor cells (Rachidi et al.,2007). For 
example p53 is normally expressed throughout the complete epidermis but after a 
phosphorylation due to UV light phosphorylated p53 can only be observed in basal 
epidermal layers, where the epidermal stem cells are located (Finlan et al.,2006). In 
addition activation of EGFR (epidermal growth factor receptor) can be observed in 
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epidermal cells after UV treatment (El-Abaseri et al.,2006). EGFR activation leads to an 
elevated rate of proliferation of epidermal cells and a suppression of apoptosis. Both 
functions of EGFR can contribute to formation of epidermal hyperplasia (El-Abaseri et 
al.,2006).   
In keratinocyte stem cells DNA breaks, both single and double strand breaks, are 
repaired faster and more efficient then in keratinocyte progenitors (Harfouche et 
al.,2010). The fast repair is dependent on the level of Fgf2 (fibroblast growth factor 2), 
which is lower in progenitors (Harfouche et al.,2010). Artificial elevation of Fgf2 in 
progenitors leads to an increase in repair activity comparable to that seen in epidermal 
stem cells (Harfouche et al.,2010). This fast repair in epidermal stem cells contributes to 
the resistant of stem cells against apoptosis as damages are repaired before cell cycle 
checkpoints can be activated. Along with the findings in keratinocyte stem cells, 
multipotent hair follicle bulge stem cells have develop two mechanisms to raise their 
resistance against cell death due to DNA damages (Sotiropoulou et al.,2010). They 
show stabilization of p53 and a higher expression of Bcl-2 (B-cell lymphoma 2) 
(Sotiropoulou et al.,2010). In addition they also have an elevated rate of NHEJ DNA 
repair that is controlled by DNA-PK (Sotiropoulou et al.,2010). NHEJ is known to be 
error prone and a consequence of these mechanisms in hair follicle stem cells is the 
accumulation of DNA damages without undergoing a necessary apoptosis. This raises 
the risk to develop skin cancers.  
These findings illustrate the importance of proper DNA damage signaling and repair 
in the epidermis. Two mouse models with a deletion of a DNA damage signaling 
protein underline this. The deletion of ATR and ATR and p53 in adult mice leads to a 
defect in hair follicle regeneration and a high inflammation of the inner epithelium 
(Ruzankina et al.,2007; Ruzankina et al.,2009). This effect is more prominent in double 
deleted animals than in those with Atr deletion alone. Albeit slow both double and 
single defective animals regenerate hair follicles (Ruzankina et al.,2009(Ruzankina et 
al.,2007)). After continuous depilation in ATR deleted mice the hair is not regenerated 
due to a loss of hair follicle stem cells (Ruzankina et al.,2007). The animals show an 
accumulation of defective cells in the epidermis that inhibit the regeneration of new 
cells from the healthy epidermal stem cells. The inflammation of the intestine finally 
results in the death of the animals (Ruzankina et al.,2009). Brca1 deficiency after 
embryonic day E12 in mice results in a reduced number of hair follicles and a 
  Introduction 
34 
 
continuous degeneration of the existing hair follicles (Sotiropoulou et al.,2013). No hair 
is formed and the hair follicle stem cells are lost during aging of the animal. A 
combined deletion of p53 completely rescues the Brca1 phenotype (Sotiropoulou et 
al.,2013). In adult mice deletion of Brac1 leads to an impairment in regeneration of hair 
(Sotiropoulou et al.,2013). 
 
1.3 Krox20  
A long term study on the effect of deletion of the DNA damage signaling and repair 
protein Nbn in the skin and its influence on hair follicle regeneration and cycling was 
conducted. Therefore a mouse model with a knockout that would not affect the inner 
epithelium to such an extent as in the Atr and p53 deficient mice was needed 
(Ruzankina et al.,2009). Additionally the risk for premature lethality had to be limited 
and the possibility for the mice to properly start the development of normal skin and 
hair follicles before the onset of the knockout was wanted. Therefore an Nbn deletion 
under Krox20-Cre recombinase was done in this study.  
Krox20 is also known as EGR2 (early growth response 2) (Joseph et al.,1988). In 
the following I will always refer to it as Krox20 as the Cre recombinase is named 
Krox20-Cre recombinase. The Krox20 gene encodes a transcription factor containing 
three zinc-finger domains which is active during G0/G1 phase (Chavrier et al.,1988; 
Chavrier et al.,1990). Expression of the 3,2 kb transcript is observed in testis, thymus, 
spleen, epidermis, hair follicle, neural crest cells and in the developing CNS (Chavrier 
et al.,1988; Wilkinson et al.,1989; Gambardella et al.,2000; Young et al.,2003). Krox20 
controls myelination of the Schwann cells and therefore the myelination within the 
peripheral nervous system (Topilko et al.,1994). Deletion of Krox20 leads to 
uncompleted myelin sheaths, continuous proliferation and apoptosis of Schwann cells 
(Topilko et al.,1994; Zorick and Lemke,1996). In Schwann cells the expression of 
Krox20 inhibits apoptosis via TGFβ (Transforming growth factor β) and inactivates 
JNK(c-Jun N-terminal kinase)-c-Jun pathway thereby causing cell cycle exit and 
subsequently proliferation arrest (Parkinson et al.,2004). These functions of Krox20 
serve to protect Schwann cells and ensure an elongated lifetime of these cells. In 
addition a role in endochondral formation of bones was described (Levi et al.,1996) and 
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its deletion results in alteration of hindbrain development (Schneider-Maunoury et 
al.,1993).    
Krox20 expression was described within the epidermis and the hair follicle starting 
during the hair follicle development and continuing after birth (Gambardella et al.,2000; 
Young et al.,2003). It was demonstrated that the expression of Krox20 has its onset at 
E16 as small patterns in epithelial cells on the upper part of the hair germ (Gambardella 
et al.,2000). At E19 it can be found in the sebaceous gland, the bulge area and the 
developing hair canal (Gambardella et al.,2000). Shortly before (E21) and after birth 
Krox20 is expressed in the lower part of the hair germ and remains expressed in the 
inner layer of the ORS of the hair (Gambardella et al.,2000). Additionally it is expressed 
in keratinocytes of the hair matrix (Gambardella et al.,2000). This expression is 
observed on both sides of the dermal papilla (Gambardella et al.,2000; Schlake,2006). 
Due to a colocalization and putative binding sides with Igfbp5 (Insulin-like growth 
factor binding protein 5) a role of Krox20 in hair shaft differentiation and zigzag hair 
development was suggested (Schlake,2006) .  
The expression pattern of Krox20-Cre recombinase in the skin was studied and 
overall matches with the Krox20 expression (Young et al.,2003). It starts at P1 as sparse 
and small patterns in the back skin of the mice (Young et al.,2003). Then it can be 
found in the epidermis around the hair follicle and the upper parts of the hair follicle 
(P10 to P18) (Young et al.,2003). In adult mice Krox20-Cre expression can be seen in 
the complete back skin but is absent in the tail and footpad skin (Young et al.,2003).  
 
1.4 Project 
Skin is the outer protection for our body and is exposed to various damaging agents 
all the time. Therefore a functioning damage repair is essential to maintain the barrier 
function of the skin. That malfunction of DNA damage signaling and repair has a broad 
impact on the skin can be seen as NBS patients show miscellaneous pathologies of the 
skin. Still little is known about the DNA damage response and repair pathways and 
functions in the skin.  
To examine the role of Nbn in skin and hair follicles mice with a knockout of Nbn in 
Krox20 specific tissue were generated. With this model the influence of Nbn in the 
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homeostasis of the skin and hair was researched as the onset of deletion occurs after 
birth of the mice. This was the first study to evaluate the function of Nbn in skin.  
The interesting question on whether Nbn and Atm function together in DNA 
damage signaling and repair in the skin was looked into. As p53 is known to play a role 
in cell cycling and apoptosis the influence of p53 on the Nbn deleted mice was worth 
investigating. Furthermore a rescue of a neurological phenotype with the combination 
of Nbn deletion and p53 was observed (Frappart et al.,2005). On the other hand the 
phenotype was aggravated by a deletion together with Atm (Dar et al.,2011). Those 
studies were performed in the neuronal system of the mice and the question was if those 
observations are similar in skin. Therefore mice with an additional Atm or p53 deletion 
were created. 
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 Materials and Methods 2.
2.1 Materials 
2.1.1 Buffers and Solutions 
 Chemicals Concentration 
Antigen 
Retrieval 
Solution 
 
Citric Acid 
Sodium Citrate 
Tween 20 
ddH2O 
 
1,8 mM 
8,2 mM 
0,05 % 
  
 
Blocking 
Solution 
BSA 
Triton X100 
Normal goat serum  
PBS 1x 
 
1 % 
0,4 % 
5 % 
  
 
Eosin solution Eosin Y 
Ethanol 70 % 
 
14 mM 
 
Hematoxylin 
solution 
Hematoxylin 
ddH2O 
Sodium iodate  
Potassium aluminum sulfate dodecahydrate  
Chloral hydrate 
Citric acid monohydrate 
 
3 mM 
1 l 
1 mM 
105 mM 
303 mM 
4 mM 
 
PCR Buffer with 
MgCl2 
KCl 
Tris-HCl pH=8.3 
MgCl2 
ddH2O 
 
0,5 M 
0,1 M 
0,015 M 
 
PBS 10X 
 
Sodium Chloride 
Potassium Chloride 
Di-Sodium hydrogen phosphate dihydrate 
Potassium dihydrogen phosphate 
ddH2O 
 
137 mM 
27 mM 
10 mM 
2 mM 
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Tail Buffer Tris-HCl (pH=8) 
EDTA 
SDS 
NaCl 
ddH2O 
 
50 mM 
100 mN 
1 % 
100 mM 
  
 
TE 10/1 Tris-HCl (pH=7,5) 
EDTA 
ddH2O 
 
1 M 
0,5 M 
  
 
 
2.1.2 Antibodies 
2.1.2.1 Primary Antibodies 
Name Acronym Host Company 
anti Neutrophils  Neutrophils  Rat Acris antibodies 
Anti-Cytokeratin 15 K15 Mouse Abcam 
Anti-gamma H2A.X (phospho S139) γH2A.X Rabbit Abcam 
Anti-IL17 IL-17 Rabbit Abcam 
Caspase-3 activ  Caspase 3 Rabbit BD Biosciences 
Keratin 10 K10 Rabbit Covance 
Keratin 14 K14 Rabbit Covance 
Ki67 (SP6) Ki67 Rabbit Thermo Scientific 
p53 (CM5) p53 Rabbit Vector Laboratories 
p63 (H-137) p63 Mouse Santa Cruz 
PCNA (PC10) PCNA Mouse Santa Cruz 
Phospho-Akt (Ser473) pAkt Rabbit Cell signaling 
Phospho-Histone H3 (Ser10) H3P Mouse Cell signaling 
Phospho-S6 (Ser235/236) S6 Rabbit Cell signaling 
Phospho-specific p44/42 MAPK 
(Erk1/2) 
Erk1/2 Rabbit Cell signaling 
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Phospho-Stat3 (Try705) (D3A7) pStat3  Rabbit Cell signaling 
Anti-CD3 CD3 Rabbit Rockland 
Immunochemicals  
53BP1 53BP1 Rabbit Bethyl Laboratories 
 
2.1.2.2 Secondary Antibodies 
Name Host Company 
Anti-Mouse IgG (H+L)-Cy3 donkey Dianova 
Anti-Rabbit IgG (H+L)-Cy3 donkey Dianova 
Anti-Mouse IgG (H+L)-FITC donkey Dianova 
Anti-Rabbit IgG (H+L)-FITC donkey Dianova 
Anti-Mouse IgG (H+L)-Biotin goat Jackson 
Anti-Rabbit IgG (H+L)-Biotin goat Dianova 
Anti-Rat IgG (H+L)-Biotin goat Jackson 
Anti-Mouse IgG (H+L)-HRPO goat Dianova 
Anti-Rabbit Immunoglobulins/HRP goat Dako 
 
2.1.3 Primers 
Primer Sequence (5’-3’) 
ATMc P1 CCCAGTGTATATGCCACCGACTGAG 
ATMc P2 ACCACTCGAAGAACACCGCTTCGC 
ATMc P3 GCCTGGTCTACATCCTGAGCTCCAGGACAGCC 
HPRT F GCTGGTGAAAAGGACCTCT 
HPRT R CACAGGACTAGAACACCTGC 
Krox20-3F GTGTCGCGCGTCAGCATGCGTG 
Krox20-4R GGGAGCGAAGCTACTCGGATACGG 
Nbn 102F ATGTGGAAGCTGCTCCCGGC 
Nbn 648R CTGTTTCTTAGATTCAACTGC 
Nbs Intron 5 F ATAAGACAGTCACCACTGCG 
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Nbs LoxPtestR AATACAGTGACTCCTGGAGG 
NeoSeq#5 TGGGCTCTATGGCTTCTGA 
P53neo18.5 TCCTCGTGCTTTACGGTATC 
P53x6.5 TATACTCAGAGCCGGCCT 
P53x7 ACAGCGTGGTGGTACCTTAT 
 
2.1.4 Chemicals and Kits 
Chemical Company 
2-mercaptoethanol Gibco 
Acetic acid Roth 
Agarose Axygen 
Biotin-16-dUTP Roche 
Bovine Serum Albumin Fraction V (BSA) Sigma 
Chloral hydrate Roth 
Citric acid monohydrate Roth 
Di-Sodium hydrogen phosphate dihydrate Merck 
Dispase II Roche 
DMEM Gibco 
DPX Sigma-Aldrich 
Eosin Y Roth 
Ethanol Roth 
Ethylendiamin tetraacetic acid (EDTA) disodiumsalt 
dihydrate 
Roth 
Formaldehyde Sigma 
Giemsa solution Sigma-Aldrich 
Glycine Roth 
Hematoxylin Merck 
Hepes Gibco 
Hydrogen peroxide Roth 
Magnesium chloride Sigma 
Methanol Sigma-Aldrich 
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Methyl green chloride salt Sigma-Aldrich 
Normal goat serum  Vector Laboratories 
Paraformaldehyde Sigma-Aldrich 
Potassium aluminum sulfate dodecahydrate Roth 
Potassium chloride Sigma 
Potassium dihydrogen phosphate Merck 
Proteinase K Roth 
Roti-Phenol Roth 
Sodium chloride Roth 
Sodium citrate Roth 
Sodium dodecylsulfate (SDS) Serva 
Sodium iodate Roth 
Sodium pyruvate Gibco 
Streptavidin-Cy3 Sigma 
Sucrose Roth 
SuperScript® II Reverse Transcriptase Invitrogen 
Terminal Deoxynucleotidyl Transferase (TdT)  Thermo Scientific 
Tris-base Sigma 
Triton X100 Sigma 
TRIzol Invitrogen 
Trypsine Gibco 
Tween 20 Roth 
Vectashield mounting medium with DAPI  Vector Laboratories 
Vectastain ABC Kit Vector Laboratories 
VIP peroxidase substrate kit  Vector Laboratories 
Xylene AppliChem 
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2.1.5 Instruments 
Instrument Company 
TPersonal Thermocycler Biometra 
DNA Engine Thermal Cycler PTC-200 Bio-Rad 
PowerPac Basic Bio-Rad 
UV Transilluminator UST-20M-8K Biostep 
EF 28mm f/1.8 USM Canon 
EOS 500D Canon 
Centrifuge 5415R Eppendorf 
Centrifuge 5418 Eppendorf 
Centrifuge 5804R Eppendorf 
Thermomixer compact Eppendorf 
MR Hei-Standard Heidolph Instruments 
Unimax 1010 Heidolph Instruments 
Manual Rotary Microtome RM2235 Leica Biosystems 
Water bath HI1210  Leica Biosystems 
NanoDrop 1000 PEQLAB 
Basic pH Meter PB-11 Sartorius 
pH-Einstabmesskette PY-P10 Sartorius 
Vortex Genie 2 Scientific Industries 
Cyber-shot DSC-W230 Sony 
Bioblock Scientific 92675 Thermolyne Corp. 
Excelsior ES Tissue Processor Thermo Fisher Scientific 
AxioCam MRc Zeiss 
AxioImager.A2 Zeiss 
HAL 100 halogen illuminator Zeiss 
HBO 100 Microscope Illuminating                          
System 
Zeiss 
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2.1.6 Software 
Software Company 
Adobe Illustrator Adobe Systems 
AxioVision Zeiss 
Microsoft PowerPoint Microsoft Corporation 
Microsoft Word Microsoft Corporation 
Sigma Plot Systat Software, Inc 
 
2.2 Methods 
2.2.1 Animals 
Animals were kept in the DKFZ (Deutsches Krebsforschungszentrum, Heidelberg, 
Germany) animal facility with a 12 hours day and 12 hours night rhythm. Cages were 
individually ventilated. Animals were feed ad libitum. 
Killing of the animals was done with CO2 and cervical dislocation.  
 
2.2.1.1 Tissue preparation 
After animals were killed the back skin was collected. The tissue was fixated in 4 % 
Paraformaldehyde overnight at 4 °C and partially kept in PFA for storage.  
To embed tissue samples in paraffin they were placed in plastic holders and 
embedded using the tissue processor Excelsior ES. This was performed in the routine 
laboratory of the neuropathology (DKFZ, Heidelberg, Germany). Sections were done 
using a microtome. Skin was cut into 5 µm thigh sections. They were collected on glass 
slides, dried at 37 °C overnight and stored in boxes at room temperature.  
 
2.2.2 Gene targeting 
Deletion of Nbn in the mice was accomplished through excision of Exon 6 using 
LoxP sites and Cre recombinase. The gene targeting strategy is described by Frappart et 
al. (Frappart et al.,2005) and is shown in Figure 10. For the studie of Nbn function in 
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the skin Nbn deleted mice were crossed with Krox20-Cre mice (Young et al.,2003) to 
obtain mice with Nbn depletion in the epidermis.  
The Krox20-Cre mice were described by Voiculescu et al. (Voiculescu et al.,2000) 
and were kindly provided by Patrick Charnay (Institut National de la Sante´ et de la 
Recherche Medicale, Ecole Normale Superieure, Paris, France). Furthermore mice were 
crossed with Atm and p53 deficient mice. Mice deficient for p53 (B6.129S2-
Trp53
tm1Tyj
/J) were as described by Jacks et al. (Jacks et al.,1994) and were obtained 
from Jackson Laboratory (Bar Harbor, Maine). Atm deficient mice were described by 
Herzog et al. (Herzog et al.,1998) and were kindly provided by Peter J. McKinnon (St. 
Jude Children’s Research Hospital, Memphis, USA).  
 
 
Figure 10: Gene targeting strategy 
The gene targeting strategy for generation of Nbn deficient mice is shown in Figure 10. Exons 5, 6 
and 7 are depicted. The localization of inserted Neomycin (Neo) cassette and LoxP sites are indicated. 
The consequences of Homologous and Cre recombination are visualized.  
 
2.2.2.1 Study group for deletion in the skin 
The control group (Nbn
Ctrl
) contained two genotypes Nbn
F/F
Krox20-Cre
-
 and 
Nbn
F/Δ
Krox20-Cre
-
. Nbn
Krox20-Cre
 group consisted of Nbn
F/F
Krox20-Cre
+
 and 
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Nbn
F/Δ
Krox20-Cre
+
 mice. The group of p53 deleted mice (Nbs1
Krox20-Cre
p53
-/-
) contained 
mice with the genotypes Nbn
F/F
p53
-/-
Krox20-Cre
+
 and Nbn
F/Δ
p53
-/-
Krox20-Cre
+
. Mice 
with the genotypes Nbn
F/F
Atm
F/F
Krox20-Cre
+
 and Nbn
F/Δ
Atm
F/F
Krox20-Cre
+ 
formed the 
group of Nbn/Atm
Krox20-Cre
 mice.   
 
2.2.3 Confirmation of genotypes 
To verify the correct genetic background of mice their DNA was isolated, amplified 
and analyzed. 
 
2.2.3.1 DNA isolation 
To isolate the DNA from tissues for mice the tip of the tails were collected in a 
1,5 ml Eppendorf tube. 500 µl Tail Buffer and 25 µl Proteinase K (10 mg/ml) were 
added to the sample. It was incubated overnight at 55 °C or 2 h at 55 °C (shaking with 
1000 rpm). Afterwards the sample was completely dissolved by vortexing. 300 µl NaCl 
(5 M) were added, it was vortexed and centrifuged 7 min at 14.000 g. The supernatant 
was transferred into a new Eppendorf tube, 500 µl Isopropanol (100 %) were added, 
vortexed and centrifuged 7 min at 14.000 g. Supernatant was discarded. 500 µl Ethanol 
(70 %) were added and the sample was centrifuged 7 min at 14.000 g. All Ethanol was 
discarded and the pellet was air-dried at room temperature. Then 100 µl TE10/1 were 
added and the sample was vortexed to dissolve the DNA.  
 
2.2.3.2 Polymerase chain reaction for DNA 
For each genotype a different polymerase chain reaction (PCR) was performed to 
amplify the corresponding DNA fragments from the isolated samples. 
Atm 
 Concentration Volume [µl] 
PCR Buffer with MgCl2 10 x 2 
dNTP 10 mM 0,5 
ATMc P1 10 µM 1 
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ATMc P2 10 µM 1 
ATMc P3 10 µM 1 
Taq 5 U/µl 0,4 
H2O  14,1 
   
Total  19 
 
Step Temperature [°C] Time 
Denaturation 94 3 min 
Denaturation 94 30 sec 
Annealing 61 30 sec 
Elongation 68 30 sec 
Elongation 68 7 min 
Keeping in machine 18  
The expected DNA fragments were Floxed (897 bp), wild-type (797 bp) and Delta 
(374 bp).  
Krox20-Cre 
 Concentration Volume [µl] 
PCR Buffer with MgCl2 10 x 2 
DMSO 100% 1 
dNTP 10 mM 0,5 
Krox20-3F 10 µM 0,75 
Krox20-4R 10 µM 0,75 
NeoSeq#5 10 µM 0,75 
Taq 5 U/µl 0,2 
H2O  13,05 
   
Total  19 
 
45x 
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Step Temperature[°C] Time 
Denaturation 94 5 min 
Denaturation 94 30 sec 
Annealing 60 45 sec 
Elongation 68 1 min 
Elongation 68 7 min 
Keeping in machine 18  
The expected DNA fragments were wild-type (165 bp) and Krox20-Cre (900 bp). 
Nbn 
 Concentration Volume [µl] 
PCR Buffer  with MgCl2 10 x 2,5 
dNTP 10 mM 0,5 
Nbs Intron 5 F 10 µM 1 
Nbs LoxPtestR 10 µM 1 
Taq 5 U/µl 0,4 
H2O  17,6 
   
Total  23 
 
Step Temperature [°C] Time 
Denaturation 94 4 min 
Denaturation 94 30 sec 
Annealing 60 1 min 
Elongation 65 2 min 30 sec 
Elongation 65 7 min 
Keeping in machine 18  
The expected DNA fragments were wild-type (1432 bp), Floxed (1160 bp) and Delta 
(576 bp).  
 
45x 
45x 
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p53 
 Concentration Volume [µl] 
PCR Buffer with MgCl2 10 x 2,5 
dNTP 10 mM 0,5 
P53x7 10 µM 0,75 
P53x6.5 10 µM 0,75 
P63neo18.5 10 µM 0,75 
Taq 5 U/µl 0,4 
H2O  17,35 
   
Total  23 
 
Step Temperature [°C] Time 
Denaturation 95 4 min 
Denaturation 95 30 sec 
Annealing 60 2 min 
Elongation 68 2 min 
Elongation 68 5 min 
Keeping in machine 18  
The expected DNA fragments were wild-type (450 bp) and knockout (650 bp).  
 
2.2.3.3 DNA gel 
DNA fragment size and availability were measured using gel electrophoresis to 
separate the fragments according to their sizes. Therefore an agarose gel was used, 
samples were loaded together with loading buffer and the gel was run with 120 V. Gel 
concentration was dependent on the fragment sizes expected. 2 % gels were used for 
small and 1,5 % gels for middle to big sized DNA fragment separation.   
 
45x 
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2.2.4 Visualization in the skin 
Morphology, cell distribution and the existence of proteins and their modifications 
within tissue samples were visualized. Visualization of protein expression, 
modifications and potential colocalization in the mouse tissue was done via 
Immunohistochemistry and Immunofluorescent staining. Hematoxylin and eosin 
staining was performed for morphological analysis. Mast cells distribution in the skin 
was detected by Giemsa staining. TUNEL (TdT-mediated dUTP-biotin nick end 
labeling) reaction was performed to show apoptotic cells.  
For all staining procedures paraffin had to be removed from the sections. Threfore 
paraffin slides were deparaffinized by putting them in Xylene three times and into 
Ethanol with declining concentration (100 %, 95 %, 70 %, 50 %) for 5 min each. 
Afterwards slides were washed in water. Washing steps were always performed with 
PBS 1x if not mentioned otherwise.  
 
2.2.4.1 Immunohistochemistry  
Slides were boiled (2 times 5 min at 700 W in microwave) in unmasking and 
antigen retrieval solution. After cooling down paraffin slides were treated for 20 min 
with 3 % Hydrogen peroxide. The sections were washed with PBS 1x and blocked with 
blocking solution for 1 hour. The primary antibody was diluted in blocking solution and 
applied to the slides overnight. The next day slides were washed and the secondary 
antibody was diluted in blocking solution. It was incubated on the slides for 1-2 hours. 
After washing ABC complex was applied for 30 min at 37 °C. Slides were washed and 
developed with VIP peroxidase substrate kit to reach a sufficient staining. Afterwards 
sections were counterstained with Methyl green chloride salt solution and dehydrated by 
putting them in Ethanol (70 %, 95 %, 100 %) and three times into Xylene. Slides were 
mounted with DPX, left to air-dry and stored at room temperature.    
 
2.2.4.2 Immunofluorescent staining 
Fluorescent staining with one antibody is similar to immunohistochemistry staining. 
The beginning procedure was the same. The secondary antibody (FITC for green, Cy3 
for red) was incubated on the sections for 1 hour at 37 °C. Then mounted with Vector 
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shield mounting medium containing 4',6-diamidino-2-phenylindole (DAPI) and stored 
at 4 °C in the dark.  
Two proteins in the same tissue were visualized with a fluorescent double staining. 
For a double staining the same procedure as for immunohistochemistry was used to 
begin with. When both primary antibodies were known to have a specific binding they 
were applied at the same time. Both secondary antibodies were also applied together. If 
the binding of one antibody was weak this antibody was applied first and also bound 
with its secondary antibody. Afterwards the second primary antibody was incubated 
overnight and its secondary antibody was administered the next day. Mounting with 
Vector shield mounting medium containing DAPI was done after both antibodies and 
their respective secondary antibodies were bound to the sections.  
 
2.2.4.3 Hematoxylin and eosin staining  
First the slides were deparaffinized and then stained with Hematoxylin solution 
(after Mayer). Afterwards they were washed in water for the desired staining. Slides 
were stained with Eosin solution and residual staining was removed by washing in 
water. Dehydration was performed and the slides were mounted with DPX, dried and 
stored at room temperature.  
The Hematoxylin and eosin staining was performed in the routine laboratory of the 
neuropathology (DKFZ, Heidelberg, Germany). 
 
2.2.4.4 Giemsa staining 
Giemsa staining was done to visualize Mast cells in the skin samples. The slides 
were deparaffinized and afterwards stained in preheated Giemsa solution. A washing 
step in water was done and slides were treated with Acetic acid 1 %. Slides were 
washed with water and three changes each of Methanol and Xylene prior to mounting 
with DPX. 
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2.2.4.5 TUNEL 
TUNEL reaction was performed to visualize the DNA fragmentation in apoptotic 
cells. The slides were deparaffinized and washed with PBS 1x. Then slides were 
incubated with the TUNEL reaction mix (for 50 µl: Buffer TdT 5x 10 µl + dUTP-biotin 
0,33 µl + TdT 20 U/µl 0,75 µl + H2O 38,92 µl) for 1,5 hours at 37 °C. After washing 
ABC complex was applied for 30 min at 37 °C. Slides were washed and developed with 
VIP peroxidase substrate kit to reach a sufficient staining. Afterwards sections were 
counterstained with Methyl green chloride salt solution and dehydrated by putting them 
in Ethanol (70 %, 95 %, 100 %) and three times into Xylene. Slides were mounted with 
DPX, left to air-dry and stored at room temperature. 
When a double staining with an antibody was conducted the TUNEL reaction mix 
was used but no ABC complex was applied. The sections were washed with PBS 1x and 
blocked with blocking solution for 1 hour. The primary antibody was diluted in 
blocking solution and applied to the slides overnight. The next day slides were washed, 
a secondary antibody (FITC) was diluted in blocking solution together with 
Streptavidin-Cy3. The slides were incubated for 45 min at 37 °C. Afterwards they were 
mounted with Vector shield mounting medium containing DAPI and stored at 4 °C in 
the dark. 
 
2.2.5 Keratinocyte isolation 
In 50 ml Medium 0,25 g Dispase II were dissolved. Animals were killed. The back 
was shaven and back skin was isolated. The skin was put dermal side down in 
Dispase II solution overnight at 4 °C. The next day epidermis and dermis were 
separated. The epidermis was shaken in Trypsine 5x for 30 min at room temperature. 
Medium was added to stop Trypsine and cells were singularized. Afterwards the 
medium was filtered through a cell strainer to remove the debris of hair. The medium 
containing single cells was centrifuged for 10 min at 405 g. The liquid was removed and 
cells were suspended in PBS 1x.  
 
2.2.6 Protein expression analysis via mRNA 
The deletion of Nbn in the epidermis was confirmed by an analysis of mRNA of the 
keratinocytes. RNA was isolated from the epidermal cells and via revers transcription 
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translated into cDNA (complementary DNA). The amount of cDNA was amplified with 
a PCR and existence or absence of the Nbn fragment was visualized. To confirm the 
result Hypoxanthin-Phosphoribosyl-Transferase (HPRT) expression analysis was used 
as control.  
 
2.2.6.1 RNA isolation 
PBS 1x was removed from the cells and Trizol was added. Samples were 
homogenized and incubated at room temperature. Rotiphenol was added and incubated 
at room temperature. Afterwards samples were centrifuged and the aqueous phase, 
containing the RNA, was transferred into a new tube. Isopropanol was added. The 
sample was mixed and incubated at room temperature. RNA was pelleted and washed 
with Ethanol 70 % to remove salts. Ethanol was discarded and the RNA pellet was 
air-dried at room temperature. It was dissolved in DNase/RNase free water. The 
concentration was measured using NanoDrop 1000. 
 
2.2.6.2 cDNA synthesis 
cDNA was synthesized using SuperScript® II Reverse Transcriptase. It was done 
according to the product manual using 2 µg of RNA.  
 
2.2.6.3 PCR for RNA analysis 
PCR was performed with 2 µl of reverse transcription product.  
 Concentration Volume [µl] 
PCR Buffer with MgCl2 10 x 2 
dNTP 10 mM 2 
HPRT F 10 µM 1 
HPRT R 10 µM 1 
Nbn 102F 10 µM 1 
Nbn 648R 10 µM 1 
Taq 5 U/µl 0,2 
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H2O  9,8 
   
Total  18 
 
Step Temperature [°C] Time 
Denaturation 95 4 min 
Denaturation 95 30 sec 
Annealing 61 1 min 
Elongation 68 1 min 
Elongation 68 7 min 
Keeping in machine 18  
The expected fragments were Nbn (567 bp) and HPRT (249 bp). 
 
2.2.6.4 RNA gel 
RNA fragment size and availability were measured using gel electrophoresis to 
separate the fragments according to their sizes. Therefore an agarose gel was used, 
samples were loaded together with loading buffer and the gel was run with 120 V. Gel 
concentration was 1,5 %.   
 
2.2.7 GEO data analyses  
Data on NBN expression in human psoriasis was obtained from GEO Profiles 
database (Edgar et al.,2002; Barrett et al.,2013). The GEO accessions were analyzed 
using the GEO2R analysis tool provided on the accession display for each GEO data set 
and values for NBN were extracted. Additionally the GEO Profiles of each data set 
were searched for NBN. Values from the GEO2R analyses and GEO Profiles were 
compared. The data was used for statistical analyses and visualization of individual 
patient values for NBN mRNA.   
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2.2.8 Statistical analyses 
Statistical analyses were performed using Sigma Plot. Pictures of skin were taken 
and cells were counted. For the analyses in the skin cells were counted in the epidermis 
and hair follicles or in the dermis (Neutrophils and Mast cells) that were visible in 
pictures (referred to as sections) with a size of 444 µm * 333 µm (for Neutrophils 902 
µm * 676 µm). For each analysis five representative sections were counted. No 
calculation of cells per mm
2
 was performed as epidermis size increased in the animals 
and therefore such a calculation would falsify the results. The mean and standard 
deviation were calculated. A Normality Test (Shapiro-Wilk) was performed. If 
Normality was confirmed a t-test was done. Mann-Whitney Rank Sum Test was 
conducted when the Normality Test failed. Differences were considered significant 
when P < 0,05. In graphs of the statistical analyses the standard deviation is shown as 
error bars and the P value as stars.  
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 Results 3.
The results of the study of deletion of Nbn, Nbn and p53 and Nbn and Atm in the 
epidermis are presented.  
For each experiment a short explanation is given why it was conducted. The results of 
the experiments are shown and described. The pictures shown are representative images 
for the corresponding genotype and age of the animals. Interpretations and further 
explanations are given in the chapter “Conclusions and Discussion”.  
 
3.1 Analyses of genomic deletions and integrations  
The gene construct for Nbn as shown in (Figure 10) was integrated into the mice. 
The proper integration and the individual genotype from each mouse were determined 
through DNA analysis.  
 
DNA extraction from the tails and analysis thereof showed the status of Nbn gene 
expression in the mice (Figure 11). The bands for wild-type (WT), Floxed and Delta are 
visible. Nbn
+/+
 animals had two wild-type alleles. Animals with one wild-type and one 
Floxed allele were Nbn
+/F
. Animals with two Floxed (Nbn
F/F
) or Floxed/Delta (Nbn
F/Δ
) 
alleles had the Nbn deletion genotype. Mice with one or two wild-type alleles were not 
used for further experiments. 
Figure 11: Analysis of 
Nbn DNA expression 
The integration of flox-
sides for Nbn was 
determined via DNA 
extraction. The genotypes 
shown are Nbn
+/+
, Nbn
+/F
, 
Nbn
F/F
 and Nbn
F/Δ
. The 
fragments for wild-type 
(WT), Floxed and Delta 
Nbn are visible.  
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Tail DNA analysis for p53 expression in the mice showed knockout and wild-type 
p53 (Figure 12). p53
+/-
 mice had one wild-type and one KO allele. Mice with two 
wild-type alleles were p53
+/+
. Mice were only used for Nbn
Krox20-Cre
p53
-/-
 studies when 
both alleles were KO (p53
-/-
).  
 
Atm status of the mice was also evaluated by tail DNA analysis (Figure 13). Mice 
with two wild-type alleles were Atm
+/+
. Atm
+/F
 animals had one wild-type and one 
Floxed allele. The animals that were used for Nbn/Atm
Krox20-Cre
 had two Floxed alleles 
and were Atm
F/F
. 
Figure 12: DNA 
expression of p53 
The expression and 
deletion of p53 was 
determined via DNA 
extraction. The fragments 
for knockout (KO) and 
wild-type (WT) p53 are 
visible. The genotypes 
p53
+/-
, p53
+/+
 and p53
-/-
 
are shown. 
Figure 13: Atm DNA 
expression 
The integration of flox-
sides for Atm was 
confirmed via DNA 
extraction. The genotypes 
shown are Atm
+/+
, Atm
+/F
 
and Atm
F/F
. The fragments 
for Floxed and wild-type 
(WT) are visible.  
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The integration of Krox20-Cre recombinase was tested via DNA analysis (Figure 
14). It was shown by the appearance of the specific DNA band for Krox20-Cre 
recombinase (Krox20-Cre
+
) in addition to the wild-type band. Animals positive for 
DNA of Krox20-Cre were used for the deletion animals while mice without Cre 
recombinase (Krox20-Cre
-
) were used in the control group.  
The complete analyses of all different genes identified the genotype of each animal. 
The mice were grouped according to the combination of gene expressions.   
 
3.2 Consequences of Nbn deletion in the epidermis 
3.2.1 Analysis of expression and deletion of Nbn in the epidermis 
The deletion of Nbn in the epidermis was confirmed with an isolation of 
keratinocytes from the skin. RNA was extracted from the keratinocytes and transcribed 
via reverse transcription into cDNA. It was amplified and visualized.  
Figure 14: Krox20-Cre 
expression 
The integration of 
Krox20-Cre was 
confirmed via DNA 
extraction. The fragments 
for Krox20-Cre and wild-
type (WT) are visible. The 
genotypes Krox20-Cre
+
 
and Krox20-Cre
-
 are 
shown. 
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The Nbn band in the control RNA (Nbn
Ctrl
) verified the expression of Nbn in the 
epidermis in mice (Figure 15). Loss of the Nbn band confirmed the deletion of Nbn in 
the genetically modified animals (Nbn
Krox20-Cre
). The fragment for HPRT was used as an 
internal control to evaluate the isolation of RNA and the amount of analyzed RNA in 
relation between samples. HPRT was present in the same concentration in both RNAs. 
In the samples from Nbn
Krox20-Cre
 and H2O control debris from primers were visible.    
 
3.2.2 Examination of mice morphology 
Nbn
Ctrl
, Nbn
Krox20-Cre
, Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre 
mice were monitored 
for morphological changes. Animals were collected at 18 (P18) and 35 days (P35) and 3 
months (3m) after birth (Figure 16). The fur color did not have any impact on the 
genotype of the animals. 
Figure 15: RNA 
expression analysis 
of Nbn in 
keratinocytes 
The expression and 
deletion of Nbn and 
HPRT was determined via 
RNA extraction. The 
fragments for Nbn is 
visible in Nbn
Ctrl
, HPRT is 
expressed in Nbn
Ctrl
 and 
Nbn
Krox20-Cre
.  
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Figure 16: Morphology of mice from different genotypes and ages 
In Figure 16 pictures of Nbn
Ctrl
, Nbn
Krox20-Cre
, Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre 
mice at different 
points in time are shown. Those are 18, 35 days and 3 months after birth.  
 
For Nbn
Ctrl 
animals a thick fur coat could be seen at all ages (Figure 16). At the age 
of P18 no differences between Nbn
Ctrl
 and mutated mice were visible. 35 days after birth 
first small changes in the skin structure were obvious while handling the animals and 
could be seen in the neck area of the Nbn
Krox20-Cre
p53
-/-
 mice. The skin was more elastic 
than in Nbn
Ctrl
 mice. Nearly complete loss of fur on the animals back skin was observed 
in Nbn
Krox20-Cre
, Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre
 mice at 3 months of age. The 
changes of the skin texture were more pronounced. Scaly hardened skin areas were 
detected on all 3 months old deletion animals. They were most prominent on the skin of 
Nbn
Krox20-Cre
p53
-/-
 mice.    
To evaluate the morphological changes further skin was collected, fixed and 
embedded in paraffin. Skin samples were stained with H&E to show the morphological 
structure (Figure 17). 
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Figure 17: Histological analysis of skin morphology   
Sections from skin of Nbn
Ctrl
, Nbn
Krox20-Cre
, Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre 
mice at different 
ages (18, 35 days and 3 months after birth) are shown. Skin was stained with H&E. Scale bar: 100 µm   
 
Analysis of H&E staining confirmed the changes seen on visual examination. While 
control animals showed a high number of hair follicles and a thin layer of epidermis at 
all stages, in Nbn
Krox20-Cre 
 , Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre 
 mice stark changes 
were visible at 3 months. Only single hair follicles were left and those had an altered 
structure. The epidermis was highly enlarged. Changes in the morphology were already 
observed to a certain degree in deletion mice 35 days after birth. For Nbn
Krox20-Cre
, 
Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre
 animals at 35 days the epidermis started to 
enlarge and hair follicles looked altered but were still present. In addition to the changes 
visible in 3 months old Nbn
Krox20-Cre 
and Nbn/Atm
Krox20-Cre
 mice, Nbn
Krox20-Cre
p53
-/-
 mice 
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showed invaginations of the epidermis. Those formed cyst-like structures that contained 
dead keratinocytes and were surrounded by keratinocytes even when they were 
localized in dermal areas.  
 
3.2.3 Analysis of DNA damage distribution and apoptosis in the 
epidermis  
Possible causes of the hair loss can be an elevated rate of apoptosis in the hair 
follicle. In addition a lack of apoptosis within the epidermis could cause the increase in 
epidermis size.  
To investigate both possibilities stainings with different apoptosis marker were 
done. p53 staining was conducted to show a possible increase in apoptosis. It was 
stained for p53 independent apoptosis with activated Caspase 3. DNA damages, 
especially DSBs, were visualized with γH2A.X. In addition TUNEL reaction was 
performed to show apoptotic cells.  
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Figure 18: p53 
expression in mouse 
skin 
p53 expression was 
visualized with an 
antibody. The skin of 
Nbn
Krox20-Cre
, 
Nbn
Krox20-Cre
p53
-/-
, 
Nbn/Atm
Krox20-Cre 
and 
Nbn
Ctrl
 is shown. Mice 
were collected at 18, 35 
days and 3 months after 
birth.  
Scale bar: 100 µm   
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p53 expression in the skin is shown in Figure 18. In the epidermis and around the 
hair follicle in control mice few p53 positiv cells can be seen. Most were locolazied 
around the hair follicle at the age of 35 days. In Nbn
Krox20-Cre
 and Nbn/Atm
Krox20-Cre
 mice 
some positive cells were visible. Those increased in number in the few remaining hair 
follicle structures that could be seen at 3 months after birth. In the p53 deleted skin only 
background staining and no positive cells were observed, as was expected due to the 
deletion of p53 in the mice.  
 
 
Figure 19: Analysis of p53 expression in the epidermis 
The number of p53 expressing cells was counted. Statistical analysis was performed. The data was 
sorted by age. Nbn
Ctrl
, Nbn
Krox20-Cre
, Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre
 were compared. (n = 5; 
**P < 0,01; ***P < 0,001)   
Counting of p53 positive cells and statistical comparison between Nbn
Ctrl
, 
Nbn
Krox20-Cre
, Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre
 mice was conducted (Figure 19). 
In mice 18 days after birth Nbn
Ctrl
 had 0,4 (± 0,55), Nbn
Krox20-Cre
 had 2,8 (± 0,84) and 
Nbn/Atm
Krox20-Cre
 had 13,4 (± 5,55) p53 positive cells. At 35 days after birth Nbn
Ctrl
 
showed 6,2 (± 2,39), Nbn
Krox20-Cre
 18,4 (± 2,7) and Nbn/Atm
Krox20-Cre
 showed 52,4 
(± 8,53) cells per section that were p53 positive. The number of cells with p53 
expression changed to Nbn
Ctrl
 3,2 (± 0,84), Nbn
Krox20-Cre
 12,4 (± 4,72) and 
Nbn/Atm
Krox20-Cre
 14,6 (± 3,13) in the mice. All animals with p53 deletion showed no 
p53 positive cells. A statistical difference was detected between Nbn
Ctrl
 and Nbn
Krox20-Cre
 
at all ages. The same was true for Nbn
Ctrl
 and Nbn/Atm
Krox20-Cre
. At day 18 and day 35 
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after birth the number of p53 positive cells in Nbn/Atm
Krox20-Cre
 mice was significantly 
higher than in Nbn
Krox20-Cre
 mice.  
The number of p53 positive cell was increased in Nbn
Krox20-Cre 
and Nbn/Atm
Krox20-Cre
 
mice. The elevation was more prominent in Nbn/Atm
Krox20-Cre
 animals.  
 
Figure 20: Age dependent p53 expression in epidermis 
The number of p53 expressing cells was sorted by genotypes and analyzed statistically. (n = 5; 
*P < 0,05; **P < 0,01; ***P < 0,001) 
The differences in number of p53 positive cells were studied in regard to variations 
within the individual groups dependent on the age of animals (Figure 20). In Nbn
Ctrl
, 
Nbn
Krox20-Cre
 and Nbn/Atm
Krox20-Cre
 mice a significant increase from day 18 to day 35 and 
from day 18 and 3 months was seen. The comparison of P35 to 3 months old animals 
showed a significant decrease in cell number in those genotypes.  
The number of p53 expressing cells had reached its peak at the age of 35 days in all 
animals.  
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Figure 21: Activated 
Caspase 3 
distribution in the 
skin  
Skin of different ages 
(P18, P35 and 3 months) 
of mice was stained for 
the activated form of 
Caspase 3. Sections from 
Nbn
Ctrl
, Nbn
Krox20-Cre
, 
Nbn
Krox20-Cre
p53
-/-
 and 
Nbn/Atm
Krox20-Cre
 are 
shown.  
Scale bar: 100 µm    
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The antibody staining against active Caspase 3 is depicted in Figure 21. The Nbn
Ctrl
 
mice showed positive cells in der epidermal structures at all points in time. An amount 
of Caspase 3 cells was also found in Nbn
Krox20-Cre
, Nbn
Krox20-Cre
p53
-/-
 and 
Nbn/Atm
Krox20-Cre 
mice at 18 and 35 days after birth. Most of those positive cells were 
detected around the hair follicle. In 3 months old animals Nbn
Krox20-Cre
 and 
Nbn/Atm
Krox20-Cre
 only few cells with activated Caspase 3 were present while in 
Nbn
Krox20-Cre
p53
-/-
 mice more cells were visible. 
 
 
Figure 22: Evaluation of active Caspase 3 in epidermis 
The staining for active Caspase 3 was analyzed statistically. The number of cells in the epidermis and 
hair follicle was counted. It was sorted according to age. (n = 5; *P < 0,05; **P < 0,01; ***P < 0,001) 
The amount of Caspase 3 positive cells in the epidermis of the mice was evaluated 
(Figure 22). It showed a significant higher number of Caspase 3 cells in control animals 
at P18 (Nbn
Ctrl
 16,4 ± 6,1) than in animals with deletions (Nbn
Krox20-Cre
 4,8 ± 2,68; 
Nbn
Krox20-Cre
p53
-/-
 2,2 ± 0,84 and Nbn/Atm
Krox20-Cre
 3 ± 0,7). This was reversed at day 35 
(Nbn
Ctrl
 2,4 ± 2,07; Nbn
Krox20-Cre
 6,2 ± 4,92; Nbn
Krox20-Cre
p53
-/-
 5,8 ± 1,79 and 
Nbn/Atm
Krox20-Cre
 5,2 ± 1,92). In 3 months old Nbn
Ctrl
 and Nbn
Krox20-Cre
 mice no Caspase 
3 activated cells were observed. In Nbn
Krox20-Cre
p53
-/-
 mice (3,8 ± 2,39) and in 
Nbn/Atm
Krox20-Cre
 mice (1,2 ± 1,3) a significant higher amount of Caspase 3 active cells 
were detected. At P35 a significant increase in Nbn
Krox20-Cre
p53
-/-
 compared to Nbn
Ctrl
 
was visible. This was also observed 3 months after birth. Here an increase of 
Nbn
Krox20-Cre
p53
-/-
 in comparison to Nbn
Krox20-Cre
 was detected too.   
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Figure 23: Changes in activated Caspase 3 dependent on age 
In Nbn
Ctrl
, Nbn
Krox20-Cre
, Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre
 mouse epidermis the cells with active 
Caspase 3 were counted. The number of Caspase 3 positive cells was sorted by genotype and analyzed. 
(n = 5; *P < 0,05; **P < 0,01; ***P < 0,001) 
Sorting of cells with activated Caspase 3 by age revealed a high amount of cells in 
18 days old Nbn
Ctrl
 mice (Figure 23). Both at 35 days and 3 months it was significantly 
decreased. In Nbn
Krox20-Cre
, Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre
 a significant increase 
was detected from P18 to P35. After day 35 the number decreased again in those 
animals.   
The number of cells with active Caspase 3 in the epidermis was elevated at 35 days 
after birth in Nbn
Krox20-Cre
, Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre
 mice.  
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Figure 24: yH2A.X foci 
distribution in the 
skin 
Skin of 3 months, 18 and 
35 days old mice was 
stained for 
phosphorylated Histone 
H2A.X. The mice were 
Nbn
Ctrl
, Nbn
Krox20-Cre
, 
Nbn
Krox20-Cre
p53
-/-
 and 
Nbn/Atm
Krox20-Cre 
mice. 
The arrows indicate cells 
with γH2A.X foci and 
stars show γH2A.X 
positive apoptotic cells. 
The red staining shows 
γH2A.X and DAPI is 
stained in blue.   
Scale bar: 100 µm    
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Staining of the skin showed an increase in γH2A.X foci (Figure 24). Some of these 
foci were found at all ages in Nbn
Ctrl mice. Cells with γH2A.X foci were located along 
the hair follicles in those animals. In Nbn
Krox20-Cre
 and Nbn
Krox20-Cre
p53
-/-
 animals a 
higher amount of positive cells was detected at all points in time. They were localized 
mostly in cells of the hair follicle and few foci were found in keratinocytes of the 
epidermal layers. In Nbn/Atm
Krox20-Cre
 less γH2A.X foci were present.  
 
 
Figure 25: Analysis of yH2A.X foci positive cells in the epidermis 
Numbers of cells with γH2A.X foci were enumerated. A statistical analysis was executed. The 
number of cells was shown for Nbn
Ctrl
, Nbn
Krox20-Cre
, Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre
 mice and put 
in order according to age of the mice. (n = 5; *P < 0,05; **P < 0,01; ***P < 0,001)  
The cells with γH2A.X foci were counted in the mice (Figure 25). 18 days after 
birth Nbn
Ctrl
 showed 14,6 (± 2,3), Nbn
Krox20-Cre
 had 34,4 (± 4,93), Nbn
Krox20-Cre
p53
-/-
 
26,8 (± 8,61) and Nbn/Atm
Krox20-Cre
 showed 11 (± 3,16) cells with γH2A.X foci per 
section. The numbers changed to Nbn
Ctrl
 53 (± 8,92), Nbn
Krox20-Cre
 51,6 (± 11,72), 
Nbn
Krox20-Cre
p53
-/-
 75,2 (± 3,49) and Nbn/Atm
Krox20-Cre
 12,6 (± 3,78) at 35 days after 
birth. Sections from mice 3 months after birth showed 2,8 (± 0,84) for Nbn
Ctrl
, 
18 (± 2,92) for Nbn
Krox20-Cre
, 28,2 (± 6,3) for Nbn
Krox20-Cre
p53
-/-
 and 17,8 (± 4,03) for 
Nbn/Atm
Krox20-Cre
 animals. Statistical analysis of the number of γH2A.X foci revealed 
significant increases in Nbn
Krox20-Cre 
and Nbn
Krox20-Cre
p53
-/-
 mice. Those existed at 18 
days and 3 months after birth. At 3 months the increase was also seen in 
Nbn/Atm
Krox20-Cre
 animals while at 35 days the number of cells was significantly 
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decreased. There was no increase in Nbn
Krox20-Cre
 but in Nbn
Krox20-Cre
p53
-/-
 mice 
compared to Nbn
Ctrl. γH2A.X foci positive cells were increased in NbnKrox20-Crep53-/- in 
comparison to Nbn
Krox20-Cre
 mice.  
An increase of cells with γH2A.X foci was detected in deletion mice. 
 
Figure 26: Age dependents of the number of yH2A.X foci containing cells 
The numbers of cells were sorted by Nbn
Ctrl
, Nbn
Krox20-Cre
, Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre
. 
For each genotype numbers from 18, 35 days and 3 months old animals were shown. (n = 5; **P < 0,01; 
***P < 0,001) 
Cells with γH2A.X foci were analyzed regarding the age of the animals within the 
different groups (Figure 26). Nbn
Ctrl
 mice showed a significant increase of foci from 18 
to 35 days. 3 months after birth the cell number with foci was decreased and was lower 
than at 18 days of age. An increase was detected in Nbn
Krox20-Cre
 mice between P18 and 
P35. Afterwards the γH2A.X foci decreased and reached a lower level than at P18. The 
increase for 35 day old animals was also observed in Nbn
Krox20-Cre
p53
-/-
 mice. In 
Nbn/Atm
Krox20-Cre
 animals no increase was detected at 35 days but at 3 months compared 
to 18 day old mice.  
The increase of foci peaked at 35 days in Nbn
Ctrl
, Nbn
Krox20-Cre
 and Nbn
Krox20-Cre
p53
-/-
 
mice. 
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Figure 27: 
Colocalization study 
of yH2A.X foci and 
TUNEL positive cells 
Skin of mice from Nbn
Ctrl
, 
Nbn
Krox20-Cre
, 
Nbn
Krox20-Cre
p53
-/-
 and 
Nbn/Atm
Krox20-Cre 
are 
depicted. The skin was 
collected at 18, 35 days 
and 3 months after birth. 
It was stained against 
phosphorylated Histone 
H2A.X and TUNEL 
reaction was performed. 
The arrows indicate cells 
with γH2A.X foci. Stars 
show γH2A.X positive 
apoptotic cells and hash 
marks TUNEL positive 
cells. The green staining 
shows γH2A.X, red is 
TUNEL and DAPI is 
stained in blue. Yellow 
staining shows an overlap 
of TUNEL and γH2A.X.  
Scale bar: 100 µm    
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A colocalization study from cells containing γH2A.X foci and positive TUNEL cells 
was done (Figure 27). TUNEL positive cells were located along the hair follicles in 
Nbn
Ctrl
 (P18, P35, 3 months), Nbn
Krox20-Cre
 (P18, P35), Nbn
Krox20-Cre
p53
-/-
 (P18, P35) and 
Nbn/Atm
Krox20-Cre
  (P18, P35) animals. A comparable distribution of γH2A.X foci in the 
hair follicles was observed. In the epidermis no TUNEL positive cells were detected in 
Nbn
Ctrl
, Nbn
Krox20-Cre
 and Nbn
Krox20-Cre
p53
-/-
 animals. In Nbn/Atm
Krox20-Cre
 few positive 
cells were found at 3 months of age. In the epidermis of 3 months old animals (except 
Nbn
Ctrl) few γH2A.X foci positive cells were visible in the epidermis. All cells that were 
considered apoptotic cells due to complete staining with γH2A.X were also positive for 
TUNEL. No colocalistaion of TUNEL and γH2A.X foci in cells was detected.  
TUNEL staining confirmed the apoptotic character of cells stained completely with 
γH2A.X antibody. The existence of γH2A.X foci within a cell did not indicate 
completed apoptosis in the cell as cells with γH2A.X foci were not stained for TUNEL. 
TUNEL positive cells did not contain γH2A.X foci.  
 
3.2.4 Analysis of differentiation of keratinocytes 
The different stages of keratinocyte differentiation are characterized with changes in 
keratin expression. Keratin 15 is a marker for stem cells within the hair follicle and in 
stem cells in the basal layer of the epidermis (Liu et al.,2003; Morris et al.,2004). The 
basal layer with its proliferating cells is distinguished with the expression of Keratin 14 
(Fuchs and Green,1980). With the start of differentiation of the keratinocytes they leave 
the basal layer and Keratin 14 expression is lost. Keratin 10 is started to be expressed 
(Fuchs and Green,1980). It is maintained during the complete differentiation of the 
keratinocytes.  
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Figure 28: Staining for 
Keratin 15 positive 
cells 
Analysis of Keratin 15 
positive cell distribution is 
shown in Figure 28. Skin 
of Nbn
Ctrl
, Nbn
Krox20-Cre
, 
Nbn
Krox20-Cre
p53
-/-
 and 
Nbn/Atm
Krox20-Cre 
mice was 
stained in green for 
Keratin 15. DAPI was 
stained in blue. The skin 
was from 18, 35 days and 
3 months old animals.   
Scale bar: 100 µm    
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The normal distribution of Keratin 15 positive cells in the epidermis and along the 
hair follicle is visible in the control animals of all ages (Figure 28). Keratin 15 positive 
cells localize in the basal layer of the epidermis and in the bulge area of the hair 
follicles. This pattern can also be seen in Nbn
Krox20-Cre
, Nbn
Krox20-Cre
p53
-/-
 and 
Nbn/Atm
Krox20-Cre
 mice at 18 and 35 days after birth. With 3 months no Keratin 15 
positive cells were detected in Nbn
Krox20-Cre
, Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre
 
animals.  
Disappearance of Keratin 15 expressing cells revealed the loss of hair follicle stem 
cells in Nbn
Krox20-Cre
, Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre
 mice.   
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Figure 29: Keratin 10 
staining of mouse 
skin 
Skin of mice, at the age of 
18, 35 days and 3 months 
after birth, from Nbn
Ctrl
, 
Nbn
Krox20-Cre
, 
Nbn
Krox20-Cre
p53
-/-
 and 
Nbn/Atm
Krox20-Cre 
mice was 
stained with anti-Keratin 
10. Keratin 10 staining is 
green and DAPI is blue.  
Scale bar: 100 µm 
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Keratin 10 is a marker for differentiating epidermal layers. It was observed in the 
upperpart of the epidermis (one layer) and partially within hair follicles from Nbn
Ctrl
 
mice at all stages (Figure 29). The same observation was made in Nbn
Krox20-Cre
, 
Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre
 mice at day 18 and day 35 after birth. 
Nbn
Krox20-Cre
, Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre
 mice with 3 months showed 3-4 
layers of Keratin 10 positive differentiated cells. It was seen that the layers did not have 
a clear boundary and that some Keratin 10 negative cells were spread between positive 
cells. In addition the DAPI staining visualized few epidermal layers beneath the Keratin 
10 layers that were not positive.  
The distribution of Keratin 10 in the epidermis of Nbn
Krox20-Cre
, Nbn
Krox20-Cre
p53
-/-
 
and Nbn/Atm
Krox20-Cre
 mice showed an accumulation of differentiated keratinocytes. 
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Figure 30: Analysis of 
Keratin 14 expression 
in mouse skin 
Epidermis of control, 
Nbn
Krox20-Cre
, 
Nbn
Krox20-Cre
p53
-/-
 and 
Nbn/Atm
Krox20-Cre
 mice 
was stained with an 
antibody against Keratin 
14 (Figure 30). Keratin 14 
staining is green and 
DAPI is blue.  
Scale bar: 100 µm 
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Keratin 14 is expressed in proliferating basal keratinocytes. The expression pattern 
was seen in control animals (Figure 30). Nbn
Ctrl
 mice of all ages showed the Keratin 14 
in one layer of epidermal cells and along the hair follicle. The same pattern was visible 
in skin of 18 day old Nbn
Krox20-Cre
, Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre
 mice. When 
the mice reached 35 days the expression pattern changed. In all deletion lines few layers 
of Keratin 14 positive keratinocytes existed. The number of cells increased even more in 
Nbn
Krox20-Cre
 and Nbn/Atm
Krox20-Cre
 epidermis. Keratin 14 expression in those animals 
reached up to the outer border of the epidermis to the environment in animals collected 
3 months after birth. In 3 months old Nbn
Krox20-Cre
p53
-/-
 mice keratinocytes showed 
Keratin 14 in the upper layers of the epidermis but not in the basal layer anymore.   
The expression of Keratin 14 in Nbn
Krox20-Cre
, Nbn
Krox20-Cre
p53
-/-
 and 
Nbn/Atm
Krox20-Cre
 mice demonstrated an accumulation of proliferating non-differentiated 
keratinocytes and a disturbed differentiation.  
 
3.2.5  Evaluation of apoptosis in hair follicle stem cells 
With the staining of Keratin 15 the disappearance of hair follicle stem cells was 
illustrated. The extinction of Keratin 15 cells might be due to a loss of stem cell 
properties of the cells or apoptosis in the stem cells after DNA damages. Investigation 
of DNA damages was done with a double staining of Keratin 15 and 53BP1 (Figure 31). 
Apoptosis in the stem cells was analyzed through double staining with Keratin 15 and 
TUNEL (Figure 32). 
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Figure 31: Staining of 
Keratin 15 and 53BP1 
Skin of Nbn
Ctrl
, 
Nbn
Krox20-Cre
, 
Nbn
Krox20-Cre
p53
-/-
 and 
Nbn/Atm
Krox20-Cre 
mice was 
stained against Keratin 15 
and 53BP1. The animals 
were collected at P18, P35 
and 3 months. The 
staining for 53BP1 is in 
red. Keratin 15 positive 
cells were stained in green 
and DAPI is blue. The 
arrows indicate cells 
positive for 53BP1 foci.  
Scale bar: 100 µm 
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The staining of 53BP1 (Figure 31) showed a general staining of the nucleus in some 
cells but also foci formation in other cells. This foci formation indicates the response to 
DNA damages (Anderson et al.,2001; Panier and Boulton,2014). A few cells with foci 
were present in all animals collected. In Nbn
Ctrl
 mice they partially colocalized with the 
Keratin 15 positive cells at all ages. This was the case in Nbn
Krox20-Cre
, Nbn
Krox20-Cre
p53
-/-
 
and Nbn/Atm
Krox20-Cre
 mice with 18 and 35 days of age too. But the number of Keratin 
15 positive cells was already decreased in 35 days old deleted mice. In 3 months 
Nbn
Krox20-Cre
, Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre
 old mice most foci were visible in 
the lower parts of the epidermis while Keratin 15 was not detected at that age anymore 
(see Figure 28).  
The staining showed few stem cells with signs for DNA damages.  
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Figure 32: 
Colocalisation of 
Keratin 15 and TUNEL 
Figure 32 shows stainings 
of Nbn
Ctrl
, Nbn
Krox20-Cre
, 
Nbn
Krox20-Cre
p53
-/-
 and 
Nbn/Atm
Krox20-Cre 
mouse 
skin. The skin was 
collected at 18 and 35 
days and 3 months after 
birth. It was stained 
against Keratin 15 and 
TUNEL reaction was 
performed. The staining 
for TUNEL is in red, 
Keratin 15 in green and 
DAPI is stained in blue.  
Scale bar: 100 µm 
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In Nbn
Ctrl
 mice no overlap of TUNEL and Keratin 15 in cells was detected in all 
animals collected (Figure 32). The same was seen in the other mice. No cells with 
Keratin 15 expression and positive for TUNEL staining were detected in Nbn
Krox20-Cre
, 
Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre
 animals at any point in time.  
Lack of TUNEL staining in Keratin 15 stem cells demonstrated that disappearance of 
hair follicle stem cells was not due to apoptosis. It seems to be a consequence of the loss 
of stem cell integrity.  
  
3.2.6 Characterization of proliferation of keratinocytes 
The enlargement of the epidermis can have various reasons. It can be due to an 
increased number of proliferating cells, difficulties in differentiation of the 
keratinocytes or invasion of non-epidermal cells into the epidermis. The later reason 
should be visible in an altered appearance of epidermal structure and appearance of 
other cells normally not localized in the epidermis. This was not observed (Figure 17). 
The problems in differentiation were already demonstrated (Figure 28 to Figure 30). To 
visualize higher proliferation different markers had to be considered as protein 
expression changes according to the different steps in cell cycle progression. PCNA is 
expressed during DNA replication (S phase) (Tan et al.,1986; Baserga,1991). A typical 
marker for mitosis is Histone 3 phosphorylation at Serine 10 (Gurley et al.,1974; Li et 
al.,2013). Ki67 is a marker for S, G2 and M phase and is not present in G0 and early G1 
phase (Gerdes et al.,1984). p63 is generally expressed in the proliferating keratinocytes 
of the basal layer (Yang et al.,1998; Koster et al.,2007; Xin et al.,2011).  
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Figure 33: 
Distribution of PCNA 
positive cells in the 
epidermis 
Cells positive for PCNA 
were visualized with 
antibody staining in 
Figure 33. The skin was 
taken from mice at the age 
of 18, 35 days and 3 
months after birth. The 
mice were Nbn
Ctrl
, 
Nbn
Krox20-Cre
, 
Nbn
Krox20-Cre
p53
-/-
 and 
Nbn/Atm
Krox20-Cre
.  
Scale bar: 100 μm 
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The analysis of distribution of PCNA positive cells in the epidermis showed one 
layer of proliferating cells with one layer of non-proliferating cells on top for all mice 
with the age of 18 and 35 days (Figure 33). In Nbn
Ctrl
 this was also observed for 3 
months old mice. In Nbn
Krox20-Cre
, Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre
 mice with 3 
months PCNA staining was not seen in one single layer. It comprised more than half of 
the enlarged epidermis. The cells were not organized in distinguishable layers but were 
distributed more or less randomly. Some PCNA positive cells were observed between 
cells not stained and an area of non-proliferating cells was placed in between PCNA 
positive cells.  
PCNA staining demonstrated the elevation in proliferating cell number. A possible 
localization of proliferating cells outside the basal layer was hinted at.  
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Figure 34: 
Visualization of Ki67 
expression in skin 
cells 
Skin from Nbn
Ctrl
, 
Nbn
Krox20-Cre
, 
Nbn
Krox20-Cre
p53
-/-
 and 
Nbn/Atm
Krox20-Cre 
mice was 
stained. The mice were 
collected at 18 and 35 
days and 3 months after 
birth. The staining was 
done with an antibody 
against Ki67.  
Scale bar: 100 μm 
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In control animals some Ki67 positive cells were seen in der basal layer of the 
epidermis and around the hair follicle at 18, 35 days and 3 months after birth (Figure 
34). The number of Ki67 positive cells in P18 Nbn
Krox20-Cre
, Nbn
Krox20-Cre
p53
-/-
 and 
Nbn/Atm
Krox20-Cre
 animals appeared to be at the same level as for P18 Nbn
Ctrl
 mice. 
Starting with 35 days after birth the number of Ki67 positive cells increased in 
Nbn
Krox20-Cre
, Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre
 animals. At this age all positive 
cells were detected in the basal layer of the epidermis and in the hair follicle. At the age 
of 3 months some cells were also observed above the basal layer.  
A proliferation increase was confirmed with Ki67 staining and a localization of 
proliferating cells outside the basal layer was indicated. 
 
 
Figure 35: Analysis of number of Ki67 positive cells in the epidermis 
Ki67 positive cells in the epidermis and the hair follicle were counted. Numbers from Nbn
Ctrl
, 
Nbn
Krox20-Cre
, Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre
 were arranged by age. (n = 5; **P < 0,01; 
***P < 0,001) 
The amount of Ki67 positive cells in the epidermis of the mice was evaluated 
(Figure 35). In mice 18 days after birth Nbn
Ctrl
 had 25,6 (± 6,58), Nbn
Krox20-Cre
 had 
14,2 (± 11,37), Nbn
Krox20-Cre
p53
-/-
 had 12,8 (± 13,68) and Nbn/Atm
Krox20-Cre
 had 
55 (± 7,71) Ki67 positive cells. At 35 days after birth Nbn
Ctrl
 showed 25,2 (± 5,72), 
Nbn
Krox20-Cre
 62,2 (± 19,79), Nbn
Krox20-Cre
p53
-/-
 54,4 (± 16,77) and Nbn/Atm
Krox20-Cre
 
showed 59,8 (± 18,87) cells per section that were Ki67 positive. The number of cells 
with Ki67 expression changed to Nbn
Ctrl
 48,8 (± 6,76), Nbn
Krox20-Cre
 79,2 (± 17,54), 
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Nbn
Krox20-Cre
p53
-/-
 87,4 (± 18,49) and Nbn/Atm
Krox20-Cre
 83,6 (± 13,81) in the mice 3 
months after birth. Statistical analysis of Ki67 expression in the epidermis was 
conducted. At the age of 18 days the number of positive cells was statistically increased 
in Nbn/Atm
Krox20-Cre
 mice. When 35 days and 3 months old the Nbn
Krox20-Cre
, 
Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre
 mice had a significant gain of Ki67 cells 
compared to Nbn
Ctrl
.  
Ki67 cell number increased in all deletion animals starting with 35 days.  
 
Figure 36: Assessment of changes of Ki67 expression with age 
Statistical data from Ki67 epidermal cells were compared. The comparison of age specific 
differences was done within genotypes. . (n = 5; **P < 0,01; ***P < 0,001) 
An age dependent evaluation of Ki67 cells was performed and is depicted in Figure 
36. In Nbn
Ctrl
 mice a significant increase was detected at 3 months compared to 18 and 
35 days. Nbn
Krox20-Cre
 and Nbn
Krox20-Cre
p53
-/-
 presented a rise in cells with Ki67 at the age 
of 35 days and 3 months. The number of cells was also elevated in Nbn/Atm
Krox20-Cre
 
mice at 3 months.  
The amount of Ki67 positive cells increased with the aging of the animals. This was 
most prominent in Nbn
Krox20-Cre
 and Nbn
Krox20-Cre
p53
-/-
 mice.  
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Figure 37: Staining for 
phosphorylated 
Histone 3  
Skin from mice at 
different points in time 
(18, 35 days and 3 
months) was collected. 
Mice were Nbn
Ctrl
, 
Nbn
Krox20-Cre
, 
Nbn
Krox20-Cre
p53
-/-
 and 
Nbn/Atm
Krox20-Cre
. A 
staining against H3P was 
performed.  
Scale bar: 100 μm 
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The staining for phosphorylation of Histone 3 (H3P) in Figure 37 showed only 
scattered H3P positive cells in Nbn
Ctrl
 mice at 18, 35 days and 3 months after birth. 
Those cells were placed within the basal layer of the epidermis or around the hair 
follicle. In Nbn
Krox20-Cre
, Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre
 mice the number was 
increased at all points in time in comparison to Nbn
Ctrl
. The cells were distributed 
throughout the complete epidermis.  
 
 
Figure 38: Analysis of H3P in the epidermis 
In Nbn
Ctrl
, Nbn
Krox20-Cre
, Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre
 mice phosphorylated Histone 3 
positive cells were enumerated. An age depended analysis was performed. (n = 5; *P < 0,05; **P < 0,01; 
***P < 0,001) 
Mice with an age of 18 days showed nearly no H3P positive cells no matter which 
genotype (Nbn
Ctrl
 0,4 (± 0,55); Nbn
Krox20-Cre
 0,4 (± 0,55); Nbn
Krox20-Cre
p53
-/-
 0,6 (± 0,55); 
Nbn/Atm
Krox20-Cre
 0,8 (± 0,45)) (Figure 38). With 35 days a significant increase can be 
seen for Nbn
Krox20-Cre
 (4,8 ± 1,3), Nbn
Krox20-Cre
p53
-/-
 (4,8 ± 0,84) and Nbn/Atm
Krox20-Cre
 
(6,4 ± 1,52) compared with Nbn
Ctrl
 (0,4 ± 0,55). At 3 months the number of H3P cells 
remained significantly higher in deletion mice (Nbn
Krox20-Cre
 5,8 (±0,84); 
Nbn
Krox20-Cre
p53
-/-
 12,8 (± 5,4); Nbn/Atm
Krox20-Cre
 3,8 (± 1,64)) than in the control group 
(Nbn
Ctrl
 1,2 (± 2,17)). Both in Nbn
Krox20-Cre
 and Nbn
Krox20-Cre
p53
-/-
 mice the amount of 
cells was higher than in Nbn/Atm
Krox20-Cre
.   
The number of cells with a phosphorylation of Histone 3 increased in genetically 
modified mice.    
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Figure 39: Evaluation of changes in H3P expression with aging of the animals 
H3P positive cells were sorted according to genotype and statistically evaluated. The Nbn
Ctrl
, 
Nbn
Krox20-Cre
, Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre
 mice were collected at P18, P35 and 3 months. 
(n = 5; **P < 0,01; ***P < 0,001) 
The quantity of H3P positive cells remained at a low level in Nbn
Ctrl
 mice at all 
points in time (Figure 39). In Nbn
Krox20-Cre
, Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre
 
animals number of positive cells increased from day 18 to day 35 after birth. In 
Nbn
Krox20-Cre 
and Nbn
Krox20-Cre
p53
-/-
 mice the number remained at the same level in 3 
months old mice. Animals with the genotype Nbn/Atm
Krox20-Cre
 exhibited a decrease of 
H3P cells at 3 months after birth. 
Histone 3 phosphorylation increased in Nbn
Krox20-Cre 
and Nbn
Krox20-Cre
p53
-/-
 mice with 
aging of the animals. In Nbn/Atm
Krox20-Cre
 animals an increase was observed first (P18 to 
P35) followed by a decrease at 3 months that left the number of H3P cells still 
significantly above the amount at 18 days.  
 
All markers for cells in different steps of the cell cycle in which proliferation takes 
place showed an increase in cells within proliferation phase. The enlargement is 
therefore partially due to an elevation of proliferation. 
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All proliferation stainings showed few proliferating cells that were spread into areas 
of non-proliferating cells. To investigate if those cells retained all characteristics of 
proliferating cells or if they started to express differentiation markers double stainings 
were conducted. 
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Figure 40: Analysis of 
colocalization from 
Keratin 10 and PCNA 
Nbn
Ctrl
, Nbn
Krox20-Cre
, 
Nbn
Krox20-Cre
p53
-/-
 and 
Nbn/Atm
Krox20-Cre 
were 
collected at 18, 35 days 
and 3 months after birth. 
Stainings against Keratin 
10 and PCNA were done. 
Keratin 10 is stained in 
green, PCNA is colored in 
red and DAPI is blue. 
Scale bar: 100 µm 
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Figure 40 shows the localization of proliferating cells with PCNA expression in 
comparison the differentiation marker Keratin 10. There was no overlapping of the 
stainings in any cells from Nbn
Ctrl
, Nbn
Krox20-Cre
, Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre
 
mice. The PCNA cells in Nbn
Krox20-Cre
, Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre
 3 months 
old mice that were distributed through the epidermis localized between already 
differentiating cells with Keratin10 expression. On the other hand there were clearly 
distinguishable layers present in Nbn
Ctrl
 mice.  
The double staining of PCNA and Keratin 10 showed a loss of the organized 
structure of the epidermis in mice with Nbn, Nbn and p53 and Nbn and Atm deletion. 
Proliferating cells were not organized in one layer. More than one layer was always 
visible and the boundaries of the layers were lost. Differentiating cells were spread in 
between proliferating cells. 
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Figure 41: Staining of 
Keratin 14 and p63 
positive cells in the 
epidermis 
Skin from Nbn
Ctrl
, 
Nbn
Krox20-Cre
, 
Nbn
Krox20-Cre
p53
-/-
 and 
Nbn/Atm
Krox20-Cre 
mice 
were stained. Antibody 
staining was performed 
against Keratin 14 and 
p63. The green staining 
visualizes Keratin 14, the 
red cells are p63 positive 
and DAPI is stained in 
blue.  
Scale bar: 100 µm 
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In Nbn
Ctrl
 mice p63 positive cells showed an expression of Keratin 14 for all animals 
(Figure 41). At 18 days after birth this was the same in Nbn
Krox20-Cre
, Nbn
Krox20-Cre
p53
-/-
 
and Nbn/Atm
Krox20-Cre
 mice. Both in P35 and 3 months old animals of Nbn
Krox20-Cre
, 
Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre
 genotype all p63 positive cells were positive for 
Keratin 14. But not all Keratin 14 cells showed a positive staining for p63. The cells 
positive for both markers were oriented at the epidermal side towards the dermis. The 
upper layers showed no p63 but Keratin 14 expression.   
Double staining of the proliferation marker of the basal keratinocytes p63 and 
Keratin 14 showed a partial colocalization. This colocalization was observed in the 
lower part of the epidermis.  
Both double stainings of proliferation and differentiation markers showed that the 
proliferating cells retained the characteristics of non-differentiated cell. Those cells 
spread through the epidermis still belonged to a non-differentiated cell population. This 
also demonstrated that the epidermis lost its normal organizational structure with clearly 
distinguishable layers.  
 
3.2.7 Psoriasis 
The morphological evaluation of the mice showed, besides hair loss, a high increase 
of the number of layers of the epidermis and plaques on the surface of the mice. In 
addition the histological stainings revealed a rise of proliferation (acanthosis) and 
disturbed differentiation (parakeratosis). All those observations are typical for psoriasis 
(Griffiths and Barker,2007; Gudjonsson et al.,2007; Hertl,2011).  
To clarify if the mice with a lack of Nbn, Nbn and p53 and Nbn and Atm showed a 
psoriasis-like phenotype further experiments were conducted.  
 
3.2.7.1 Analysis of invasion of leucocytes 
The invasion of leucocytes is a typical sign for inflammation. Mast cell and 
Neutrophil invasion from the underlining tissue and blood system into the dermis 
towards the epidermal border is a typical sign for psoriasis (Griffiths and Barker,2007; 
Gudjonsson et al.,2007; Hertl,2011).  
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Figure 42: Analysis of 
localization of Mast 
cells 
Giemsa staining was done 
on mouse skin from 
different ages (18, 35 days 
and 3 months). Skin was 
collected from Nbn
Ctrl
, 
Nbn
Krox20-Cre
, 
Nbn
Krox20-Cre
p53
-/-
 and 
Nbn/Atm
Krox20-Cre 
mice. 
The epidermis and hair 
follicles are stained in a 
dark blue. Purple cells in 
the dermis are Mast cells. 
Mast cells are marked 
with arrows.  
Scale bar: 100 µm  
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In skin from Nbn
Ctrl
 animals very few Mast cells were detected in animals of 18 
days, 35 days and 3 months of age (Figure 42). In the dermis of Nbn
Krox20-Cre
, 
Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre
 mice a higher number of Mast cells was 
observed at all points in time. They started to be present in the dermal part towards the 
underlying tissue (P18) und traveled upward towards the epidermis with the aging of the 
animals (P35, 3 months).  
 
 
Figure 43: Statistical analysis of Mast cell occurrence in skin of mice 
Mast cells in the dermis of the mice were counted. Statistical analysis was performed and results 
from Nbn
Ctrl
, Nbn
Krox20-Cre
, Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre
 mice were sorted according to age of 
the animals. (n = 5; *P < 0,05; **P < 0,01; ***P < 0,001) 
The Mast cells were counted in the skin of the mice and the analysis is shown in 
Figure 43. 18 days after birth Nbn
Ctrl
 showed 8,4 (± 3,4), Nbn
Krox20-Cre
 had 12,2 (± 1,3), 
Nbn
Krox20-Cre
p53
-/-
 19,4 (± 3,7) and Nbn/Atm
Krox20-Cre
 showed 11,2 (± 5,2) Mast cells per 
section. The numbers changed to Nbn
Ctrl
 3,2 (± 2,2), Nbn
Krox20-Cre
 8,2 (± 4,3), 
Nbn
Krox20-Cre
p53
-/-
 11,2 (± 4,4) and Nbn/Atm
Krox20-Cre
 7,2 (± 2,6) at 35 days after birth. 
Sections from mice 3 months after birth showed 2,4 (± 1,5) for Nbn
Ctrl
, 11,6 (± 2,2) for 
Nbn
Krox20-Cre
, 67 (± 12,9) for Nbn
Krox20-Cre
p53
-/-
 and 25 (± 11,4) Mast cells for 
Nbn/Atm
Krox20-Cre
 animals. Analysis of Mast cell number in the skin of mice revealed a 
significant increase in Nbn
Krox20-Cre
 and Nbn
Krox20-Cre
p53
-/-
 animals at 18 days after birth. 
At 35 days the amount of Mast cells was also elevated in Nbn/Atm
Krox20-Cre
 mice. 
Nbn
Krox20-Cre
p53
-/-
 animals with 3 months showed the highest increase. The Mast cell 
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number was not only significantly higher than in the control group but also compared to 
Nbn
Krox20-Cre
 and Nbn/Atm
Krox20-Cre
 mice. The level of cells in Nbn/Atm
Krox20-Cre
 animals 
was significantly higher than in Nbn
Ctrl
 and Nbn
Krox20-Cre
 mice.   
Mast cell number increased most prominently in Nbn
Krox20-Cre
p53
-/-
 animals. 
 
 
Figure 44: Study on shift in Mast cells number with age 
In Nbn
Ctrl
, Nbn
Krox20-Cre
, Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre
 mice Mast cells in the dermis were 
counted. The number of Mast cells was sorted by genotype and analyzed. (n = 5; *P < 0,05; **P < 0,01; 
***P < 0,001) 
In Nbn
Ctrl
 mice the number of Mast cells was highest at 18 days (Figure 44). It 
significantly decreased at 35 days and 3 months. Mast cell number in Nbn
Krox20-Cre
 mice 
remained at the same level at all points in time. In Nbn
Krox20-Cre
p53
-/-
 animals the number 
of Mast cells decreased from P18 to P35. From day 35 to 3 months after birth it 
increased significantly. A significant increase of Mast cells in Nbn/Atm
Krox20-Cre
 mice 
was detected at 3 months.  
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Figure 45: Staining 
against Neutrophils 
Skin of mice from 
different ages (P18, P35 
and 3 months) of Nbn
Ctrl
, 
Nbn
Krox20-Cre
, 
Nbn
Krox20-Cre
p53
-/-
 and 
Nbn/Atm
Krox20-Cre 
mice are 
depicted. It was stained 
against Neutrophils. 
Neutrophils are red and 
blue is the staining of 
DAPI. Arrows mark 
single or clusters of 
Neutrophils.  
Scale bar: 50 µm  
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Neutrophils in the skin of Nbn
Ctrl
 animals were visible only in the part of the dermis 
towards the underlying tissue (Figure 45). This distribution of Neutrophils in the skin 
was the same at 18, 35 days and 3 months after birth. The number of Neutrophils 
increased in Nbn
Krox20-Cre
, Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre
 mice compared to 
control animals at all ages animals were collected. The localization of Neutrophils in 
those animals changed from the dermal border to the underlying tissue (P18) to the 
border between dermis and epidermis (P35 and 3 months).  
 
 
Figure 46: Analysis of Neutrophils in the skin of mice 
Number of Neutrophils was counted in the dermis of Nbn
Ctrl
, Nbn
Krox20-Cre
, Nbn
Krox20-Cre
p53
-/-
 and 
Nbn/Atm
Krox20-Cre 
mice. Numbers were analyzed and are shown grouped by age (P18, P35 and 3 months). 
(n = 5; *P < 0,05; **P < 0,01; ***P < 0,001) 
At 18 days after birth Nbn
Krox20-Cre
p53
-/-
 (40,2 ± 9,73) and Nbn/Atm
Krox20-Cre
 
(23,2 ± 4,44) mouse skin showed an increase in number of Neutrophils compared to 
Nbn
Ctrl
 (8 ± 2,74) and Nbn
Krox20-Cre
 (4,6 ± 2,7) (Figure 46). The amount of Neutrophils in 
Nbn/Atm
Krox20-Cre
 was significantly lower than in Nbn
Krox20-Cre
p53
-/-
. Nbn
Ctrl
 and 
Nbn
Krox20-Cre
 mice had a similar number of Neutrophils in the dermis. All those 
observations were the same in 35 days and 3 months old mice. 35 days after birth 
Nbn
Ctrl
 showed 12 (± 3,6), Nbn
Krox20-Cre
 showed 17 (± 3,6), Nbn
Krox20-Cre
p53
-/-
 presented 
77,8 (± 18,46) and Nbn/Atm
Krox20-Cre
 had 46,4 (± 9,74) Neutrophils per section. The 
count of cells changed to 10,8 (± 2,87) for Nbn
Ctrl
, 13,6 (± 5,08) in Nbn
Krox20-Cre
, 
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118 (± 14,61) for Nbn
Krox20-Cre
p53
-/-
 and 52,6 (± 6,54) in Nbn/Atm
Krox20-Cre
 mice 3 
months after birth. 
 
 
Figure 47: Evaluation of age dependent Neutrophil accumulation in skin 
Neutrophils from Nbn
Ctrl
, Nbn
Krox20-Cre
, Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre 
mice were analyzed to 
shown the age dependent variations within genotypes. Animals were collected at 18, 35 days and 3 
months after birth. (n = 5; **P < 0,01; ***P < 0,001) 
The amount of Neutrophils in Nbn
Ctrl
 mice remained the same in animals collected 
18, 35 days and 3 months after birth (Figure 47). Nbn
Krox20-Cre
 mice showed a significant 
increase of Neutrophils from 18 to 35 days and from 18 days to 3 months of age. In 
Nbn
Krox20-Cre
p53
-/-
 animals this was also the case. In addition an increase from 35 days to 
3 months was detected. Nbn/Atm
Krox20-Cre
 animals exhibited an elevation from 
Neutrophil numbers in 35 days to 3 months old animals compared to 18 days.  
The number of Neutrophils and Mast cells rose with the aging of the Nbn
Krox20-Cre
, 
Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre 
animals. Both Mast cells and Neutrophils 
invaded the dermis and spread till they reached the border between dermis and 
epidermis.  
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3.2.7.2 Study of CD3 T-cells in the epidermis 
The existence of T-cells is a sign of inflammation. T-cells with an expression of 
CD3 (cluster of differentiation 3) are commonly observed in skin with psoriatic lesions 
(Weinshenker et al.,1989; Bos and De Rie,1999). 
A study of CD3 positive T-cell was conducted in the skin of the mice.  
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Figure 48: Study of 
CD3 positive cells  
CD3 positive T-cells in 
the skin of Nbn
Ctrl
, 
Nbn
Krox20-Cre
, 
Nbn
Krox20-Cre
p53
-/-
 and 
Nbn/Atm
Krox20-Cre 
mice 
were stained with an anti 
CD3 antibody. The 
staining was performed in 
3 months, 18 and 35 days 
old mice.  
Scale bar: 100 μm  
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In Nbn
Ctrl
 mice few CD3 positive T-cells were present in the epidermis and along 
the hair follicles in all collected animals (Figure 48). A comparable amount of cells was 
observed in the Nbn
Krox20-Cre
, Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre
 mice at day 18. 
Starting at 35 days a higher the amount of CD3 positive cells was seen in Nbn
Krox20-Cre
, 
Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre
 mice.  
 
Figure 49: Assessment of CD3 positive cells in the epidermis 
In the epidermis of Nbn
Ctrl
, Nbn
Krox20-Cre
, Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre 
mice the number of 
CD3 positive cells was counted. They were studied in regard to ages of the animals. Skin was collected at 
18, 35 days and 3 months after birth. (n = 5; *P < 0,05; **P < 0,01; ***P < 0,001) 
At 18 days no increase in CD3 positive T-cells was detected between Nbn
Ctrl
 
(18,8 ± 5,1) and Nbn
Krox20-Cre
 (10,4 ± 7,3), Nbn
Krox20-Cre
p53
-/-
 (19,8 ± 4,3) and 
Nbn/Atm
Krox20-Cre
 mice (22,2 ± 4,5) (Figure 49). Only the number of Nbn
Krox20-Cre
 CD3 
cells was significantly less than in Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre
. The numbers 
of CD3 positive cells per section in 35 days old animals were 10,6 (± 4,7) for Nbn
Ctrl
, 
21,3 (± 8,3) for Nbn
Krox20-Cre
, 15,2 (± 3,3) in Nbn
Krox20-Cre
p53
-/-
 and 17,2 (± 1,3) in 
Nbn/Atm
Krox20-Cre
 mice. With 3 months Nbn
Ctrl
 presented 7,4 (± 3,8), Nbn
Krox20-Cre
 had 
25,2 (± 7,5), Nbn
Krox20-Cre
p53
-/-
 showed 16,8 (± 8,5) and Nbn/Atm
Krox20-Cre
 showed 
30,2 (± 7,7) CD3 positive cells per section. In 35 days and 3 months old animals a 
statistically significant increase was seen between Nbn
Ctrl
 and Nbn
Krox20-Cre
 and 
Nbn/Atm
Krox20-Cre
 mice. The number of T-cells in Nbn
Krox20-Cre
p53
-/-
 was not changed 
significantly in 35 days and 3 months old animals.  
An increase in CD3 T-cells was observed in Nbn
Krox20-Cre
 and Nbn/Atm
Krox20-Cre
 mice.  
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Figure 50: Analysis of age related changes of CD3 in the epidermis 
CD3 cells were analyzed by genotype (Nbn
Ctrl
, Nbn
Krox20-Cre
, Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre
). 
The different collection times are shown (18, 35 days and 3 months). (n = 5; *P < 0,05; **P < 0,01) 
Nbn
Ctrl
 mice expressed a significant decrease of CD3 positive T-cells from P18 to 
P35 and 3 months (Figure 50). An increase in CD3 positive T-cells was detected from 
18 day old Nbn
Krox20-Cre
 mice to 3 months old animals. The level of CD3 cells remained 
constant in Nbn
Krox20-Cre
p53
-/-
 mice. Nbn/Atm
Krox20-Cre
 mice showed a decrease from 18 
to 35 days. At the age of 3 months the cell number was significantly increased.  
In control animals the number of CD3 cells decreases with the aging of the animals. 
In Nbn
Krox20-Cre
 and Nbn/Atm
Krox20-Cre
 mice this was reversed while in Nbn
Krox20-Cre
p53
-/-
animals the level of T-cells remained the same at all collected ages. 
 
3.2.7.3 Characterization of Stat3 phosphorylation at Tyrosine 705 
An activation of Stat3 is commonly observed in psoriasis (Sano et al.,2005). The 
activation occurs through a phosphorylation at Tyrosine (Tyr) 705. This 
phosphorylation triggers a relocalization of Stat3 in the nucleus of the cells.  
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Figure 51: 
Visualization of Stat3 
phosphorylation at 
Tyr 705 
Nbn
Ctrl
, Nbn
Krox20-Cre
, 
Nbn
Krox20-Cre
p53
-/-
 and 
Nbn/Atm
Krox20-Cre
 mice 
skin was stained. The 
staining was performed 
against Stat3 
phosphorylated at Tyr 
705. The animals were 
collected 18 and 35 days 
and 3 months after birth. 
Scale bar: 100 μm 
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Stat3 activation by phosphorylation at Tyr 705 was not detected in the epidermis of 
Nbn
Ctrl
 mice at any point in time (Figure 51). At the age of 18 days no positive cells 
were visible in Nbn
Krox20-Cre
, Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre
 mice. Starting with 
35 days after birth those animals showed Stat3 Tyr 705 positive cells. In Nbn
Krox20-Cre
 
and Nbn
Krox20-Cre
p53
-/-
 mice the number of cells increased further with 3 months. The 
positive cells were spread within the whole epidermis. The epidermis of 
Nbn/Atm
Krox20-Cre
 mice was not completely positive for Stat3 phosphorylation. In these 
animals few spots in the epidermis remained without Stat3 activation.     
Analysis revealed an activation of Stat3 with phosphorylation at Tyr 705 in 
Nbn
Krox20-Cre
, Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre
 mice at 35 days and 3 months after 
birth.  
 
3.2.7.4 Analysis of Akt phosphorylation 
Interleukin-22 expression is elevated in psoriasis (Wolk et al.,2006; Lowes et 
al.,2008). Cell proliferation resulting from IL-22 was found to be regulated by the 
PI3K (Phosphoinositide 3-kinase)/Akt/mTOR signaling cascade (Mitra et al.,2012). 
Additionally the phosphorylation of Akt was described in human psoriasis (Madonna et 
al.,2012). Those facts led to an analysis of Akt phosphorylation in the skin of our mice.  
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Figure 52: Study of 
Akt phosphorylation  
Phosphorylation of Akt is 
visualized with an 
antibody staining. The 
staining was done on mice 
skin from Nbn
Ctrl
, 
Nbn
Krox20-Cre
, 
Nbn
Krox20-Cre
p53
-/-
 and 
Nbn/Atm
Krox20-Cre
 mice. 
Mice were collected with 
the age of 18, 35 days and 
3 months.  
Scale bar: 100 μm 
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Phosphorylated Akt was only visible in very few epidermal cells of Nbn
Ctrl
 animals 
of all ages (Figure 52). It was only detected in suprabasal layers. The basal layer of 
Nbn
Ctrl
 animals remained without Akt phosphorylation. A similar pattern was seen in 
P18 animals of Nbn
Krox20-Cre
, Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre
 mice. In 
Nbn
Krox20-Cre
 mice at 35 days it was the same but with 3 months a distribution in most of 
the epidermis, including the basal layer, was detected. Nbn
Krox20-Cre
p53
-/-
 and 
Nbn/Atm
Krox20-Cre
 animals exhibited phosphorylated Akt in most of the epidermal cells at 
35 days. At 3 months epidermal cells were positive for Akt phosphorylation only a few 
non-positive cells remained in the basal layer.  
A slight increase in phosphorylation of Akt was detected in mice skin of 3 months 
old Nbn
Krox20-Cre
, Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre
 mice.  
 
3.2.7.5 Visualization of S6 phosphorylation in the epidermis 
In skin from psoriasis patients a phosphorylation of the regulator for mRNA 
translation S6 (ribosomal protein S6) was found (Buerger et al.,2013). Therefore the 
skin of the mice was examined for S6 phosphorylation.  
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Figure 53: 
Characterization of S6 
phosphorylation in 
the skin 
Antibody against 
phosphorylated S6 was 
applied to mice skin. The 
skin of Nbn
Ctrl
, 
Nbn
Krox20-Cre
, 
Nbn
Krox20-Cre
p53
-/-
 and 
Nbn/Atm
Krox20-Cre 
was 
collected at 18, 35 days 
and 3 months after births.  
Scale bar: 100 μm  
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The phosphorylation of S6 was detected in the suprabasal layers of the epidermis 
and in the hair follicle bulge area in control animals from each collected point in time 
(Figure 53). In Nbn
Krox20-Cre
 and Nbn/Atm
Krox20-Cre
 mice the same distribution of 
phosphorylated S6 was observed in 18 days and 3 months old animals. At the age of 35 
days a raised amount of positive cells in the hair follicle was apparent in Nbn
Krox20-Cre
, 
Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre
 mice. In Nbn
Krox20-Cre
p53
-/-
 mice the expression 
was still elevated at 3 months of age and epidermal cells of the basal layer were 
positive. The outmost suprabasal layers showed no phosphorylation of S6.  
The pattern of S6 phosphorylation was changed in the Nbn
Krox20-Cre
p53
-/-
 mice. In 
Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre
 animals the amount of cells with 
phosphorylation of S6 increased but the expression pattern was the same as in Nbn
Ctrl
 
mice. 
 
To evaluate a correlation of S6 phosphorylation and proliferation a staining with 
PCNA was conducted. 
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Figure 54: S6 
phosphorylation in 
relation to PCNA 
Staining for PCNA 
(green) and S6 (red) 
positive cells was 
performed on Nbn
Ctrl
, 
Nbn
Krox20-Cre
, 
Nbn
Krox20-Cre
p53
-/-
 and 
Nbn/Atm
Krox20-Cre
 mice. 
Skin was obtained from 
mice at the age of 3 
months, 18 and 35 days. 
Cells were also stained 
with DAPI (blue).  
Scale bar: 100 μm 
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Epidermis of Nbn
Ctrl
, Nbn
Krox20-Cre
 and Nbn/Atm
Krox20-Cre
 mice showed no 
colocalization of PCNA and S6 in cells (Figure 54). This was the same in 18, 35 days 
and 3 months old mice. For Nbn
Krox20-Cre
p53
-/-
 mice at 18 and 35 days after births the 
observation was similar. In 3 months old Nbn
Krox20-Cre
p53
-/-
 mice an expression of 
PCNA and S6 phosphorylation was detected in some cells.  
A colocalization of phosphorylated S6 and PCNA was only detected in 
Nbn
Krox20-Cre
p53
-/-
 with an age of 3 months.  
 
3.2.7.6 Study of Erk1/2 phosphorylation in the epidermis 
In psoriasis Interleukine-17 level is elevated (Lowes et al.,2008) and IL 17 was 
found to activate extracellular signal-regulated kinase (Erk1/2) (Guo et al.,2014). 
Additionally a connection between Nbn and the Erk1/2 pathway was found (Hematulin 
et al.,2008) and a positive regulation of ATM and HRR was described (Golding et 
al.,2007). Therefore the status of Erk1/2 phosphorylation in the mice was checked.  
  Results 
114 
 
 
Figure 55: Analysis of 
Erk1/2 
phosphorylation 
Nbn
Ctrl
, Nbn
Krox20-Cre
, 
Nbn
Krox20-Cre
p53
-/-
 and 
Nbn/Atm
Krox20-Cre 
mouse 
skins were stained against 
pErk1/2. Skin was 
collected at 3 months, 18 
and 35 days after birth. 
Scale bar: 100 μm 
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Nbn
Ctrl
 animals showed few cells with Erk1/2 phosphorylation in the suprabasal 
layer and at the hair follicle (Figure 55). This was the same for animals at the age of 18, 
35 days and 3 months. In Nbn
Krox20-Cre
 mice phosphorylated Erk1/2 is also only detected 
in suprabasal layers in all animals. Animals with the genotype Nbn
Krox20-Cre
p53
-/-
 and 
Nbn/Atm
Krox20-Cre
 started to show Erk1/2 phosphorylation in most epidermal cells with 
35 days and 3 months. First it was detected in the suprabasal layers and then reached 
down in the lower layers. Few cells in the basal layer remained without Erk1/2 
phosphorylation.  
A change in Erk1/2 phosphorylation pattern was detected in Nbn
Krox20-Cre
p53
-/-
 and 
Nbn/Atm
Krox20-Cre
 animals. 
 
3.2.8 Expression of NBN in human psoriasis 
So far no analysis of NBN expression in the skin of human psoriasis patients was 
published. Therefore GEO Profiles database (Edgar et al.,2002; Barrett et al.,2013) was 
screened for data from skin of psoriasis patients. Three studies were found and data was 
analyzed (GEO accession GSE13355 (Nair et al.,2009), GEO accession GSE6710 
(Reischl et al.,2007) and GEO accession GSE14905 (Yao et al.,2008)).  
The data from GEO accession GSE13355 (Nair et al.,2009) contained both positive 
and negative values. A statistical analysis could not be performed. The data contained 
information from a control group (n = 64) and from psoriasis patients (n = 58). From 
psoriasis patients sample from psoriatic plaques and uninvolved skin were taken.  
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Figure 56: NBN mRNA from GSE13355 individual patients 
The values for NBN mRNA of 21 patients are depicted. The levels of NBN mRNA from uninvolved 
skin and from psoriatic plaques are shown.  
Individual patients showed a decrease of NBN while others showed an increase 
from uninvolved skin to psoriasis. The data from 21 representative patient samples are 
shown in Figure 56. An increase in NBN mRNA level was detected in patients 4294, 
4136, 4162, 4247, 4269, 4298, 4505 and 5242. In patients 582, 4368, 4089, 4665, 4177, 
4216, 4339, 4362, 4397, 5331, 3591, 4079 and 3992 a decrease in NBN mRNA was 
observed.  
 
The samples from the study of GEO accession GSE6710 (Reischl et al.,2007) were 
collected from 13 patients. Skin from psoriasis and uninvolved areas were analyzed.     
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Figure 57: Statistical analysis of NBN mRNA in GSE6710 
The value of NBN mRNA in the dataset of GSE6710 was analyzed. The level of uninvolved skin and 
psoriasis are shown. n = 13 
The statistical analysis of the samples showed no differences in the level of NBN 
mRNA between skin from psoriatic plaques and uninvolved skin (Figure 57). The value 
was for uninvolved skin 947 ± 228 and for psoriasis 871 ± 171. A tendency towards a 
reduction of NBN level was seen and led to look analysis of data from individual 
patients.   
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Figure 58: Values of NBN mRNA from individual patients of GSE6710 
The values of NBN mRNA of 13 patients from the GSE6710 data are shown. The patients were 
labeled with letters. The levels of uninvolved skin and psoriasis of each patient are depicted.  
The examination of the individual patient data (Figure 58) revealed an increase of 
NBN mRNA in six patients (patient B, C, E, G, N and R). For patients D, F, J, L, P, W 
and Z the level of NBN decreased from uninvolved skin to psoriatic plaques.  
 
The data from GEO accession GSE14905 (Yao et al.,2008) was analyzed in regard 
to NBN levels. In the study samples from 21 healthy controls were collected. From 28 
psoriasis patients samples from psoriatic plaques and uninvolved skin were taken.  
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Figure 59: Statistical analysis of NBN values from GSE14905 
NBN mRNA values were analyzed. The values of healthy controls (normal skin; n = 21) and from 
psoriasis patients (uninvolved and psoriasis skin; n = 28) are shown. (*P < 0,05; **P < 0,01; 
***P < 0,001) 
The statistical analysis of NBN mRNA values from GSE14905 showed a decrease 
of mRNA levels (Figure 59). Normal skin from the control group showed the highest 
level of NBN mRNA (7 ± 0,5). A statistical significant decrease was detected in 
uninvolved skin (6,7 ± 0,3) and in psoriasis skin (6,5 ± 0,4) compared to control skin. 
The level of NBN mRNA was also significantly decreased between samples from 
involved skin and psoriatic plaques in psoriasis patients.  
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 Conclusions and Discussion  4.
4.1 Nbn is essential for skin homeostasis 
An important role of NBN in skin homeostasis was suggested due to the different 
skin diseases that were found in patients with NBS. Examples for those are 
Porokeratosis and the thin and sparse hair observed in the patients (Wolf and 
Shwayder,2009; Chrzanowska et al.,2012). Discovery of NBN mutations in malignant 
melanomas pointed additionally towards an important role of NBN in the maintenance 
of regular skin function (Debniak et al.,2003; Thirumaran et al.,2006; Meyer et 
al.,2007). 
To obtain data on the expression of NBN in skin GEO Profiles database (Edgar et 
al.,2002; Barrett et al.,2013) was looked into and data sets were analyzed. So far no 
papers were published containing analysis of data in regard to general NBN expression 
in healthy human skin. All data obtained from GEO datasets was data from microarray 
analyses. 
NBN expression was found in the skin of healthy humans (GEO accession GSE1719 
(Strunnikova et al.,2005), GEO accession GSE5667 (Plager et al.,2007; Plager et 
al.,2010) and GEO accession GSE31652 (Krueger et al.,2012) ). In hair follicles its 
expression was also detected (GEO accession GSE3058 (Kim et al.,2006) and GEO 
accession GSE3419 (Ohyama et al.,2006)). In studies of gene expression in psoriasis 
NBN was found to be expressed (GEO accession GSE13355 (Nair et al.,2009), GEO 
accession GSE6710 (Reischl et al.,2007) and GEO accession GSE14905 (Yao et 
al.,2008)). Analysis of the data revealed that GEO accession GSE13355 (Nair et 
al.,2009) contained both positive and negative values. Therefore statistical analysis was 
not performed. No statistical differences was found in data from GEO accession 
GSE6710 (Reischl et al.,2007). Samples of individual patients showed a decrease of 
NBN level from non-lesional skin to psoriatic plaques in some patients while others 
showed an increase (GEO accession GSE13355 (Nair et al.,2009), GEO accession 
GSE6710 (Reischl et al.,2007)). The data analysis of the third study identified a 
significant decrease in NBN expression from a non-patient group to lesion free patient 
skin (GEO accession GSE14905 (Yao et al.,2008)). The level of NBN was significantly 
lower in psoriatic plaques compared to both the control group and to non-lesional skin 
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of the same patients (GEO accession GSE14905 (Yao et al.,2008)). The status of NBN 
in psoriasis seems to vary from patient to patient. Therefore the overall expression of 
NBN in a complete study depends on the patients included. If NBN status needs to be 
determined each patient has to be evaluated individually.    
In the conducted study Nbn was deleted in the epidermis using Krox20-Cre 
recombinase. The deletion of Exon 6 was shown to lead to a null mutation of Nbn 
(Dumon-Jones et al.,2003; Frappart et al.,2005). The deletion occurred after birth. It 
started at P1 in small patches, spread to the hair follicles and the surrounding epidermis 
between P10 to P18 and was deleted in the complete back skin in adult mice. As 
Krox20-Cre recombinase is not expressed in the tail no effects were expected in this 
area (Young et al.,2003).  
The expression of Nbn in the skin of mice was not documented before. Therefore 
RNA was extracted and confirmed the expression of Nbn in the keratinocytes of mice 
from the control group. Deletion of Nbn was also confirmed with the absence of Nbn on 
RNA level.  
Visual examination showed healthy mice at birth. The development of the mice 
continued in the same way for control and deletion mice. At the first point in time of 
animal collection (P18) no differences between Nbn
Ctrl
 and Nbn
Krox20-Cre
 mice were 
apparent. Both analysis of histological morphology and visual examination of the mice 
showed no differences. At this point in time Krox20-Cre expression had already caused 
a deletion of Nbn in the hair follicles and the surrounding epidermis. The hair on the 
back reached the catagen phase at 18 days after birth and were in a regression phase 
(Muller-Rover et al.,2001; Alonso and Fuchs,2006). First differences were observed 
both in visual examination and in histology at 35 days after birth. The hair follicles and 
epidermis showed altered structures and the hair started to thin out. At the age of 35 
days the hair follicles are in the first anagen phase after hair follicle morphogenesis 
(Muller-Rover et al.,2001). In this phase growth of new hair is initiated from the hair 
follicles stem cells to replace or add new hair to the dead club hair (Muller-Rover et 
al.,2001; Alonso and Fuchs,2006). At this age the next catagen phase is soon to follow. 
Three months after birth the hair cycle of the mice is in resting (telogen) phase (Muller-
Rover et al.,2001). In adult mice of 3 months most of the fur was lost. The tail remained 
covered with fur, as expected due to the Krox20-Cre recombinase expression pattern. 
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Histology revealed the existence of single hair follicles with an altered structure in the 
skin of the mice. The epidermis was enlarged.  
Those findings indicated an important role of Nbn in the perpetuation of skin 
homeostasis. Both hair follicle cycling and epidermal balance were highly affected by 
the deletion of Nbn.   
 
4.2 Nbn is needed for repair of DNA damages in the hair 
follicle and maintenance of stem cells 
The fur of mice started to thin out around 35 days after birth. Nearly the complete 
hair was gone at 3 months after birth. To examine the cause of the hair loss different 
stainings were conducted. The apoptosis rate and the amount of DNA damages in the 
hair follicles of the deletion mice was evaluated. In addition an analysis of the Keratin 
15 expressing hair follicle stem cells was performed.  
The role of p53 dependent apoptosis in the hair follicle cycling is not fully 
understood by now. A constant p53 expression was shown during anagen and catagen 
phases, implicating an independence of the hair regression from p53 apoptosis (Seiberg 
et al.,1995). On the other hand p53 deficient mice showed no hair loss and apoptosis 
after chemotherapy and the expression of p53 in apoptotic catagen hair follicle cells was 
shown (Botchkarev et al.,2000; Botchkarev et al.,2001). In addition a difference in 
response to p53 increase was seen in different epidermal cells. While an increase of p53 
in the keratinocytes in the epidermis causes growth arrest, it caused apoptosis in hair 
follicles (Song and Lambert,1999). Due to this unclear role of p53 in apoptosis of the 
different epidermal compartments the analysis of apoptosis in this study was done using 
various markers. It was stained against p53 for p53 dependent apoptosis. Active 
Caspase 3 staining was done to show p53 independent apoptosis and TUNEL reaction 
was performed to visualize apoptotic cells independent on the pathway involved.   
Most cells positive for makers of apoptosis were localized in the hair follicles in all 
animals. This showed that apoptosis does not play a major role in the keratinocytes of 
the different epidermal layers. Sheading of those is only due to differentiation processes 
and not due to apoptosis. On the other hand in the cycling of hair follicles apoptosis 
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plays an important role in catagen phase for the regression of the hair follicle 
(Slominski et al.,1994; Lindner et al.,1997). 
The role of apotosis in hair regression was visible in Nbn
Ctrl
 mice. They showed the 
highest amount of Caspase 3 active cells in the hair follicles at P18 (catagen phase). On 
day 35 after birth the amount was lower as the cells were in anagen phase but short 
before the next catagen phase started. Nearly no activity of Caspase 3 was detected in 
the hair follicles of 3 months old animals. At this point of time the hair follicle was in 
the resting phase and no apoptotic cells were expected to be found. In conclusion the 
Caspase 3 activity in Nbn
Ctrl
 mice was as expected from literature. In Nbn
Krox20-Cre
, 
Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre
 mice few Caspase 3 active cells were detected at 
18 days after birth. For those animals the peak of Caspase 3 activity was seen in 35 days 
old mice. The amount of p53 expressing cells in control animals was low during the 
observed time. It reached its peak in 35 days old control animals. Deletion mice showed 
a higher amount of p53 positive cells at all points in time but the peak also lays at 35 
days.  
Those observations of Caspase 3 activity and p53 expression in deletion animals 
could indicate a change in hair follicle cycle progression. In p53 deleted mice a change 
in hair cycling was described before (Botchkarev et al.,2001). On the other hand it could 
show an accumulation of apoptotic cells in the hair follicle due to an elevated rate of 
DNA damages independent of the hair cycle step. The lower activity of Caspase 3 and 
p53 expression in 3 months old mice with deletions was probably due to the lack of hair 
follicle structures. This also corresponds to the observations that apoptotic cells were 
mainly detected in the hair follicles. The discovery that the changes and absence of hair 
follicles in Nbn
Krox20-Cre
p53
-/-
 mice were comparable to those seen in Nbn
Krox20-Cre
 and 
Nbn/Atm
Krox20-Cre 
mice indicates an important role of p53 independent apoptosis in the 
hair loss in mice of this study. This would be in agreement with p53 independent 
apoptosis in hair regression observed by Seiberg et al. (Seiberg et al.,1995). On the 
other hand the amount of p53 positive cells in Nbn/Atm
Krox20-Cre 
mice was significantly 
higher than in Nbn
Krox20-Cre
. This could point to a more important role of p53 dependent 
apoptosis in animals with a combined deletion of Atm and Nbn. This is supported by the 
fact that functional Atm is known not to be required for p53 apoptosis in epidermis 
(Gurley and Kemp,2007).  
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DNA damage and especially DSB accumulation was screened via the number of 
γH2A.X foci. Those were highest in NbnKrox20-Cre andNbnKrox20-Crep53-/- mice at 35 days 
of age. In Nbn
Ctrl
 the amount at 35 days was comparable to Nbn
Krox20-Cre
 mice but at 18 
days was significantly lower. Even with the presences of hair follicles at 3 months the 
amount of γH2A.X foci decreased in the NbnCtrl mice below the level of 18 days. This 
pointed out a general dependence of accumulation of DNA damages in the hair follicle 
on the hair cycle phase. During the dying of hair follicles in catagen DNA damages that 
arise are not repaired and therefore accumulate in the cells. The onset of new growth 
during the anagen (P35) phase explains a high amount of DNA damages. Those are due 
to the increase in DNA replication and proliferation in the cells. During those processes 
errors occur. In the hair follicles of control mice the errors are repaired, new hair are 
formed and show only a basal level of DNA damages in telogen (3 months) phase. In 
the deletion mice the errors cannot be repaired properly and the apoptosis rate increases, 
as seen through Caspase 3 activation, during the growth phase of the hair follicles. In 
stem cells of the epidermis the repair of DNA damages was described to be faster than 
in surrounding cells (Harfouche et al.,2010). Despite the lack of Nbn the repair is not 
possible anymore in the mice. In 3 months old animals nearly no hair follicles are 
observed anymore. Thus the low amount of γH2A.X foci at this stage can be explained. 
Only in Nbn/Atm
Krox20-Cre mice the level of γH2A.X foci remained relatively low. A 
possible explanation would be that with the inactivation of both Nbn and Atm the 
amount of DNA damages that finally result in apoptosis is lower and that those cells die 
faster. On the other hand it can also suggest dependence of phosphorylation of Histone 
H2A.X on Atm in the epidermis. With the lack of Nbn and p53 Atm still causes 
phosphorylation of Histone H2A.X (Burma et al.,2001; Stiff et al.,2004). In the hair 
follicles no other member of the PIKK kinase family (e.g. DNA-PKcs, ATR) (Burma et 
al.,2001; Stiff et al.,2004; Friesner et al.,2005) seems to be able to substitute sufficiently 
for Atm. The peak of γH2A.X foci in 3 months old animals from Nbn/AtmKrox20-Cre 
showed the higher amount of DNA damages in the keratinocytes in those mice. This 
could point to different roles of Atm in hair follicle stem cells and basal keratinocytes. It 
could indicate that another PIKK kinase family member functions in basal 
keratinocytes. This would also support the activation of p53 apoptosis after loss of Atm 
postulated above and by others (Gurley and Kemp,2007).  
Previously an important role of NHEJ in hair follicle stem cells was described 
(Sotiropoulou et al.,2010). The NHEJ was mediated through DNA-PK. Nbn is known to 
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be able to act in NHEJ. The importance of Atm for the formation of γH2A.X foci in the 
hair follicles in the mice here points additionally towards HRR. While NHEJ mostly 
happens during G0/G1 phase of the cell cycle HRR occurs during the rest of the cell 
cycle. With the proliferation markers it was shown that most cells of the hair follicle 
were not in G0 or G1 phase. Therefore HRR might have a more important role in the 
hair follicles at the collected points in time. It is possible that both the lack of Nbn leads 
to a defect not only in HRR but also in NHEJ in the hair follicle stem cells. The 
damages are not repaired at any step during cell cycling and this results in damage 
accumulation, partially in cell death and in loss of stem cell properties.  
To analyze the apoptotic character of γH2A.X positive cells a staining in 
combination with TUNEL reaction was performed. This showed only few TUNEL 
positive cells in hair follicles of all animals. In the epidermis TUNEL staining was 
observed exclusively in Nbn/Atm
Krox20-Cre
 mice at the age of 3 months. An overlap of 
TUNEL and γH2A.X was observed in cells completely positive for γH2A.X. In cells 
with γH2A.X foci no TUNEL was detected and inverted. This is probably due to the 
fact that γH2A.X foci show DSBs that arise at an early stage of a starting cell death 
while TUNEL staining showed fully apoptotic cells. The staining also gives rise to the 
idea that there might be another reason for the disappearance of the hair follicles besides 
cell death.   
As Keratin 15 is a marker for stem cells in the hair follicles and in the basal layer of 
the epidermis, a staining was done to look at those cells. Keratin 15 was expressed in all 
mice from the control group in the expected compartments. In the deletion mice Keratin 
15 staining could only be seen at 18 days and partially at the age of 35 days. 3 months 
old mice showed no Keratin 15 expression anymore. An analysis of the Keratin 15 cells 
with 53BP1 revealed DNA damages in stem cells in the hair follicles of the younger 
mice. This showed that hair follicle stem cells were either lost through apoptosis or 
changes occurred that abolished the stem cell properties of those cells. A limiting factor 
of DNA damages to stem cell self-renewal was recently demonstrated (Wang et 
al.,2012). It is possible that the hair follicle stem cells started to differentiate into basal 
keratinocytes (Cotsarelis et al.,1990; Taylor et al.,2000; Oshima et al.,2001; Ito et 
al.,2005; Levy et al.,2007). This could explain the raised proliferation at 35 days and the 
high population of basal keratinocytes at 3 months in deletion animals.  
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Several studies showed a higher resistance of epidermal and hair follicle stem cells 
against DNA damages due to a fast repair and apoptosis (El-Abaseri et al.,2006; Rachidi 
et al.,2007; Harfouche et al.,2010; Sotiropoulou et al.,2010). In one study a mouse 
model was used (Sotiropoulou et al.,2010) while the others worked with cell culture. 
The DNA damage induction was done with one-time application of UV or IR. DNA 
damage response in those experiments was not impaired. Due to these differences those 
studies do not contradict the results observed in this work. Here mouse models were 
used which were impaired in DNA damage response. Therefore a constant existence of 
non-repaired DNA damages occurred as compared to one-time DNA damages in the 
studies mentioned above. This can explain the different behaviors observed in hair 
follicle stem cell, e.g. no resistance against apoptosis, in our animals.  
Two studies with defects in DNA damage response in skin of mouse models support 
the observations made here (Ruzankina et al.,2007; Sotiropoulou et al.,2013). The loss 
of hair follicle stem cells was also observed in mice lacking ATR (Ruzankina et 
al.,2007). In those mice the loss of stem cells was demonstrated after continuous 
depilation of the hair. In combination with p53 deletion the results were similar or 
slightly more pronounced (Ruzankina et al.,2009). A study of Brca1 deletion in the 
Keratin 14 expressing cells during the embryonic development revealed a decrease in 
hair follicles (Sotiropoulou et al.,2013). A combination with p53 deletion resulted in a 
rescue of the phenotype (Sotiropoulou et al.,2013). Deletion of Brca1 in adult Keratin 5 
expressing keratinocytes led to delayed regeneration of hair after shaving and a 
progressive loss of hair follicle stem cells in those animals (Sotiropoulou et al.,2013). In 
our mice the effects seem to be more pronounced than in those studies. The effects can 
be detected without further manipulation of the animals and it occurs already after one 
completed hair cycle. In addition the pathways involved are probably corresponding to 
the ones involved in ATR deletion mice but differ from Brca1 deletion mice. This 
conclusion can be drawn from the effect of additional p53 deletion in the animals.   
Due to all the different analyses it can be concluded, that the hair loss observed in 
mice with Nbn
Krox20-Cre
, Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre
 is due to an increase of 
DNA damages and a failure in repair of those. It leads to a rise in apoptosis, disruption 
of epidermal stem cell properties and differentiation of those stem cells into basal 
keratinocytes. Those events result in the loss of hair follicle stem cells and thereby the 
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inability to regenerate hair follicles. Additionally it leads to an increase of the 
population of basal keratinocytes.  
 
4.3 Nbn prevents development of a psoriasis-like phenotype 
Nbn
Krox20-Cre
, Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre
 mice with 3 months of age 
showed besides the hair loss, both acanthosis and parakeratosis. Those effects were 
demonstrated by the increase of proliferating cells and by the disturbed differentiation 
of keratinocytes observed in the mice. Invasion of the dermis with Mast cells and 
Neutrophils was observed. T-cells with CD3 expression were detected in the epidermis. 
An activation of Stat3 at Tyr 705 was observed in the mice. These are typical signs for 
psoriasis (Figure 60) (Weinshenker et al.,1989; Bos and De Rie,1999; Sano et al.,2005; 
Griffiths and Barker,2007; Gudjonsson et al.,2007; Hertl,2011).  
Common sign for 
psoriasis in humans 
Observed in this mouse 
model 
Remarks 
Scall development Yes  
Elongation of rete ridges No Do not exist in mice 
Increase of capillary 
number 
No  
acanthosis Yes PCNA, Ki67, H3P, p63 
parakeratosis  Partially; everywhere 
disturbed differentiation 
Keratin 10, Keratin 14 
Invasion of leucocytes Yes Mast cells, Neutrophils 
Invasion of T-cells  Yes CD3 T-cells  
Activation of Stat3 Yes Stat3 phosphorylation on 
Tyr 705 
Figure 60: Signs of psoriasis 
In Figure 60 a table of psoriasis signs is shown. It lists typical signs of psoriasis observed in human 
patients. The mouse model refers to Nbn
Ctrl
, Nbn
Krox20-Cre
, Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre 
mice 
with 3 months of age. The appearance of the psoriasis signs is stated. Under remarks the stainings that 
were done to show the psoriasis sign are named. Possible explanations for signs that were not detected are 
given. 
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The observed processes in our mice lead to the conclusion that in all genotypes the 
animals of 3 months show a psoriasis-like phenotype (Figure 60). In the double deleted 
mice with p53 a difference can be seen as those animals also show invaginations in the 
epidermis. To further evaluate the differences and to look into the pathways possibly 
involved in causing the psoriasis in Nbn deleted mice more analyses were performed.  
Besides the activation of Stat3 being a general sign for psoriasis, Stat3 is known to 
activate c-Myc (Kiuchi et al.,1999). c-Myc is a cell cycle promotor and oncogene. The 
change of expression levels of c-Myc in human psoriasis patients is diversely discussed. 
An increase in c-Myc antibody staining was shown on frozen sections (Osterland et 
al.,1990) while analysis of RNA and in situ hybridization on tissue from human 
psoriasis patients no increase in c-Myc expression could be seen (Elder et al.,1990; 
Schmid et al.,1993). In mouse models an overexpression of c-Myc in suprabasal layers 
of the epidermis was shown to cause hyperplasia, hyperkeratosis and abnormal 
differentiation of keratinocytes (Pelengaris et al.,1999; Waikel et al.,1999). In addition 
the upregulation of c-Myc in mice skin caused a loss of stem cells (Waikel et al.,2001). 
From those studies it can be concluded, that, at least in mice, c-Myc has an influential 
role in epidermis homeostasis. The role in human psoriasis remains unclear. Targeted c-
Myc overexpression in mice was described to cause changes in the skin as can be 
observed in our mice (Pelengaris et al.,1999; Waikel et al.,1999). An activating role of 
c-Myc in regulation of NBN expression was described (Chiang et al.,2003; Wan et 
al.,2013). The studies also showed a binding site for c-Myc on Intron1 of NBN (Chiang 
et al.,2003; Wan et al.,2013). Therefore it is possible that the activation of Stat3 seen in 
our mice might lead to c-Myc overexpression which results in increased proliferation 
and disturbance of differentiation.    
In psoriasis, besides IL-17, Interleukin-22 (IL-22) expression is elevated (Wolk et 
al.,2006; Lowes et al.,2008). Both Interleukins are produced by Th17 cells (Liang et 
al.,2006). IL-22 was found to activate Stat3, MAPK and Erk1/2 (Lejeune et al.,2002). 
The cell proliferation in the epidermis induced via IL-22 was found to be regulated by 
the PI3K/Akt/mTOR signaling cascade (Mitra et al.,2012). IL-17 induced proliferation 
is regulated via mTOR (Saxena et al.,2011). In psoriasis PI3K was found to be 
overexpressed compared to normal tissue (Pike et al.,1989). The phosphorylation of Akt 
was described in human psoriasis (Madonna et al.,2012). mTOR is also activated in skin 
from psoriasis patients (Buerger et al.,2013). NBN was shown to interact with PI3K and 
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increases its activity (Chen et al.,2005; Chen et al.,2008). This leads to an activation of 
Akt and mTOR (Chen et al.,2005). mTOR is part of the mTORC2 complex and in this 
complex activates Akt additionally (Sarbassov et al.,2005). mTOR belongs to the family 
of PIKKs (Kunz et al.,1993; Keith and Schreiber,1995). Nbn was shown to interact with 
mTORC2 complex to activate Akt (Wang et al.,2013). The analysis of Akt 
phosphorylation via mTORC2 pathway detected only slight changes. Those were visible 
in skin of Nbn
Krox20-Cre
, Nbn
Krox20-Cre
p53
-/-
 and Nbn/Atm
Krox20-Cre
 mice at 3 months after 
birth. The activation of Akt through mTORC2 complex seems to be involved in 
development of the psoriasis-like phenotype in the mice.     
MAPK and mTOR (via mTORC1) activate S6 kinase (S6K1) (Mukhopadhyay et 
al.,1992; Dufner and Thomas,1999; Hay and Sonenberg,2004). S6K1 then 
phosphorylates a regulator for mRNA translation S6 (Jeno et al.,1988; Dufner and 
Thomas,1999; Hay and Sonenberg,2004). In skin from psoriasis patients a 
phosphorylation of S6 was found (Buerger et al.,2013). Therefore the skin of the mice 
was examined for S6 phosphorylation. In Nbn
Ctrl
, Nbn
Krox20-Cre
 and Nbn/Atm
Krox20-Cre
 
mice the phosphorylation was only detected in the suprabasal layers of the epidermis. In 
35 day old mice from Nbn
Krox20-Cre
and Nbn/Atm
Krox20-Cre
 S6 activation was also seen 
around the hair follicle. A double staining with the proliferation marker PCNA showed 
that cells with S6 phosphorylation all belonged to the differentiating keratinocytes. This 
is in line with the S6 phosphorylation pattern in suprabasal and differentiating 
keratinocytes described in human psoriasis (Buerger et al.,2013). The pattern of S6 
activation in Nbn
Krox20-Cre
and Nbn/Atm
Krox20-Cre
 mice confirms a psoriasis-like 
phenotype. Also a higher activation of S6 after Nbn deletion can be seen.   
S6 was also found to be phosphorylated by Erk1/2 using an mTOR independent 
pathway (Roux et al.,2007). IL-17 and IL-22 were found to activate Erk1/2 (Lejeune et 
al.,2002; Lee et al.,2008; Guo et al.,2014). An elevated level of MAPK and Erk1/2 was 
detected in biopsies from psoriasis patients (Johansen et al.,2005). MAPK dependent 
epidermal hyperplasia required Stat3 to develop (Tarutani et al.,2013). Besides those 
events a connection between NBN and the Erk1/2 pathway was found and a positive 
regulation of ATM and HRR was described (Golding et al.,2007; Hematulin et 
al.,2008). Due to this knowledge the phosphorylation status of Erk1/2 was checked in 
this study. An activation of Erk1/2 in Nbn
Ctrl
 and Nbn
Krox20-Cre
 mice was detected in the 
Stratum corneum at all points of time. Both in Nbn/Atm
Krox20-Cre
 and Nbn
Krox20-Cre
p53
-/-
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animals a higher level of Erk1/2 activation in all epidermal layers was observed starting 
at 35 days after birth.   
The analyses of the mice revealed the role of Nbn in prevention of formation of a 
psoriasis-like phenotype in mice. Mice lacking Nbn show a vast number of changes that 
correspond to human psoriasis. Invasion of different immune cells can be observed. 
Epidermis enlarges due to higher proliferation and disturbed differentiation. 
Additionally many protein expressions and activations change similarly to human 
psoriasis. Furthermore the experiments confirm Nbn involvements seen in pathways that 
were described before. With the mouse model those interactions are now indicated in 
vivo and a possible link between the different networks is added.  
 
4.4 Atm function differs between keratinocytes and hair 
follicle cells 
Nbn and Atm are known to interact. The interaction is bidirectional. Together they 
function in cell cycle signaling, DNA damage signaling and repair (details in 
Introduction). Different mouse studies were conducted to show the consequences of 
combined deletion of Nbn and Atm and to shed light on the interdependence of the two 
proteins. In the CNS a joint function was detected due to the worsening of the single 
deletion phenotypes after combined elimination of Nbn and Atm (Dar et al.,2011). Nbn 
and Atm deletion was shown to have different cell type and time dependent 
consequences (Rodrigues et al.,2013). In epidermis autophosphorylated ATM was 
found to locate mostly in Golgi apparatus instead of the nuclear localization described 
in other cells (Ismail et al.,2011). Nuclear distribution in keratinocytes was detected 
after UV treatment or in precancerous lesions (Ismail et al.,2011). p53 apoptosis in 
epidermis was shown to be independent from Atm, while it was necessary in spleen, 
thymus and brain (Gurley and Kemp,2007). As the role of Atm in combination with 
Nbn seems to vary in different tissues and the role of Atm in the epidermis is still 
unclear a combined inactivation of Nbn and Atm was performed in this study. The mice 
of Nbn
Krox20-Cre
and Nbn/Atm
Krox20-Cre
 groups showed largely the same results. Both show 
a psoriasis-like phenotype in aging animals and a hair loss due to increase in DNA 
damages, apoptosis and stem cell failure. Differences were only observed in the small 
details. The amount of p53 positive cells was higher after Atm was abolished in 
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addition. This showed that p53 apoptosis in the epidermal cells started to be more 
important when both Nbn and Atm fail. In Nbn/Atm
Krox20-Cre mice the level of γH2A.X 
foci remained relatively low compared to Nbn
Krox20-Cre
. No other PIKK kinase was able 
to completely replace Atm in its role in Histone H2A.X phosphorylation in the hair 
follicle. When no hair follicles were left at 3 months the level of γH2A.X foci was the 
same in Nbn
Krox20-Cre
and Nbn/Atm
Krox20-Cre
 mice. The observed Histone H2A.X 
phosphorylation at this point in time was in the keratinocytes of the epidermis. This 
demonstrated that another PIKK kinase family member functions in basal keratinocytes 
which also supports the observations made with p53. The psoriasis-like phenotype of 
Nbn deficient mice seems to worsen slightly with an additional Atm deficiency. This can 
be seen as the number of invading immune cells is increased while the presented 
phenotype of the mice remains similar. In the analyses of pathways a difference due to 
Atm deletion was detected in Erk1/2. Here the activation was increased. This indicates a 
role of Atm in the prevention of Erk1/2 phosphorylation.  
The results from this study indicate a minor role of Atm in keratinocytes. In hair 
follicle cells Atm is needed for the phosphorylation of Histone H2A.X which makes 
DNA accessible for repair. The influence of Atm on Nbn in the skin is therefore 
dependent on the cell type. A possible role of Atm in circumvention of Erk1/2 
phosphorylation in the skin was discovered.   
 
4.5 p53 inhibits tumor formation in Nbn deficient epidermis 
p53 is known to be involved in the regulation of cell cycle progression and apoptosis 
after DNA damages. Various mouse models were created to show the involvement of 
p53 in processes following DNA damages. The recovery of hematopoetic cells with p53 
depletion after treatment with cytotoxic agents showed the importance of p53 in 
apoptosis that normally takes place (Wlodarski et al.,1998). Often mice with a p53 
deletion rescued the phenotype of mice deficient in aspects of DNA damage signaling 
and repair. p53 deletion in mice deficient for telomerase rescued the first generations 
(Chin et al.,1999). After four generations the combined defect of telomerase and p53 led 
to cancer development (Chin et al.,1999). Cells without Ku80 die (Lim et al.,2000). 
After additional p53 deletion those cells were able to survive due to an impairment of 
G1/S checkpoint processing (Lim et al.,2000). Neuronal defects after Nbn deletion were 
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also rescued after p53 depletion (Frappart et al.,2005). A decrease of hair follicles was 
detected after Brca1 deletion in the Keratin 14 expressing cells (Sotiropoulou et 
al.,2013). An additional p53 deletion resulted in development of hair in those mice 
(Sotiropoulou et al.,2013). In the absence of p53 the hair loss normally observed after 
chemotherapeutic treatment did not occur (Botchkarev et al.,2000). A rescue of 
epidermal stem cells was observed in mice with non-functional telomeres combined 
with p53 deletion (Flores and Blasco,2009). On the other hand not all p53 deletions 
resulted in a rescue. Inactivation of ATR led to the loss of hair follicle stem cells in mice 
(Ruzankina et al.,2007). After combined deletion of ATR and p53 no rescue was 
observed (Ruzankina et al.,2009). The mice showed the same phenotype (Ruzankina et 
al.,2009). It was even slightly more pronounced (Ruzankina et al.,2009). Similar to this 
observation no rescue was observed in this study. Nbn
Krox20-Cre
p53
-/-
 mice showed the 
same rate in Caspase 3 activation as Nbn
Krox20-Cre
 mice. The hair loss occurred at roughly 
the same speed. The increase of γH2A.X foci at 35 days points more towards a 
worsening of the phenotype. Otherwise most of the observations seemed to match with 
the psoriasis-like phenotype in the other mice. On the other hand the lack of CD3 
T-cells increase points toward another inflammatory process than psoriasis. The 
appearance of p53 in human psoriasis (Tadini et al.,1989; Yazici et al.,2007) also would 
not match with a psoriasis-like phenotype in our p53 deletion mice. That the level of 
p53 in psoriasis patients increases after sun exposure of the lesion (Yazici et al.,2007) 
could point towards an activation of p53 apoptosis after DNA damages due to the sun 
light and UV treatment in psoriasis patients and not to a general expression of p53 in 
psoriasis lesions.   
The phenotype of Nbn
Krox20-Cre
p53
-/-
 mice seemed more severe than of Nbn
Krox20-Cre
 
mice on visual examination. Morphology of the skin revealed thickening of the 
epidermis like in Nbn
Krox20-Cre
 mice but additional invaginations of the epidermis and 
cyst-like structures. In our mice with p53 deletion the p53 dependent apoptosis after 
DNA damages in psoriasis is not functioning. This leads to a higher inflammatory 
reaction that was visible in the raised number of Mast cells and Neutrophils that invaded 
the epidermis. Additionally the level of Erk1/2 activation was higher and S6 activation 
was observed in proliferating cells. This leads to an elevated rate of mitosis, seen in the 
higher rate of Histone 3 phosphorylation, in the epidermis. It results in a precancerous 
lesion in Nbn
Krox20-Cre
p53
-/-
 mice with the cyst-like structures. Development of squamous 
cell carcinoma after p53 deletion was detected before (Martinez-Cruz et al.,2008). This 
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process was mediated by inflammation and chromosomal instability (Martinez-Cruz et 
al.,2009). Both inflammation and non-repaired DNA damages that lead to chromosomal 
instability are present in the Nbn
Krox20-Cre
p53
-/-
 mice. This supports the classification of 
the cyst-like structures as precancerous lesions in the mice. 
The results from this study show that p53 existence inhibits tumor formation and 
favors psoriasis in the skin of Nbn
Krox20-Cre
 mice. Absence of both Nbn and p53 leads to 
a start of tumor formation in the epidermis.  
  
4.6 Tests before PUVA treatment might protect psoriasis 
patients from skin cancer development 
In patients with NBS thin and spares hair and Porokeratosis were described (Wolf 
and Shwayder,2009; Chrzanowska et al.,2012). NBN mutations were found in malignant 
melanoma and basal cell carcinoma (Debniak et al.,2003; Thirumaran et al.,2006; 
Meyer et al.,2007). Psoriasis patients exhibit a higher risk for non-melanoma skin 
cancer, such as squamous cell carcinoma and basal cell carcinoma (Pouplard et 
al.,2013). This is seen after the treatment with immune suppressing agents and PUVA 
(Pouplard et al.,2013). In psoriasis patients NBN decrease was detected in biopsies from 
skin lesions compared to non-affected areas (GEO accession GSE14905 (Yao et 
al.,2008). The non-patient control group showed higher NBN expression in the skin 
(GEO accession GSE14905 (Yao et al.,2008). But overall the status of NBN is highly 
dependent on the single patient as shown with the analysis of three studies (GEO 
accession GSE13355 (Nair et al.,2009), GEO accession GSE6710 (Reischl et al.,2007) 
and GEO accession GSE14905 (Yao et al.,2008)). It was already demonstrated that 
UVA application comparable to PUVA treatment causes DNA damages 
(Bredberg,1981; Pathak et al.,1986). The repair of those damages was suggested to 
function in DNA break dependent manner (Bredberg et al.,1982). In addition UV light 
was described to cause DNA damages that lead to mutations of p53 and probably skin 
cancer (Tornaletti et al.,1993). The decrease of NBN in some psoriasis patients indicates 
that DNA damage signaling and repair in those patients is partially inhibited or not 
functioning at all. The DNA damages caused by PUVA or other mutagenic treatment in 
patients with lower NBN level would not be repaired. This would lead to mutations of 
e.g. p53 and cause cancer development in the patients. This seems a likely process 
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considering the results in the mentioned studies. The study of DNA damage signaling 
and repair failure in mouse now confirms this. The study here demonstrates that the 
inactivation of the DNA damage signaling and repair protein Nbn leads to psoriasis 
development in prior healthy skin. In combination with p53 inactivation tumor 
development started.  
Taking all these findings into account it should be considered to test the status of 
DNA damage signaling and repair in psoriasis patients prior to PUVA treatment. Such 
evaluation might protect patients from the development of non-melanoma skin cancers.  
 
4.7 Summary statements 
4.7.1 Function of Nbn and Atm in DNA damage repair is tissue dependent 
Deletion of Nbn caused a failure to repair DNA damages in the hair follicle stem 
cells. It is possible that the lack of Nbn caused failure of both NHEJ and HRR. This 
resulted in increased p53 independent apoptosis and loss of cells. In the hair follicle 
stem cells it led to a possible differentiation into basal keratinocytes. In the 
differentiated cells of the epidermis Nbn deletion did not cause apoptosis but a 
disturbance of the differentiation and an increase in proliferation. The consequence of 
Nbn deactivation seems to depend on the whether the tissue is composed of 
stem/progenitor cells or differentiated cells.  
The role of Atm in combination with Nbn is demonstrated to be tissue dependent. 
Even in proliferating cells differences are detected depending on the tissue. In hair 
follicle stem cell Atm was essential for formation of γH2A.X foci while Atm was 
shown not to be required for γH2A.X foci formation in the external germinal layer 
(EGL) of the cerebellum (Rodrigues et al.,2013). The Atm status influenced the 
occurrence of p53 dependent apoptosis in the hair follicles. In EGL apoptosis was 
always p53 independent (Rodrigues et al.,2013). A worsening of the Nbn deletion 
phenotype after Atm deficiency was detected in EGL (Rodrigues et al.,2013) while the 
impact in the epidermis was minimal.  
While the loss of Nbn activity alone has various impacts on both proliferating and 
differentiated tissue the consequences of an additional deletion of Atm are detectable 
mostly in proliferating tissue. In differentiated cells it seems to have only fractional 
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impact. This was also seen in other studies and tissues (Zhou et al.,2012; Rodrigues et 
al.,2013). 
 
4.7.2 Nbn is essential for skin homeostasis 
The deletion of Nbn in the epidermis of mice showed the important role of Nbn in 
DNA damage repair in the skin and the maintenance of skin homeostasis.  
The disrupted DNA damage response results in the inability of the hair follicles to 
regenerate. This is due to a rise in apoptosis and disruption of epidermal stem cell 
properties. Those cells then start to give rise to basal keratinocytes. The activation of 
Stat3 in the epidermis can also contribute to this process (Rao et al.,2013). Along with 
the hair follicle loss an enlargement of the epidermis was observed. Screening of 
different factors revealed a psoriasis-like phenotype in the Nbn deleted mice. The 
changes observed are indicated in Figure 61. The involvement of Nbn in the network of 
pathways that are altered in psoriasis is shown.   
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Figure 61: The Nbn/Psoriasis network  
Immune cells typically involved in psoriasis and the factors they secret are visualized. Those factors 
activate different pathways known to be altered in psoriasis. These pathways are shown and a connection 
to Nbn is depicted. The relationships of the proteins are characterized. The links of the different proteins 
and pathways were found in literature (Jeno et al.,1988; Mukhopadhyay et al.,1992; Scott et al.,1998; 
Dufner and Thomas,1999; Kiuchi et al.,1999; Lejeune et al.,2002; Chiang et al.,2003; Hay and 
Sonenberg,2004; Chen et al.,2005; Hendarmin et al.,2005; Sarbassov et al.,2005; Liang et al.,2006; 
Golding et al.,2007; Huang et al.,2007; Roux et al.,2007; Yang et al.,2007; Chen et al.,2008; Hematulin et 
al.,2008; Lee et al.,2008; Lowes et al.,2008; Faurschou,2010; Kim et al.,2010; Lin et al.,2011; Mitra et 
al.,2012; Wan et al.,2013; Wang et al.,2013; Guo et al.,2014).   
 
There are different interaction partners for Nbn in the pathways. As the animals 
showed no change in Erk1/2 activation after Nbn deletion, it can be excluded as a 
partner in the psoriasis-like phenotype. Both c-Myc and the PI3K/Akt/mTOR pathways 
are possible ways of Nbn deletion to induce the psoriasis-like phenotype in the mice. 
Deletion of Nbn caused an activation of Stat3 which might result in c-Myc over-
activation that results in increased proliferation and disturbance of differentiation. The 
activation of S6 detected in the mice also is a known cause of increased proliferation. 
Here it is likely not a direct but an indirect effect of the Nbn deletion. Nbn deletion was 
before described to result in a decrease of Akt activation via mTORC2 (Wang et 
al.,2013). Therefore the slight activation of Akt seen in the mice is probably a 
consequence of an increase of Th17 cells and TNFα secretion. Such activation is also in 
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accordance with the activation role of Nbn for PI3K which is not taking place in the 
mice and also limits the activation of Akt (Chen et al.,2005; Chen et al.,2008).  
The psoriasis-like phenotype could also have another possible source. The absence 
of hair follicles and the resulting increase of basal keratinocyte population could cause 
the phenotype of the mice. The high amount of apoptosis and the increase in cell 
proliferation might trigger a small inflammatory response. Due to the lack of Nbn and 
its regulatory role in the network of proteins the mice were not protected against further 
consequences, e.g. DNA damages in the highly proliferating cells, and the psoriasis-like 
phenotype was caused.  
The findings from the inactivation of Nbn in the skin also point towards important 
consequences for the treatment of patients with psoriasis. The NBN level in some 
patients is decreased, as demonstrated by the analysis of GEO Profiles database, and a 
higher rate of non-melanoma skin cancers was detected after PUVA treatment 
(Pouplard et al.,2013). The combined inactivation of Nbn and p53 in the mice also 
resulted in precancerous lesions. In humans the correlation of NBN level and the 
development of skin cancers after PUVA should be evaluated. If DNA repair in 
psoriasis patients is indeed deficient, the role of UV irradiation and other mutagenic 
treatments should be reconsidered in this disease.  
Overall the importance of functional DNA damage signaling and repair in the skin 
was demonstrated.    
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